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ABSTRACT 
 
 
Cerebral parenchymal arterioles (PAs) play a critical role in assuring appropriate 
blood flow and perfusion pressure within the brain. PAs are unique in contrast to 
upstream pial arteries, as defined by their critical roles in neurovascular coupling, distinct 
sensitivities to vasoconstrictors, and enhanced myogenic responsiveness. Dysfunction of 
these blood vessels is implicated in numerous cardiovascular diseases. However, 
treatments are limited due to incomplete understanding of the fundamental control 
mechanisms at this level of the circulation. One of the key elements within most vascular 
networks, including the cerebral circulation, is the presence of myogenic tone, an 
intrinsic process whereby resistance arteries constrict and reduce their diameter in 
response to elevated arterial pressure. This process is centrally involved in the ability of 
the brain to maintain nearly constant blood flow over a broad range of systemic blood 
pressures. The overall goal of this dissertation was to investigate the unique mechanisms 
of myogenic tone regulation in the cerebral microcirculation. To reveal the contributions 
of various signaling factors in this process, measurements of diameter, intracellular Ca2+ 
concentration ([Ca2+]i), membrane potential and ion channel activity were performed. 
Initial work determined that two purinergic G protein-coupled receptors, P2Y4 and P2Y6 
receptors, play a unique role in mediating pressure-induced vasoconstriction of PAs in a 
ligand-independent manner. Moreover, a particular transient receptor potential (TRP) 
channel in the melastatin subfamily, i.e. TRPM4, was also identified as a mediator of PA 
myogenic responses. Notably, the observations that inhibiting TRPM4 channels 
substantially reduces P2Y receptor-mediated depolarization and vasoconstriction, and 
that P2Y receptor ligands markedly activate TRPM4 currents provide definitive evidence 
that this ion channel functions as an important link between mechano-sensitive P2Y 
receptor activation and the myogenic response in PAs. Next, the signaling cascades that 
mediate stretch-induced TRPM4 activation in PA myocytes were explored. Interestingly, 
these experiments determined that the RhoA/Rho kinase signaling pathway is involved in 
this mechanism by facilitating pressure-induced, P2Y receptor-mediated stimulation of 
TRPM4 channels, leading to subsequent smooth muscle depolarization, [Ca2+]i increase 
and contraction. Since Rho kinase is generally accepted as a “Ca2+-sensitization” 
mediator, the present, contrasting observations point to an underappreciated role of 
RhoA/Rho kinase signaling in the excitation-contraction mechanisms within the cerebral 
microcirculation. Overall, this dissertation provides evidence that myogenic regulation of 
cerebral PAs is mediated by mechano-sensitive P2Y receptors, which initiate the 
RhoA/Rho kinase signaling pathway, subsequent TRPM4 channel opening, and 
concomitant depolarization and contraction of arteriolar smooth muscle cells. Revealing 
the unique mechanochemical coupling mechanisms in the cerebral microcirculation may 
lead to development of innovative therapeutic strategies for prevention and treatment of 
microvascular pathologies in the brain. 
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CHAPTER 1: LITERATURE REVIEW 
 
Introduction 
While the regulation of vascular tone in cerebral pial arteries has been intensely 
investigated, mechanistic studies of the intracerebral vessels branching from the surface 
arteries, i.e. the cerebral parenchymal arterioles (PAs), are uncommon, despite the fact 
that the PAs have unique functional roles and properties. PAs contribute up to 40% of 
cerebrovascular resistance and play a key role in regulating local blood flow within the 
brain. By maintaining appropriate local perfusion pressure, PAs serve to protect 
downstream capillaries from the potential damaging effects of high intravascular 
pressure1. When these small arterioles branch from pial arteries to perfuse the cerebral 
cortex, they enter a unique environment where surrounding astrocytes and neurons 
modulate vascular diameter and blood flow through a process called neurovascular 
coupling2, 3. Compared to pial arteries, PAs display distinct sensitivities to 
vasoconstrictors, including Angiotensin II4, norepinephrine5, suggesting that PAs may 
have a unique receptor profile and cellular signaling pathways. The shift of intracellular 
Ca2+ events from Ca2+ sparks in pial arterial myocytes to Ca2+ waves in PA smooth 
muscle and concomitantly altered K+ channel activity6 further point to the existence of 
different mechanisms for vascular reactivity regulation in PAs. In addition, PA smooth 
muscle exhibits substantially enhanced myogenic depolarization and vasoconstriction7. It 
is therefore likely that some of the fundamental contractile mechanisms in PA smooth 
muscle are unique as well. Structurally, in contrast to the robust circulating networks 
created by pial vessels and capillaries, PA organization creates a bottleneck effect in the 
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cerebral circulation as they form a fragile, one-dimensional network with limited 
collateral blood supply. Dysfunction of the cerebral microcirculation is therefore not 
uncommon, and it is implicated in numerous cerebrovascular diseases, including cerebral 
small vessel diseases8, 9, subarachnoid hemorrhage10, ischemic stroke11, vascular 
dementia12 and hypertension13. A better understanding of vascular tone regulation in PAs 
may reveal potential therapeutic targets for treatment of cerebral microvascular diseases.     
As one of the essential processes that modulate vascular tone, myogenic reactivity 
represents the ability of small arteries and arterioles to constrict and reduce their diameter 
in response to increased intravascular pressure. Myogenic regulation ensures that blood 
flow remains relatively constant despite moment-to-moment fluctuations in arterial 
pressure. In the brain, myogenic control plays a key role in cerebral autoregulation. 
Mechanisms of myogenic tone development have been extensively studied and it is 
widely accepted that vascular smooth muscle cells respond to increased intraluminal 
pressure via membrane depolarization14, calcium entry through voltage-dependent 
calcium channels and vasoconstriction15. However, the signaling pathways accounting for 
the translation of mechanical stretch into membrane depolarization have not been fully 
elucidated.  
Prior research in our laboratory has demonstrated the contribution of G protein-
coupled receptors (GPCRs), specifically P2Y4 and P2Y6 purinergic receptors, to 
myogenic responsiveness of PAs. P2Y receptors in mesenteric arteries have been 
previously reported to mediate myogenic response in an autocrine/paracrine fashion 
whereby pyrimidines released from local sources by mechano-stimulation act on P2Y 
receptors in smooth muscle, leading to myogenic vasoconstriction16, 17. Interesting, these 
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receptors appear to be directly mechano-activated in cerebral microvasculature, leading 
to subsequent vascular smooth muscle contraction4, similar to a proposed role for 
angiotensin II receptors in pial arteries18. 
Another important finding from our laboratory indicates a critical role of transient 
receptor potential (TRP) channels, specifically TRPM4, in this pathway involving 
monovalent cation influx (mainly Na+) and membrane depolarization in the smooth 
muscle cells of cerebral pial arteries19. Further studies of this channel revealed that it is 
regulated by protein kinase C (PKC) and Ca2+ release from the sarcoplasmic reticulum20, 
21. However, neither the significance nor the regulation of TRPM4 channels has been 
investigated in the PAs.  
Emerging evidence points to the dynamic role of the RhoA/Rho-associated 
protein kinase (ROCK) pathway in regulating cerebrovascular function, including 
facilitating the myogenic response22-24. It is generally accepted that ROCK promotes 
contraction by inactivating myosin light chain phosphatase, i.e. via a “Ca2+ sensitization” 
mechanism. Nevertheless, recent findings have revealed that Rho signaling also regulates 
ion channel activity, including epithelial sodium channels25, inward rectifying potassium 
channels26, 27 and delayed rectifying potassium channels28, 29. Moreover, the observation 
that ROCK also participates in smooth muscle membrane depolarization in cerebral 
arterial smooth muscle28, 29 further supports the hypothesis that in addition to increasing 
Ca2+ sensitivity of the contractile apparatus, ROCK may also modulate the Ca2+-
dependent pathways.  
Following from these important findings, the major goals of this dissertation 
project are 1) to elucidate the contributions of TRPM4 channels to myogenic regulation 
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in cerebral PAs, 2) to explore the possible coupling between TRPM4 channels and P2Y 
receptor in mediating myogenic constriction of PAs, 3) to test the hypothesis that 
RhoA/ROCK signaling mediates pressure-induced activation of TRPM4 channels in the 
brain microcirculation, and 4) to decipher the mechanisms underlying TRPM4 channel 
activation by ROCK stimulation in PA smooth muscle cells. 
This literature review will provide an overview of regulation of cerebrovascular 
tone with a major emphasis on myogenic control. Part one will discuss the mechanisms 
and regulation of pressure-induced depolarization and vasoconstriction. Part two will 
focus on the key contributors to myogenic tone development in cerebral microvasculature 
with an emphasis on TRPM4 channels and Rho signaling.    
 
Part I: Cerebrovascular Physiology  
1.1 General Anatomy of the Cerebral Arterial Blood Supply 
The brain is highly perfused to ensure constant supply of oxygen and nutrients. In 
order to meet the demands of energy consumption, blood supply to the brain consists of 
two pairs of large arteries, the left and right internal carotid arteries, which are essential 
for blood supply to the cerebrum, and the left and right vertebral arteries, which join 
distally to form the basilar artery on the base of cerebellum2. Branches coming off the 
vertebral and basilar arteries are responsible for perfusing cerebellum and brain stem2. On 
the proximal side of the base of brain, a complete anastomotic ring of arteries is formed 
by the basilar artery joining with the left and right internal carotid arteries, which is 
known as the Circle of Willis. The unique structure of the Circle of Willis plays a 
fundamental role in providing collateral and redundant blood supply to the entire brain 
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surface. It is particularly important under pathological conditions; occlusion of a cerebral 
artery or arteriole can be quickly compensated by blood flow coming from other vessels 
to preserve adequate cerebral perfusion30.  
The Circle of Willis gives rise to three pairs of main pial arteries, the anterior 
cerebral arteries (ACAs), middle cerebral arteries (MCAs) and posterior cerebral arteries 
(PCAs). The ACAs extend upward and forward from the internal carotid artery on the 
Circle of Willis and supply the most midline portions of the frontal lobes and superior 
medial parietal lobes, the part of the brain that control logical thought, personality, and 
voluntary movement, especially the legs31. The MCAs supply a portion of the frontal lobe 
and the lateral surface of the temporal and parietal lobes, including the primary motor and 
sensory areas of the face, throat, hand and arm, and in the dominant hemisphere, the areas 
for speech31. These arteries have also been found to be the most often occluded vessels in 
stroke31. The PCAs originate from the basilar arteries for most individuals, but sometimes 
originate from the ipsilateral internal carotid artery. The PCAs supply the temporal and 
occipital lobes of the left and right cerebral hemisphere31. All these cerebral arteries are 
surrounded by cerebrospinal fluid (CSF), which occupies the subarachnoid space and the 
ventricle system, providing protection to the brain from basic mechanical insults2. 
Cerebral pial arteries give rise to smaller arteries that eventually penetrate into the 
cerebral cortex. These penetrating arterioles lie within the Virchow-Robin space, which is 
a continuation of the subarachnoid space, and become parenchymal arterioles (PAs) once 
they penetrate deeper into the brain cortex2. In contrast to the robust and anastomotic pial 
and capillary networks, PAs form a fragile, one-dimensional organization with limited 
collateral supply32. They create a bottleneck effect that makes the brain parenchyma 
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especially vulnerable to any insult that affects flow through PAs32. Therefore, it is not 
surprising to find that dysfunction of PAs is implicated in numerous cardiovascular 
diseases, including hypertension13, 33, subarachnoid hemorrhage10, ischemic stroke11, 
cerebral small vessel diseases9 and vascular dementia12.  
Fragile as they are, PAs have unique functional roles and properties in the 
cerebral circulation. Firstly, they contribute as much as 40% to total cerebrovascular 
resistance, thus regulating PA reactivity is a key process for adjusting blood perfusion 
within the brain1. Next, by maintaining appropriate perfusion pressure, PAs serve to 
protect downstream capillaries from the potential detrimental effects from high 
intraluminal pressure1. Thirdly, when penetrating into the cerebral cortex, PAs enter a 
unique cellular and molecular environment where they are completely encased by 
surrounding astrocytes and neurons that modulate local smooth muscle contractility and 
blood flow through a process called neurovascular coupling3. In other words, PAs are 
“intrinsically” innervated as compared to pial arteries that are under great influence of 
sympathetic and parasympathetic nerve activity, i.e. extrinsic innervation. Indeed, PAs 
are essentially unresponsive to several neurotransmitters, including norepinephrine and 
serotonin5. Additionally, that PAs respond differently to vasoconstrictors, like 
angiotensin II, suggests PAs may exhibit different receptor profile and subsequent 
intracellular signaling mechanisms4. Furthermore, Ca2+ signaling patterns in smooth 
muscle cells shift from Ca2+ sparks in pial arteries to Ca2+ waves in PAs, resulting in lack 
of contribution from large conductance Ca2+-activated K+ (BKCa) channels to membrane 
potential regulation under physiological conditions6. More importantly, PAs have 
considerably more depolarized membrane potentials and greater myogenic tone10, 23, 34. 
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This is physiologically crucial as it sets a contractile background in order for tight 
regulation of vascular tone, particularly by vasodilatory influences from neurons and 
endothelium.   
 
1.2 Cerebral Autoregulation and Myogenic Tone 
Cerebral autoregulation is a physiological process for resistance arteries in the 
brain to maintain adequate and stable blood flow. Though most systems in the body 
exhibit some degree of autoregulation, the brain is extremely sensitive to changes in 
blood flow. Either under- or overperfusion is potentially detrimental to brain functions. 
The autoregulatory control of blood flow ensures that adequate and relatively constant 
oxygen and nutrient supply is provided, and carbon dioxide and waste is disposed35. The 
reasons why the brain is particularly sensitive to changes in blood flow reside in both 
high level of metabolic activity and lack of fuel storage36, 37. Being the most perfused 
organ in the body, the brain receives up to 15% of the cardiac output, and consumes up to 
20% of oxygen and glucose, even though it represents about 2% of body weight38.  
Though not completely understood, it is widely accepted that a fundamental 
physiological process, such as cerebral autoregulation, is multifactorial and relies on 
numerous factors and signaling mechanisms. To date, both extrinsic (neuronal, hormonal) 
and intrinsic (myogenic, metabolic) mechanisms have been identified. Extrinsic 
innervation involving sympathetic and parasympathetic nerves plays an important role in 
regulating vascular tone. Neurotransmitters, like norepinephrine39, serotonin40 and 
nucleotides41, are released from nerve endings, interact with corresponding receptors on 
vascular smooth muscle and endothelium, and initiate primarily G protein-coupled 
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signaling pathways to modulate vascular contractility39. However, it was found that 
sympathetically and parasympathetically denervated animals still display cerebral 
autoregulation, suggesting that rather than playing an exclusive role, neurogenic factors 
serve only as one of the mechanisms underlying autoregulatory functions42. In addition to 
extrinsic innervation, cerebral penetrating arterioles are also influenced by intrinsic 
perivascular innervation (note this is different from the intrinsic mechanisms for cerebral 
autoregulation), whereby increased activity of surrounding neurons is coupled to 
arteriolar dilation. It is mediated by signaling pathways in the astrocytes, which 
completely encase parenchymal arterioles, i.e., neurovascular coupling3. Relaxation of 
downstream arterioles would further lead to dilation of upstream feed arteries to prevent a 
drop in intravascular pressure43. Therefore, neurovascular coupling is also involved in 
blood flow autoregulation. Furthermore, metabolic byproducts have been proposed to 
contribute to cerebral vascular tone regulation. For example, H+ and CO2, normally 
accumulated in underperfused tissue, induce vasodilation as a function to increase blood 
flow and perfusion6, 44.  
One fundamental mechanism responsible for autoregulation is myogenic control. 
This is a process by which resistance arteries constrict and reduce their diameter in 
response to increased intravascular pressure. It was first observed and described by 
Bayliss in 1902, hence the name Bayliss effect45. Ever since then, elucidating the 
mechanisms of myogenic response has been a sustained area of research in numerous 
laboratories. Though endothelium is significant for regulation of myogenic tone, this 
process is determined by the vascular smooth muscle contractile status based on the 
observation that the myogenic response is preserved or even enhanced in endothelium-
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denuded arteries42. Part of its mechanisms has been well established. Elevation in 
intraluminal pressure leads to membrane depolarization14 and Ca2+ entry through 
activated L-type voltage-dependent Ca2+ channels15. Increase in intracellular Ca2+ 
concentration leads to greater Ca2+-calmodulin interaction, and concomitant myosin light 
chain kinase activation. This kinase in turn phosphorylates and activates myosin light 
chain. Simultaneously, pressure-dependent, PKC or Rho kinase-mediated inhibition on 
myosin light chain phosphatase activity further augments myosin light chain activation, 
and promotes myosin-actin interaction, and thus vasoconstriction46. As implied by this 
mechanism, pressure-induced depolarization plays a central role. Nevertheless, the nature 
of the ion channels and intracellular signaling pathways that translate the mechanical 
force into a biological depolarizing responses remains an open question. The following 
section will focus on various ion channels, primarily K+ channels and TRP channels, 
which have been shown to be centrally involved in regulation of myogenic depolarization 
and vasoconstriction.   
 
1.3 Regulation of smooth muscle membrane potential 
Membrane potential is the difference in electric potential of the interior of plasma 
membrane in reference to the exterior of a biological cell. It is established by asymmetric 
concentration gradients of electrolytes maintained by cellular ion transporters and 
pumps47. The resting membrane potential of arterial smooth muscle is about -60 mV. In 
pressurized arteries, membrane potential can elevate to about -40 mV48. This 
depolarization subsequently increases intracellular Ca2+ concentration and initiates 
smooth muscle contraction15. The relationship between membrane potential and arterial 
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tone is very steep. Numerous studies have demonstrated that even membrane potential 
changes of a few millivolts cause significant changes in blood vessel diameter15, 49, 50. 
Therefore, membrane potential is a major determinant of vascular smooth muscle 
contractility.  
    The resting membrane potential is modeled by the Goldman-Hodgkin-Katz 
equation: 
𝐸𝑚 =  
𝑅𝑇
𝐹
𝑙𝑛(
𝑃𝐾[𝐾
+]𝑜𝑢𝑡 + 𝑃𝑁𝑎[𝑁𝑎
+]𝑜𝑢𝑡 + 𝑃𝐶𝑙[𝐶𝑙
−]𝑖𝑛
𝑃𝐾[𝐾+]𝑖𝑛 + 𝑃𝑁𝑎[𝑁𝑎+]𝑖𝑛 + 𝑃𝐶𝑙[𝐶𝑙−]𝑜𝑢𝑡
) 
Em = the membrane potential 
Pion = the permeability for that ion 
R = the ideal gas constant 
T = the temperature in degrees Kelvin 
F = Faraday’s constant 
It is clearly indicated by this equation that membrane potential is dictated not only 
by the concentrations of different ions inside and outside the cell, but also by the 
permeability of plasma membrane to each ion. Therefore, the activity of various ion 
channels and pumps plays a key role in modulating membrane potential. In this section, 
regulators of smooth muscle membrane potential in cerebral arteries will be discussed, 
including potassium channels, TRP channels, chloride channels and epithelial sodium 
channels.  
 
 
 11 
1.3.1 K+ channels 
 
Given that the intracellular and extracellular K+ concentrations of cerebrovascular 
smooth muscle cells are ≈ 140 mmol/L and 3 mmol/L, respectively, the equilibrium 
potential of K+ is ≈ -100 mV calculated with the Nernst Equation:  
𝐸𝐾 =
𝑅𝑇
𝐹
ln 
(𝐾+)𝑜𝑢𝑡
(𝐾+)𝑖𝑛
 
 EK = potassium equilibrium potential 
R = the ideal gas constant 
T = the temperature in degrees Kelvin 
F = Faraday’s constant 
The equilibrium potential is a voltage where net movement of K+ is zero since 
electrical gradient and concentration gradient are balanced. However, the Na+ reversal 
potential is ≈ + 89 mV (given that [Na+]out ≈ 140 mmol/L and [Na+]in ≈ 5 mmol/L). 
Though the membrane potential is considerably more depolarized than EK, it is still 
largely dominated by the K+ conductance due to high permeability to K+. An increase in 
permeability to K+ would potentiate K+ efflux and bring the membrane potential closer to 
EK, i.e. cause hyperpolarization; a decrease in K
+ conductance would cause 
depolarization. Therefore, potassium channels contribute essentially to regulating arterial 
smooth muscle membrane potential and arterial contractility. There are primarily four 
types of K+ channels present in vascular smooth muscle cells: Voltage-dependent K+ (Kv) 
channels, large-conductance Ca2+-activated K+ (BKCa) channels, inward rectifying K
+ 
(Kir) channels and ATP-sensitive K
+ (KATP) channels
49. This section briefly reviews the 
involvement of these channels in modulation of smooth muscle membrane potential.    
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Voltage-dependent K+ (Kv) channels. Several subtypes of Kv channels have been 
identified in arterial myocytes51. Among them, heteromultimeric Kv composed of Kv1.2 
and Kv1.5 have been shown to participate in control of vascular tone
52, 53. Plan et al. 
showed that Kv currents were attenuated by pharmacological inhibitors (4-AP and 
correolide), which enhanced myogenic constriction in rat mesenteric arteries, indicating 
that Kv channels are active during myogenic regulation
54. To further differentiate the 
relative contributions of these subtypes of Kv channels, Chen et al. utilized a dominant 
negative cDNA construct to suppress Kv1 channel activity in rat cerebral arteries
53. They 
found that myogenic tone was potentiated in arteries overexpressing a Kv1.5 dominant 
negative construct, whereas myogenic constriction was reduced in arteries overexpressing 
wild-type Kv1.5 channels, pointing to important involvement of Kv1.5 in regulating tone 
development53. Kv channels are steeply activated by membrane depolarization, resulting 
in K+ efflux and membrane hyperpolarization. Together with BKCa, these channels 
initiate an important feedback mechanism to counteract myogenic constriction and 
stabilize tone. In this regard, Kv channels can be highly significant for membrane 
potential regulation in the cerebral microcirculation, where BKCa channels are not 
functionally active under physiological conditions6. In addition to myogenic response, Kv 
channels are also involved in various vasodilator-induced membrane hyperpolarization, 
including responses to statins55, adenosine56, prostacyclin57, H2O2
58 and endothelial-
derived nitric oxide59. Furthermore, several vasoconstrictors depolarize smooth muscle 
by inhibiting Kv channels through either cAMP/PKC or RhoA/Rho kinase pathways
28, 60. 
For example, Luykenaar and colleagues have shown UTP inhibits 4-AP-sensitive Kv 
currents, which is rescued by Rho kinase inhibition, demonstrating that UTP activates 
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Rho kinase, which subsequently inhibits Kv and facilitates depolarization and 
constriction28.  
Large-conductance Ca2+-activated K+ (BKCa) channels. BKCa channels are 
activated by both elevation of intracellular Ca2+ and membrane depolarization61, 62. As 
both of these activating signals for BKCa channels result from myogenic stimulation, the 
critical role of BKCa channels in myogenic tone has been intensely investigated. 
Activation of BKCa channels increases K
+ efflux and hyperpolarizes plasma membrane. 
Hence blocking BKCa would cause membrane depolarization and constriction, which was 
demonstrated in various vascular beds. Brayden et al. showed that BKCa channel blockers 
tetraethylammonium ion (TEA+) and charybdotoxin depolarized and constricted 
pressurized rat cerebral arteries with myogenic tone50. In uterine arteries, chronic hypoxia 
inhibited upregulation of BKCa channels during pregnancy and suppressed BKCa channel 
current density63. Reduced BKCa channel expression resulting in enhanced myogenic 
constriction was observed in the uterine arteries in pregnant animals acclimatized to 
chronic hypoxia63.  This work illustrate that BKCa channels play a dynamic role in the 
control of arterial membrane potential by functioning as a negative feedback pathway to 
reduce membrane excitability regulated by pressure or even vasoactive agents62, 64, 65. 
BKCa channels are activated by high levels of intracellular Ca
2+, which come from Ca2+ 
release events of the ryanodine receptors (RyRs) in the sarcoplasmic reticulum, i.e. Ca2+ 
sparks66. Ca2+ spark sites are in close proximity to BKCa channels, and each spark can 
increase local [Ca2+] to 10~100 µmol/L and activate 20~100 BKCa channels in the plasma 
membrane66. This high level of interaction ensures that smooth muscle membrane 
potential is tightly controlled. Interestingly, this does not seem to be the case the in the 
 14 
cerebral penetrating arterioles under physiological conditions. Dabertrand et al. reported 
that in parenchymal arteriolar myocytes, Ca2+ spark activity is extremely low, resulting in 
very little BKCa channel contribution to vascular tone
6. BKCa channel blocker paxilline-
induced constrictions in parenchymal arterioles that were much smaller than those in 
cerebral pial arteries6. These observations imply that in PAs, the role of BKCa channels in 
negative feedback mechanisms that limit myogenic depolarization is largely replaced by 
Kv channels.  
ATP-sensitive K+ (KATP) channels. KATP channels are inhibited by intracellular 
ATP, hence the name ATP-sensitive channels. After they were initially identified in 
cardiac muscle67, they were later found in skeletal muscle, pancreatic β-cells, and smooth 
muscle62, 68.  KATP channel blockers (glibenclamide and tolbuamide) are well-
characterized antidiabetic drugs. By inhibiting KATP channels and K
+ efflux, 
glibenclamide causes β-cell membrane depolarization, Ca2+ entry and insulin release. 
Since this compound is relatively selective for KATP channels, it is widely used as a 
pharmacological tool to study the functional importance of KATP channels in other 
systems. However, recent evidence has shown that high concentrations of glibenclamide 
(100 µmol/L) also block TRPM4 channels69, since similar to KATP channels, TRPM4 
channels are also co-expressed with the sulfonylurea receptor 1, which is the target of 
glibenclamide70. In vascular smooth muscle, through mediating hyperpolarization, KATP 
channels participate in various physiological functions, primarily conducting vasodilator 
effects and regulating metabolic blood flow. Several vasodilators have been shown to 
induce glibenclamide-sensitive arterial hyperpolarization and dilation, including 
calcitonin gene-related peptide (CGRP)71, 72, adenosine73, prostacyclin74, 75, vasoactive 
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intestinal peptide76, nitric oxide77, pituitary adenylate cyclase activating polypeptide 
(PACAP)78, etc. Moreover, KATP channels have been reported to mediate metabolic 
regulation of vascular reactivity. Hypoxia causes vasodilation and increases blood flow in 
many vascular beds, presumably as a means to elevate blood supply to the hypoxic 
regions49. It has been observed in various vascular beds (cerebral arteries79, coronary 
arteries80 and renal arteries81) that hypoxia-induced vasodilation can be inhibited by 
glibenclamide, illustrating an essential involvement of KATP channels in this mechanism.  
More definitive evidence was also reported that hypoxia activates KATP currents in 
isolated myocytes from porcine coronary arteries82. Additionally, like other potassium 
channels, a potential role of KATP channels in myogenic regulation has been studied. 
Interestingly, this channel seems to play diverse roles in various vascular beds. For 
instance, in coronary83, 84 and mesenteric arteries77, application of glibenclamide 
effectively decreases basal blood flow in vivo, and depolarizes and constricts the arteries 
in vitro, whereas in cerebral85, 86 and renal arteries81, glibenclamide has little effect on 
vascular contractility under physiological conditions. However, during hypoxia, 
glibenclamide is able to restore myogenic vasoconstriction81, indicating that KATP channel 
activity is differentially regulated based on different tissue type and cellular environment. 
Inward rectifying K+ (Kir) channels. Kir or inward rectifying were named based on 
the observation that when membrane potential is controlled, inward currents through 
these K+ channels (K+ influx) are larger than the outward currents (K+ efflux). In addition, 
Kir channels are activated by membrane hyperpolarization, as opposed to Kv and BKCa 
that are stimulated by membrane depolarization49. Therefore, when membrane potential is 
negative to EK, Kir channels readily conduct K
+ ions flowing into cells. However, in 
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vascular smooth muscle cells, resting membrane potential (-60 ~ -40 mV) is always 
positive to EK (≈ -85 mV); Kir channels therefore normally conduct small outward 
hyperpolarizing currents49. In cerebral arteries, both Kir channel mRNA transcripts and 
Kir currents were identified in arterial smooth muscle cells
87, suggesting Kir channels may 
play a role in regulation of cerebral arterial tone. The activity of Kir channels is regulated 
by both membrane potential and the extracellular K+ concentration88, 89. Quayle et al. 
discovered that elevation in external [K+] would significantly shift the zero current 
potential to more positive potentials, and increase the inward currents at membrane 
potentials negative to the new EK, while the outward currents remained small
89. 
Interestingly, elevating external K+ from 5 mmol/L to 10 mmol/L causes significant 
membrane hyperpolarization and vasodilation in pressurized arteries90. These effects 
could be prevented by < 10 µmol/L Ba2+, indicative of an essential role of Kir channels in 
K+-induced dilation in coronary arteries, and cerebral pial and parenchymal arteries9, 90. 
The mechanism of this K+-induced dilation is that when external [K+] is increased from 5 
to 10 mmol/L, EK shifts from -79.5 to -66.3 mV. The membrane potential of pressurized 
arteries is still positive to EK (around -50 ~ -40 mV). Due to the N-shaped current-voltage 
relationship of Kir channels, an increase in external [K
+] shifts the N-shaped curve to the 
right. So over a certain range of membrane potential, the outward currents through Kir 
channels increase and hence the membrane hyperpolarizes49. In contrast to Kv and BKCa 
channels, this K+-dependent feature of Kir channels accounts largely for its critical 
importance in mediating K+-induced hyperpolarization and dilation. For instance, 
increase in neuronal activity can dilate local parenchymal arterioles through activation of 
BKCa channels on astrocytes, release of K
+, and activation of vascular smooth muscle Kir 
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channels3. Another very important example of K+-induced dilation comes from 
endothelium-derived hyperpolarizing factor (EDHF). Edwards et al. have shown that K+ 
release from endothelial cells through intermediate and small conductance Ca2+-activated 
K+ (IKCa and SKCa) channels hyperpolarizes and relaxes adjacent myocytes by activating 
Ba2+-sensitive Kir channels
91. These studies indicate that Kir channels play a pivotal role 
in integrating the interactions between smooth muscle and the surrounding environment.  
1.3.2 TRP channels 
 
As previously mentioned, the equilibrium potential for K+ in cerebral myocytes is 
≈ -100 mV, whereas the resting membrane potential is always positive to EK in the range 
of -60 ~ -40 mV. This indicates that there is considerable number of depolarizing ion 
channels on the plasma membrane that conduct Na+ and Ca2+ influx, whereby membrane 
potential is brought more positive compared to EK. The prime examples are transient 
receptor potential (TRP) channels, which are non-selective cation channels that are 
permeable to Na+ and Ca2+, and participate in regulation of membrane potential and 
intracellular [Ca2+] in the smooth muscle of different vascular beds47. Many TRP 
channels have been revealed to be functionally important in vascular smooth muscle, 
with their contributions ranging from mechano-sensing, GPCR-associated signaling 
pathways to cell proliferation and migration. The following section will briefly discuss 
the TRP channels that are implicated in the depolarization-contraction mechanism of 
smooth muscle cells. 
TRPM4. TRPM4 channels are monovalent-selective cation channels that conduct 
only to Na+, K+, Li+ and other monovalents, but are impermeable to divalent cations, 
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including Ca2+ and Mg2+ 92. TRPM4 mRNA transcripts and currents are detected in the 
cerebral artery and arterioles19, 34.  Contributions of TRPM4 channels to the coupling 
between membrane stretch and myogenic depolarization of arterial smooth muscle were 
first reported by Earley et al. in cerebral arteries. It was observed that arteries treated with 
TRPM4 antisense oligodeoxynucleotides (ODNs) were significantly less depolarized 
compared to sense-treated vessels when they were subject to same level of intravascular 
pressures (80 mmHg)19. Later, along with the discovery and widespread use of a 
relatively selective TRPM4 blocker 9-phenanthrol, this channel was further confirmed to 
participate in pressure-induced membrane depolarization as 9-phenanthrol (30 µmol/L) 
effectively hyperpolarized pressurized arteries from -40 mV to -73 mV93. Although it was 
later revealed that part of this significant hyperpolarizing effect comes from activation of 
endothelial K+ channels94, the contribution of TRPM4 to the depolarizing mechanism is 
still prominent. In accord with this notion, we found that in the penetrating arterioles 
within the brain, 9-phenanthrol (10 µmol/L) significantly hyperpolarized the smooth 
muscle of either pressurized arterioles (endothelium-denuded) or arteries exposed to 
purinergic stimulation34, demonstrating that TRPM4 is responsible for mediating 
mechano-activated and GPCR-mediated membrane depolarization. Moreover, a similar 
depolarizing mechanism involving TRPM4 has also been strongly suggested in urinary 
bladder smooth muscle, where 9-phenanthrol attenuated both spontaneous inward 
TRPM4 currents, intracellular Ca2+ levels, and decreased spontaneous as well as nerve-
evoked contractions in the rat detrusor smooth muscle95. Though membrane potential was 
not measured directly in this study, TRPM4-mediated depolarization appears to be an 
important step in the mechanism of detrusor smooth muscle excitability and contractility. 
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Because TRPM4 is the focal point of this thesis work, a much more detailed elaboration 
of TRPM4 channels regarding their roles in myogenic regulation as well as other 
physiological processes will be provided later in this chapter.  
TRPC6 channels. TRPC6 expression has also been detected in native arterial 
myocytes from portal veins96, mesenteric arteries97 and cerebral arteries98. TRPC6 
conducts both Na+ and Ca2+ with a higher permeability to Na+. It is rather well-
established that TRPC6 channels are stimulated by the phospholipase C (PLC)-
diacylglycerol (DAG) pathway but they are PKC independent, suggesting they are 
activated by PLC pathway-associated receptors, i.e. Gq-coupled receptors
99. 
Demonstration of the coupling between TRPC6 and Gq-coupled receptors in native 
vascular smooth muscle was first reported by Inoue et al.100. They found high levels of 
TRPC6 mRNA expression in both murine and rabbit portal vein smooth muscle. 
Moreover, downregulation of the channel with antisense ODNs not only abolished the 
expression of TRPC6 protein, but also largely decreased α-adrenoceptor-mediated Ca2+ 
entry through TRPC6. Later, more TRPC6-coupled GPCRs were revealed in vascular 
myocytes. For example, in A7r5 aortic smooth muscle-derived cells, nonselective cation 
channels with TRPC6 chanel biophysical properties and pharmacological profile were 
identified101. TRPC6 siRNA substantially reduced vasopressin-induced Ca2+ currents, 
whereas it had no effect on Thapsigargin-induced store-operated Ca2+ entry101.  In freshly 
isolated rabbit mesenteric myocytes, angiotensin II (Ang II) activated nonselective cation 
currents that were sensitive to TRPC6 antibodies, and were activated by the PLC-DAG 
pathway in a PKC-independent manner97, strongly indicating these were TRPC6 currents. 
In addition to its role in receptor-mediated responses, TRPC6 has also been shown to 
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facilitate myogenic depolarization and contraction. Welsh et al. reported that antisense 
ODNs targeted against TRPC6 channels selectively reduced TRPC6 mRNA expression 
and effectively decreased TRPC6 whole-cell currents. Functionally, it did not affect 
membrane potential at low intravascular pressure, but significantly hyperpolarized 
cerebral arteries when vessels were pressurized to 80 mmHg. Consequently, TRPC6 
antisense also inhibited myogenic tone at 60-100 mmHg98, indicating an essential 
contribution of this channel to the regulation of membrane potential and vascular 
myogenic tone.  
However, the exact mechanism by which TRPC6 channels are activated by an 
increase in intravascular pressure is still a matter of controversy. TRPC6 channels can be 
activated by cell swelling or suction on the membrane, but whether the channel is directly 
mechanosensitive remains unclear. To investigate the mechanosensitivity of TRPC6, 
Mederos y Schnitzler et al. used HEK293 cells overexpressing the channel. They found 
that pressure application on the inside-out patch failed to activate currents. As a control 
experiment, TRPC6 channel activity was markedly enhanced by subsequent 
administration of DAG analogue18.  On the other hand, Gonzales et al. utilized on-cell 
patch clamp configuration to show that the open probability of TRPC6 channels was 
substantially augmented by application of negative pressures on the membrane of HEK 
cells expressing TRPC6 channels, suggesting the channel can be directly activated by 
mechanical stretch102. This controversy may result from the different patch configurations 
used in the studies. It is possible that on-cell patch configuration maintains cell integrity 
and allows for stimulation of the channel by cellular factors, which are however dialyzed 
by membrane excision that occurs with inside-out patch configuration. This implies that 
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TRPC6 might not be directly activated pressure, but rather that it is stimulated by 
upstream stretch-activated signaling pathways. In agreement with this proposal, 
observations shown by Gottlieb and colleagues regarding the mechanosensitivity of 
TRPC6 failed to confirm a significant role for this channel as a stretch-activated protein. 
They found that transient expression of TRPC6 in green monkey kidney (COS) or 
Chinese hamster ovary (CHO) cells did not alter the amplitude of stretch-activated 
currents as compared with mock-transfected cells, yet intracellular administration of 
OAG (DAG analogue) consistently increased channel activity in TRPC6-transfected 
cells103. Unfortunately, at this point, more detailed molecular and biophysical 
investigation is required to elucidate the mechanosensitivity of this TRP channel.  
Whether or not this channel is directly activated by membrane stretch does not 
downgrade its functional significance in mediating myogenic depolarization and 
constriction. Mederos y Schnitzler et al. found that GPCRs are mechanosensors that are 
activated by membrane stretch in an agonist-independent manner, and subsequently 
initiate PLC-mediated TRPC6 activation18. Since both TRPC6 and TRPM4 channels 
seem to participate in the same myogenic excitation-contraction mechanism, the coupling 
between these two proteins and their relationship with upstream GPCRs and PLC were 
systemically investigated by Gonzales et al.  They demonstrated that Ca2+ entry through 
TRPC6 channels either by PLC-γ1-dependent GPCR stimulation or direct mechanical 
signal reinforces IP3 receptor-mediated Ca
2+ release from the SR, which then activates 
nearby TRPM4 channels, with subsequent depolarization, Ca2+ influx through VDCCs 
and vasoconstriction102. Surprisingly, TRPC6 knockout mice exhibited enhanced 
membrane depolarization and vasoconstriction from either agonists or increased 
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pressure104, which may be explained by a compensatory upregulation of constitutively 
active TRPC3 channels105.  
TRPP1 and TRPP2. The TRPP subfamily consists of TRPP1 (PKD2), TRPP2 
(PKD1) and TRPP3 (PKD2L2). TRPP1 is a Ca2+-permeable, non-selective cation channel 
with a quite large unitary conductance (135~175 pS). TRPP2 is structurally distinct from 
other TRPP proteins and does not form an ion channel. Both TRPPs are expressed in 
vascular smooth muscle cells106, 107 and contribute to pressure sensing as well as 
myogenic reactivity. The coupling between intraluminal pressure and TRPP proteins in 
vascular smooth muscle was first established by Sharif-Naeini et al.107. They found that 
knocking down TRPP1 channel caused a substantial decrease in stretch-activated cation 
(SAC) channel activity. Moreover, downregulation of TRPP1 markedly decreased 
myogenic tone developed by isolated mouse mesenteric arteries, but did not influence 
KCl or phenylephrine-induced vasoconstriction, indicating the essential contribution of 
TRPP1 in pressure-initiated tone. Interestingly, TRPP2 transcript knockdown resulted in 
increased SAC activity in smooth muscle cells from TRPP1 knockdown animals, and 
also restored myogenic vasoconstriction of mesenteric arteries. These observations 
demonstrate that it is the TRPP1/TRPP2 ratio that regulates the activity of native SACs in 
vascular smooth muscle cells and myogenic response of mesenteric arteries; TRPP2 
inhibits SAC mechanosensitivity while TRPP1 reverses this inhibition107. However, 
whether the TRPP1/TRPP2 ratio also modulates myogenic depolarization was not 
explored by this study. To the contrary, studies of TRPP channels in cerebral arteries 
reveal a substantially different mechanism, providing compelling evidence that cerebral 
and peripheral circulation may comprise different pressure-sensing factors and be 
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differentially regulated. Specifically, Narayanan et al. reported that in cerebral arteries 
from rats and humans, TRPP2 is the major TRPP isoform expressed106. Suppressing 
TRPP2 with a selective shRNA strongly decreased cell swelling-activated cation currents. 
Moreover, TRPP2 shRNA also decreased pressure-induced but not depolarization (KCl)-
induced vasoconstriction of cerebral arteries, suggesting that TRPP2 is an important 
player in myogenic regulation of cerebral vascular tone106, potentially via membrane 
depolarizing mechanisms, in contrast to its inhibitory role in the mesenteric arteries. The 
reasons for these apparently distinct physiological functions of TRPP2 protein in 
mesenteric and cerebral arteries are unclear, and require further interrogation.  
1.3.3 Cl- channels 
 
Cl- channels also contribute to regulation of vascular smooth muscle membrane 
potential. Cl- channels have relatively high conductance with an equilibrium potential of -
30 to -20 mV49, 108, therefore like TRP channels, they contribute to bringing membrane 
potential to more positive values than EK. Therefore, it was postulated that activation of 
Cl- channels facilitates pressure-induced membrane depolarization. In support of this 
proposal, Nelson et al. found that pharmacological chloride channel blockers significantly 
hyperpolarized and dilated pressurized cerebral arteries, whereas a blocker of Ca2+-
activated Cl- channels had no effect on arterial contractility109. The observation that 
reducing extracellular Cl- concentration from 140 mmol/L to 60 mmol/L significantly 
enhanced pressure-induced vasoconstriction strongly points to the role of Cl- channels in 
myogenic regulation109. Consistent with this study, Doughty et al. reported that myogenic 
tone development of rat cerebral arteries coincided with a pressure- and temperature-
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dependent Cl- efflux, which is sensitive to Cl- channel blocker, corroborating the 
contribution of outward Cl- currents to smooth muscle depolarization associated with 
myogenic contraction110. However, controversy exists in terms of the involvement of 
Ca2+-activated Cl- channels in myogenic tone development. It was recently argued by 
Bulley et al. that TMEM16A channels, Ca2+-activated Cl- channels identified in cerebral 
vascular smooth muscle cells, are one component of the mechanosensitive mechanisms 
that mediate myogenic vasoconstriction111. These authors provided convincing evidence 
that TMEM16A channels in arterial myocytes were activated by cell swelling. Knocking 
down the channels in arterial smooth muscle with selective siRNA, reduced pressure-
induced depolarization and vasoconstriction, but not KCl-induced responses, indicating 
the Ca2+-activated Cl- channels are implicated in the myogenic excitation-contraction 
mechanisms111.  
1.3.4 Epithelial Na+ channels (ENaC) 
 
Lately, new players in the myogenic depolarizing mechanism have been identified. 
A prime example is ENaC.  ENaC channels have a well-established role in Na+ 
reabsorption in the distal tubules in kidneys112. Recent studies by Jernigan and 
Drummond focused on the mechanosensitivity of ENaC and its potential role in 
myogenic responses of isolated intrarenal arteries. This study showed that ENaC 
inhibition with amiloride and benzamil abolished pressure-induced constriction and 
increases in cytosolic Ca2+ as well as Na+ of renal arteries113. This poses an important 
physiological function of ENaC on renal blood flow regulation. In support of this notion, 
mice with reduced levels of βENaC expression exhibited reduced myogenic tone in renal 
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afferent arterioles, reduced myogenic regulation of in vivo renal blood flow and elevated 
blood pressure114. Similar observations were obtained by Kim et al., who also presented 
evidence that cerebral arterial myogenic constriction and cytosolic [Ca2+] increases were 
inhibited by amiloride and benzamil115. Moreover, they found that siRNA specifically 
targeted against βENaC and γENaC significantly reduced the ability of isolated arteries to 
develop myogenic tone, presumably through inhibition of ENaC-mediated Na+ and/or 
Ca2+ influx and reduced membrane depolarization115. Further investigation into the 
mechanosensitivity of ENaC by the same group revealed that ENaC and TRPM4, but not 
ENaC and TRPC6, appeared to be clustered in similar subcellular locations in cerebral 
arterial myocytes116. Further, co-treatment of ENaC and TRPM4 inhibitors did not have 
additional inhibitory effects on myogenic tone compared to individual treatment with 
either inhibitor, suggesting there might be an interaction between ENaC and TRPM4 
channels116. However, this study is limited only to functional studies of isolated vessels.  
In order to corroborate the interactions between these channels, extensive 
eletrophysiological studies are required to investigate their relationship. For example, to 
test the coupling between ENaC and TRPM4 (or ENaC and TRPC6), TRPM4 and/or 
TRPC6 channel activity ought to be compared before and after application of an ENaC 
blocker. In addition, the effects of ENaC siRNA on TRPM4/TRPC6 activity should also 
be investigated. Proper control experiments, particularly concerning the potential direct 
inhibitory effect of ENaC blocker on TRPM4/TRPC6 channel activity, should be 
conducted early on.  
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1.4 Transient Receptor Potential Channels and Vascular Function 
Transient receptor potential (TRP) channels were initially discovered in 
Drosophila in 1969117. Since then, a large number of studies have been dedicated to the 
identification, characterization and cellular functions of these ion channels. Currently, 
twenty-eight TRP channels have been described. They are widely distributed to numerous 
animal cell types, mediating diverse sensations, including pressure, osmolarity, 
temperature, pain, taste, etc., and facilitating intracellular signal transduction.  Notably, 
numerous TRP channels have also been found in the heart and various vascular beds, 
contributing essentially to diverse aspects of cardiovascular functions as well as 
pathophysiology, including regulation of vascular tone, angiogenesis, pace-making, 
cardiac conduction, cardiac and vascular hypertrophy and hypertension.  
According to amino acid sequence homology, the twenty-eight TRP channels are 
grouped into six subfamilies: canonical (TRPC), vanilloid (TRPV), melastatin (TRPM), 
ankyrin (TRPA), mucolipin (TRPML) and polycystin (TRPP)47. All TRP channels are 
polypeptides with 553-2022 amino acids containing six transmembrane domains and 
intracellular NH2 and COOH termini. A TRP domain, a conserved sequence with about 
25 amino acids, was identified in TRPC, TRPM and TRPV subfamilies118. This sequence 
is located immediately C-terminal to the 6th transmembrane domain and contains a highly 
conserved 6-amino acid TRP box118. Though still not fully understood, in several TRP 
channels, the TRP box region is involved in phosphatidylinositol 4,5-bisphosphate (PIP2) 
binding and interactions119. Additionally, transcriptional splice variants exist for almost 
all TRP subunits, some of which showed very different functional properties120. One TRP 
channel is formed from the assembly of four subunits. The 5th and 6th transmembane 
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domains form the pore region to conduct cations. Both homomeric and heteromultimeric 
TRP channels were reported in native tissue. However, the heteromeric channels exhibit 
distinct conductance properties compared to homomeric subunits47, leaving 
characterization of channel properties much more complicated. 
TRP channels are also referred to as “non-selective cation channels”, however, 
that is imprecise since different TRP channels show distinct permeability to monovalent 
and divalent cations. For example, TRPM4 and TRPM5 channels in the melastatin 
subfamily are selective for monovalent cations (Na+, K+, Li+, etc.), and are essentially 
impermeable to divalent cations (Ca2+ and Mg2+)92, 121, 122.  By contrast, TRPV5 and 
TRPV6 channels are highly selective for Ca2+，with a relative Ca2+ to Na+ permeability 
ratio of ~100:1123, 124. These are rather extreme examples of cation selectivities. Other 
TRP channels, though permeable to both types of cations, display varying degrees of 
ionic preference. Some of them are essentially nonselective, like TRPC1125, whereas 
some are more permeant to Ca2+, like TRPV3126, which has a Ca2+ to Na+ permeability 
ratio of ~12:1. TRPM6 and TRPM7 are preferentially selective for Mg2+127.  
1.4.1 TRP channels in vascular smooth muscle  
 
A number of TRP channels have been found in vascular smooth muscle cells, 
contributing to various aspects of smooth muscle function, including modulation of 
vascular contractility and smooth muscle proliferation. Specifically, TRPM419, 34, 
TRPC698 and TRPP2106, 107 are involved in pressure-induced vasoconstriction through 
direct or indirect regulation of smooth muscle membrane potential and intracellular 
[Ca2+]. Moreover, TRPC3, TRPC6 and TRPM4 channels are implicated in G protein-
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coupled receptor (GPCR)-initiated contractile responses in cerebral arteries128, carotid 
arteries129, mesenteric arteries130. For instance, in brain pial arteries, TRPC3 antisense 
oligodeoxynucleotides significantly reduced inward currents, smooth muscle 
depolarization and vasoconstriction by purinergic receptor agonist UTP128. This finding is 
supported by another study demonstrating that ET-1-induced Ca2+ entry and cerebral 
arterial constriction was largely attenuated following suppression of TRPC3 channel 
expression131. TRPC6 channels are coupled to Ang II receptors18, whereas TRPM4 
channels are associated with P2Y receptor activity34. Both mechanisms are centrally 
involved in mediating myogenic response34, 102. Furthermore, TRPC1, TRPC4 and 
TRPC5 channels are proposed to participate in store-operated Ca2+ entry (SOCE), which 
is defined as Ca2+ influx occurs in response to depletion of intracellular Ca2+ stores. Via 
modulating intracellular Ca2+ levels, SOCE is a significant physiological process for 
excitation-contraction as well as cellular differentiation and proliferation47. Contribution 
of TRPC1, TRPC4 and TRPC5 to SOCE activity has been investigated both in the 
expression system132 and in native myocytes133-135. TRPC1 channels as an example, they 
were reported to mediate SOCE through interaction with STIM1 and Orai1 in mouse 
pulmonary artery smooth muscle cells134, 135.  However, conflicting evidence exists as 
smooth muscle cells of TRPC1 knockout mice isolated from thoracic aortas and cerebral 
arteries showed no significant change in SOCE activity compared to wildtype, suggesting 
TRPC1 is not an obligatory component in the SOCE mechanism136. Several TRP 
channels, TRPV4 and TRPA1 channels in particular, are responsible for mediating 
smooth muscle-dependent vasodilation. It was illustrated by Earley et al. that Ca2+-influx 
through TRPV4 stimulated directly by 11, 12-EET or through Ang II-initiated PLC-PKC 
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pathway leads to potentiation of Ryanodine receptor-mediated Ca2+ sparks and 
subsequent activation of large conductance Ca2+-activated K+ channels, resulting in K+ 
efflux, hyperpolarization and vasodilation137.  
In addition to the excitation-contraction response, alteration of cytosolic Ca2+ 
level mediated by TRP channels also stimulates other cellular processes in smooth 
muscle. For instance, elevated Ca2+ stimulates a number of proteins that are associated 
with cell cycle regulation and transcription factors, resulting in smooth muscle 
proliferation. In proliferating human pulmonary artery smooth muscle cells, TRPC1 and 
TRPC6 channel expression is upregulated138, and inhibition of either gene expression 
with antisense technique attenuates proliferation139, 140, suggesting the involvement of 
TRPC channels in pulmonary artery hypertrophy. Recent evidence reveals a novel role of 
TRPM7 in mediating aortic smooth muscle proliferation141.  
1.4.2 TRP channels in endothelium 
 
Endothelium-associated vascular relaxation relies on the release of nitric oxide, 
prostacyclin and endothelium-derived hyperpolarizing factors (EDHF), all of which are 
dependent on the level of endothelial Ca2+. As the majority of TRP channels play a 
pivotal role in conducting Ca2+ influx, their contributions to endothelial activation have 
been intensely studied. To date, TRPV1, TRPV3, TRPV4, TRPA1, TRPC3 and TRPC4 
channels have been reported to be involved in endothelium-derived vasodilation142-147. As 
a prime example, endothelial TRPV4 channels have been found to facilitate muscarinic146, 
147 and purinergic148 agonist-induced as well as flow149-151-evoked dilation. A study from 
Sonkusare et al. further revealed the cooperative gating of the channel to conduct Ca2+ 
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influx (Ca2+ sparklets), which stimulates small and intermediate conductance Ca2+-
activated K+ (SKCa and IKCa) channels
147. K+ efflux from endothelial cells causes 
hyperpolarization in smooth muscle by activating Kir channels, with concomitant 
vasodilation. Other endothelial TRP channel-associated dilatory mechanisms include 
TRPV1-mediated eNOS activation and elevated NO production observed in mesenteric 
arteries152, renal arteries153, 154 and coronary arteries155, muscarinic GPCR agonist-
induced and TRPC3-mediated IKCa, SKCa activation in mesenteric arteries
144, 156, and 
reactive oxygen species-triggered TRPA1-mediated IKCa channel opening in cerebral 
arterial endothelial cells157.  
Apart from regulation of vascular tone, the endothelium also serves as barrier that 
controls the passage of ions, water and macromolecules between blood and the 
interstitium158. The degree of vascular permeability varies in response to various stimuli 
under physiological and pathological conditions. Several TRP channels have been shown 
to dynamically influence endothelial permeability, including TRPC1, TRPC4, TRPC5 
and TRPV4 channels. Among these proteins, convincing evidence has been provided by 
several studies that TRPV4 channel is critically involved in regulation of pulmonary 
vascular permeability based on the observations that microvascular permeability can be 
markedly increased by TRPV4 agonists and attenuated by TRPV4 antagonists159.  
Angiogenesis is a process of new blood vessel growth under physiological 
circumstances of tissue damage and embryonic development, as well as pathological 
conditions like diabetes and cancer160. Angiogenesis is then followed by endothelial cell 
proliferation and migration to generate new capillary tubes. Several studies have reported 
the participation of TRP channels in angiogenic mechanisms, consisting TRPC1, TRPC3, 
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TRPC4, TRPC5, TRPC6 and TRPV4 channels47. Each of these TRP channels has been 
shown to mediate growth factor-evoked endothelial Ca2+ modulation and subsequent 
signaling mechanisms. Zadeh and coworkers reported that expressing a dominant-
negative construct of TRPC6 substantially inhibited vascular endothelial growth factor 
(VEGF)-induced cytosolic Ca2+ increase, proliferation, spouting and migration161. 
Moreover, activation of VEGF receptors has been shown increase endothelial TRPC6 
channel currents in expression systems162. Unfortunately, these observations are not 
supported by genetic techniques, as neither TRPC6 gain-of-function in humans163 nor 
gene deletion in mice104 showed abnormal blood vessel structure or capillary growth.  
 
Part II: Myogenic Tone Development 
1.5 TRPM4 Channels in Myogenic Response 
The melastatin (M) transient receptor potential (TRP) channel TRPM4 is a non-
selective cation channel that is activated by intracellular Ca2+. It was first described in 
cultured cardiac myocytes, and was later discovered in multiple tissue types, including 
cardiac muscle, neurons and vascular smooth muscle. It regulates a variety of 
physiological and pathological processes that involve TRPM4-induced sodium entry, 
membrane depolarization and modulation of intracellular Ca2+. In this section, the 
molecular and functional characterization of TRPM4 channels will be summarized with a 
particular focus on their roles in cerebral arterial smooth muscle.  
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1.5.1 TRPM4 structure 
 
The TRPM4 gene is located on human chromosome 19, and in mouse on 
chromosome 7. It comprises 25 exons, spanning 54 kb in the human genome and 31 kb in 
the mouse genome164. All TRP channels are expressed as six-transmembrane domain (S1-
S6) subunits with a pore-forming region between the S5 and S6 domains. Four of these 
subunits assemble to form a functional ion channel. Heteromultimeric channels 
composed of two or three different subunits can form and these channels have properties 
quite different from homomeric channels. Formation of heteromultimeric channels has 
been characterized for TRPC channels, TRPM6/TRPM7, and TRPV5/V6 channels164. 
However, to date, heteromultimers of TRPM4 and other TRP membrane have not been 
reported. Within the TRPM subfamily, TRPM4 is very closely related to TRPM5 in 
terms of structure since they share approximately 50% homology165. Several important 
protein domains have been identified in the TRPM4b protein sequence. The cytoplasmic 
N- and C- termini contain a number of potential protein-protein binding sites: The C-
terminus contains coiled-coil domains, and both N- and C-termini contain calmodulin-
binding sites164. Other potentially significant sites were also reported in the TRPM4 
sequence, including phosphorylation sites for protein kinases (PKA and PKC)164, four 
Walker B motifs164, a phosphatidylinositol bisphosphate (PIP2) binding site
166, and at 
least two functionally different divalent cation-binding sites that determines the Ca2+ 
sensitivity of the channel167.  
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1.5.2 TRPM4 biophysical properties and regulation 
 
A short form splice variant of TRPM4 (TRP-MLSN-4 or TRPM4a) was first 
cloned and characterized by Xu et al.168. With techniques including fura-2 Ca2+ imaging 
and immunofluorescence, it was claimed that expressed TRPM4a in HEK293 cells was 
localized very close to the plasma membrane and function as a divalent cation channel 
with a specificity for ions of Ca2+ ≥ Ba2+ ≥ Sr2+ 168. This finding was, however, not 
followed by any electrophysiological characterization, and was not able to be reproduced 
by other groups. Later, a second, longer (containing additional 174 amino acids N-
terminal) splice variant was reported by Launay et al., and was then designated as 
TRPM4b169. It was then suggested by Launay and colleagues that TRPM4a has a very 
similar length to a truncated form of TRPM4b (ΔN-TRPM4) with the first 177 amino 
acids in the N-terminus deleted, and could therefore act as a native dominant negative 
subunit170.  Hence, TRPM4b is now generally accepted to be the commonly expressed 
and functional isoform of the channel, and will be referred to in the future context simply 
as TRPM4.   
To study the single-channel properties of TRPM4, several laboratories utilized 
inside-out configuration of patch clamp technique on HEK293 cells overexpressing 
TRPM4 or on native smooth muscle cells19, 121, 169. The unitary conductance of TRPM4 is 
~25pS. TRPM4 and closely related channel TRPM5 display two defining biophysical 
properties: Ca2+-dependent activation and specific selectivity for monovalent cations169. 
The cation selectivity of TRPM4 was assessed with equimolar substitution of 
intracellular Na+ with other permeant cations. The relative permeability to sequence was 
found to be Na+ ≈ K+ > Cs+ > Li+. The study also confirmed that TRPM4 is virtually 
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impermeable to Ca2+ (PCa/PNa < 0.001). The putative selectivity filter is formed by 
negatively charged amino acids between Glu981 and Ala986 of the human TRPM4 
subunit171.  
Ca2+-dependence. TRPM4 is a Ca2+-activated cation channel and its activity is 
highly dependent on concentration of intracellular Ca2+. No TRPM4 activity was 
observed when intracellular Ca2+ level was buffered at or below 100 nmol/L. Human 
TRPM4 channels expressed in HEK cells have an EC50 for Ca
2+-dependent activation of 
300 ~ 500 nmol/L in whole cell recordings169, as reported by Launay et al., and much 
higher [Ca2+] (in µmol/L range) is required as reported by Nilius et al.121.  Though there 
is no explanation for this discrepancy in HEK cells constructs, µmol/L levels of Ca2+ are 
a prerequisite for TRPM4 opening in native vascular smooth muscle cells. Earley et al. 
reported that TRPM4 in arterial myocytes has an EC50 of 10 µmol/L under whole cell 
patching condition20 and approximately 200 µmol/L with inside-out configuration19. This 
sizable difference between the two patch configurations may result from loss of cytosolic 
factors that sustain TRPM4 channel activity, such as calmodulin, PIP2 and PKC, when 
plasma membrane is disrupted upon excision. In support of the observation in native 
tissue, TRPM4 channels in HEK cells also showed an EC50 of 370 µmol/L [Ca
2+] in 
excised inside-out recordings172. Furthermore, the Ca2+ sensitivity of TRPM4 channels is 
regulated by several cellular factors. ATP is significant for restoring the Ca2+ sensitivity 
of TRPM4 channels after rapid desensitization. With any patch configuration, TRPM4 
channels exhibit a time-dependent deactivation, with currents completely inactivated in 
120 s in HEK121 and A7r5 cell expression systems173. Elevation of intracellular Ca2+ 
accelerates the decay as HEK cells with 10 µmol/L [Ca2+]i showed a relatively slow 
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inactivation (120 s) compared to the cells in 100 µmol/L [Ca2+]i, which completely 
inactivated within 90 s121.  In cerebral artery smooth muscle cells, TRPM4 currents 
reached maximum activation approximately 4 s after whole cell conditions were 
established, which is followed by a rapid decay within 20 s20. However, this decay could 
be almost completely restored by Mg-ATP for a short period. Interestingly, ATP4- was 
previously shown to be an effective blocker of TRPM4 channel, indicating ATP plays a 
dual role with regard to regulating the TRPM4 activity174.  
Nilius et al. found that expressing a dominant negative calmodulin (CaM) 
drastically decreased TRPM4 current amplitude. Further, overexpression of functional 
CaM reduced TRPM4 current decay, indicating that CaM is essential for conferring Ca2+ 
sensitivity174. PKC-dependent phosphorylation also plays a key role in activating TRPM4 
channels expressed in HEK cells. This is demonstrated by the evidence that the PKC 
activator phorbol ester PMA considerably decreased the EC50 of [Ca
2+]-dependent 
TRPM4 activation. Moreover, mutating the putative PKC phosphorylation sites (Serine 
residues: S1145 and S1152) on TRPM4 channels essentially abolished TRPM4 
activation174. The key role of PKC to TRPM4 opening was also observed in native 
vascular smooth muscle cells, in which PMA (1 µmol/L) decreased the EC50 of Ca
2+ from 
10 µmol/L to 5 µmol/L in whole cell patch configuration, and brought the threshold of 
[Ca2+]i for TRPM4 activation to a more physiological level
20.  Finally, TRPM4 channel 
activity is regulated by the intracellular PIP2 as shown in a later study from Nilius and 
colleagues. They illustrated that TRPM4 channel deactivation (loss of Ca2+ sensitivity) is 
fully recovered by application of PIP2 in inside-out and whole-cell patch configurations.  
On the other hand, modulation of the cellular PIP2 levels, including PLC-coupled M1 
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receptor activation, pharmacological inhibition of PLC, modulation of PIP2 metabolism 
and scavenging of PIP2, all significantly altered TRPM4 channel activity. This is 
indicative of a crucial role of PIP2 in regulating TRPM4 channels. PIP2 failed to initiate 
channel opening under low [Ca2+]i conditions, suggesting PIP2 is a strong positive 
modulator rather than a direct activator of TRPM4 channels. Furthermore, putative PIP2 
binding sites were discovered by neutralizing the basic residues in a C-terminal Pleckstrin 
homology (PH) domains, which failed to recover any current decay166. Though regulation 
of TRPM4 Ca2+ sensitivity has been intensely investigated, the binding sites for Ca2+ 
remained unknown until a recent study pointed out certain negatively charged amino 
acids are determinant for Ca2+ sensitivity of TRPM4 channels167. The C-terminal tail of 
TRPM4, particularly the TRP domain and TRP box located in the C-terminal region, has 
been demonstrated essential for the regulation of its activity118. The TRP domain is a 
homologous block of roughly 25 residues immediately C-terminal to S6 that is loosely 
conserved in almost all TRP mammalian subfamilies118. Moreover, the TRP domain 
contains a highly conserved 6-amino acid TRP box118. It has been proposed that the TRP 
domain of TRPM5, TRPM8 and TRPV5 serves as a PIP2-interacting region
119, whereas 
in TRPM4, the TRP box does not appear to be associated with PIP2 interactions
166. 
Further investigation into the TRP domain on TRPM4 protein illustrated at least two 
functionally different divalent cation-binding sites167. One has a comparatively higher 
selectivity for Ca2+, while the other is the binding site for other divalent cations (Co2+, 
Mn2+, Ni2+). Ca2+-binding to the former site is prerequisite for TRPM4 channel opening. 
A binding of a divalent cation to the latter site increases the Ca2+ sensitivity of the first 
binding site and makes the channel less voltage-dependent similar to the effects of PIP2
167. 
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In addition, this study also found that two negatively charged amino acids (Asp-1049, 
Glu-1062) near and in the TRP domain are critical regulators of Ca2+ binding affinity for 
the first site, as mutation of either amino acid substantially decreased the Ca2+ sensitivity 
of the first site without much effect on the affinities of the second binding site or the 
PIP2-binding site
167. However, additional questions concerning the binding mechanisms 
remain to be elucidated, especially whether the TRP domain is a direct binding site or an 
allosteric region for Ca2+ binding, which will require resolution of the crystal structure of 
the TRPM4 channel.  
Voltage dependence. Previous reports from HEK cells and native smooth muscle 
showed some discrepancy in terms of the voltage dependence of TRPM4 channels. 
Launay et al. reported that TRPM4 channel activity exhibited both an increase in open 
probability as well as an increase in open times at positive potentials with single channel 
recording from excised membrane patches. This may in part account for the slight 
outward rectification at positive potentials shown from the whole-cell recordings. 
Furthermore, Launay and colleagues also observed that single-channel amplitudes 
exhibited slight rectification at both positive and negative membrane voltages, which may 
provide some explanation for the S-shaped appearance of both single-channel and whole-
cell current-voltage relationships169. Later, more biophysical studies of TRPM4 channel 
in HEK cells were carried out by Nilius et al.121. These investigators showed with inside-
out patch configuration that voltage steps applied from 0 mV to negative potentials 
induced small, rapidly deactivating inward currents, whereas much larger outward 
currents were activated during steps to positive potentials, indicating that gating of 
TRPM4 is a voltage-dependent process121. However, in contrast to the previous study by 
 38 
Launay et al169, Nilius et al. pointed out that the current-voltage relationship is linear121 
rather than sigmoidal. This was further supported by the biophysical studies of TRPM4 in 
native smooth muscle cells. With single-channel recordings on cerebral arterial smooth 
muscle cells, Earley et al. also observed a linear current-voltage relationship with a 
calculated single channel conductance of ≈ 24 pS19. Nevertheless, unlike cloned TRPM4, 
these channels in arterial myocytes do not exhibit voltage dependence since the open 
probabilities were not significantly different for cells held at -80 mV and +80 mV19. It is 
not clear why there is difference in voltage sensitivity between expressed and native 
channels. Investigation of TRPM4 channels in other tissue types suggests that TRPM4 
channels exhibit tissue- and species- specific properties and regulation. For example, 
TRPM4 in rat ventricular cardiomyocytes175 and mouse sino-atrial node cells69 exhibits 
both voltage dependence and linear current-voltage relationship. This difference in 
voltage sensitivity may result from different splicing, specific multimerization, or distinct 
intracellular modulating factors.  
1.5.3 Exogenous TRPM4 regulation 
 
Molecular regulation. Prior to the discovery of more selective TRPM4 inhibitors 
and activators, investigation of TRPM4 channels, particularly the functional importance 
of these channels in various tissue, was limited to using molecular approaches to 
downregulate channel expression. Launay et al. were the first to generate and utilize a 
dominant native mutant of TRPM4 channels by deleting the first 177 amino acids in the 
N terminus (ΔN-TRPM4). This mutant was initially tested in HEK 293 cells, where 
reduced Na+ entry was observed compared to the wt-TRPM4 transfected HEK cells, 
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indicating a dominant negative effect of ΔN-TRPM4 on endogenous TRPM4. Further, 
expression of ΔN-TRPM4 did not affect the homomultimerization with wt-TRPM4, 
suggesting that deleted N-terminus region is not required for multimerization170. 
Functional roles of TRPM4 channels in immune cells (Jurkat T cells) were later 
investigated in this paper using the dominant negative mutant of TRPM4. ΔN-TRPM4 
showed a profound influence on receptor-mediated Ca2+ mobilization, illustrating that 
TRPM4-mediated T cell membrane depolarization modulates Ca2+ oscillations, with 
downstream effects on cytokine production170.  
Genetic modulation of TRPM4 channels was adopted by Earley et al. to study the 
physiological implication of TRPM4 in vascular smooth muscle cells19.  To suppress the 
expression level of the channel, antisense oligodeoxynucleotides (ODNs) selectively 
targeted to TRPM4 were used. Antisense ODNs are short strands of complementary 
DNA that bind to the messenger RNA (mRNA) produced by the target gene and prevent 
transcription process by putatively recruiting ribonuclease H (RNase H) to accelerate the 
degradation of target mRNA, hence reducing the expression of target protein176. The 
effects and specificity of TRPM4 antisense ODNs were evaluated by Earley et al.. 
Semiquantitative RT-PCR results showed that the antisense significantly reduced TRPM4 
mRNA level without any influence on TRPC6 channels which were previously reported 
to regulate myogenic tone of cerebral arteries. Effects of antisense ODNs on channel 
activity were then confirmed with two patch clamp configurations. Firstly, inside-out 
membrane patch recordings on isolated arterial myocytes that were pre-exposed to the 
ODNs showed TRPM4 channels (~24pS) were observed more frequently in the sense-
(47%) treated than the antisense- (10%) treated cells19. Secondly, with conventional 
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whole-cell patch configuration, the magnitude of the peak outward current in myocytes 
from vessels treated with TRPM4 antisense was significantly less than that of cells from 
sense-treated arteries20, both of which indicate TRPM4 antisense is a useful tool to study 
the functional important of TRPM4 in vascular smooth muscle. Later, Gonzales et al. also 
reported that commercially available TRPM4 siRNA effectively and selectively reduced 
TRPM4 protein expression in cerebral arteries and TRPM4 currents in siRNA-treated 
myocytes. However, in these studies, the approach to deliver the antisense or sense ODNs 
to cerebral arterial smooth muscle cells was reversible permeabilization (RP), which 
requires isolation of arteries, RP procedures for at least 4 hours and tissue culture for 72 
hours. Though it was not studied in any detail, these laborious processes could potentially 
lead to shifts in the functional contribution of various cellular players, including different 
TRP channels.  
To illustrate the significance of vascular smooth muscle TRPM4 channels in a 
more physiological context, Reading et al. applied an approach for antisense delivery in 
vivo whereby ODNs were infused into the cerebral spinal fluid (CSF) using an osmotic 
pump that was surgically implanted in a subcutaneous scapular pocket177. Enough time 
(7-day treatment) was allowed for distribution of ODNs throughout the CSF and uptake 
of ODNs by cerebral arterial smooth muscle cells before rats were euthanized and arterial 
segments were isolated for myograph studies. The effectiveness of this method was 
confirmed with semiquantitative PCR. Functionally, in vivo suppression of TRPM4 
decreased myogenic constriction of cerebral arteries and impaired autoregulation. This is 
consistent with prior studies where in vitro TRPM4 gene knockdown also substantially 
attenuated myogenic depolarization and tone of cerebral arteries19.  
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A recent study from our laboratory further developed the ODN delivery method 
into a more targeted and efficient process; TRPM4 antisense or sense ODNs were 
directly injected into the rat cisterna magna for two consecutive days34. Rats were 
euthanized on the third day, and tissue was isolated for myograph experiments. RT-PCR 
results indicated that exposure of parenchymal arterioles (PAs) to TRPM4 antisense in 
vivo effectively reduced the expression level of TRPM4 channels. Control experiments 
on cerebral pial arteries also showed a significant reduction on TRPM4 mRNA level in 
the antisense group. Further specificity test showed no influence of TRPM4 antisense on 
TRPC6 message levels, demonstrating that the designed antisense is a useful tool for 
functional studies34. Indeed, in vivo TRPM4 suppression using the above approach 
considerably diminished myogenic tone developed by PAs at different intraluminal 
pressures34. The in vivo administration of TRPM4 ODNs was also used by other groups 
to study the functional roles of this channel in other systems. For example, to 
downregulate TRPM4 expression after spinal cord injury, Gerzanich et al. gave rats a 
loading dose of ODNs intravenously and implanted mini-osmotic pumps with jugular 
vein catheters to continue infusing ODNs for the next 24 hours178. Channel suppression 
was also demonstrated to be very effective. Most recently, TRPM4 knockout mice have 
opened the door to studies of the physiological roles of TRPM4 in a many systems, 
including the cardiac myocytes179, the nervous system180, the immune system181 and so 
forth. 
Pharmacological regulation. Before the discovery of more selective TRPM4 
channel modulators, studies of this channel were restricted to using generic activators and 
inhibitors. Decavanadate was found to potentiate Ca2+-dependent TRPM4 activity. Nilius 
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et al. reported that application of devacanadate strongly affected the voltage-dependent 
gating of the channel, which sustained currents over the voltage range between -180 mV 
and +140 mV172. However, lack of specificity significantly limits the use of this 
compound. Decavanadate was found to be a reversible and competitive antagonist of the 
P2X7 receptors with slight inhibitory influence on P2X2 and P2Y4 receptors as well182. 
Moreover, it also binds to the IP3 receptors and reduces Ca
2+ release from the 
endoplasmic reticulum in rat pancreatic acinar cells183. Some earlier research on TRPM4 
channels also used nonselective cation channel inhibitors like flufenamic acid and 
clotrimazole as gating inhibitors, and Gd3+ and spermine as pore blockers69, 184, 185. 
Further, high concentrations of glibenclamide, an ATP-sensitive potassium (KATP) 
channel blocker, were also shown to inhibit TRPM4 channel activity by several groups. It 
was first reported by Demion et al. that 100 µmol/L glibenclamide significantly 
decreased TRPM4 activity by ~80% in HEK 293 cells69. Glibenclamide interacts with 
ATP-binding cassette proteins (ABC proteins)165. Interestingly, the TRPM4 protein 
contains two ABC transporter signature-like motifs, which may explain the inhibitory 
effects of glibenclamide165.  Later, a hydroxytricyclic compound 9-phenanthrol was 
found to be a much more selective modulator of TRPM4 channel activity. Inhibition of 
TRPM4 by 9-phenanthrol was observed initially in HEK cells with both inside-out and 
whole-cell configurations, with an IC50 of 20 µmol/L
165.  This group also reported that 9-
phenanthrol (100 µmol/L) had no inhibitory effects on TRPM5, which shares 50% 
structural similarity and similar electrophysiological properties with TRPM4 channels165. 
More detailed specificity tests were conducted by Gonzales et al. who found that 30 
µmol/L 9-phenanthrol, which almost completely blocks TRPM4 currents, did not alter 
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the activity of ion channels in smooth muscle cells that are potentially involved in 
modulation of vascular membrane potential and tone (voltage dependent Ca2+ channels 
(VDCCs), big conductance Ca2+-activated K+ (BKCa) channels, voltage-gated K
+ (Kv) 
channels, inward rectifying K+ (Kir) channels)
93; 9-phenanthrol (30 µmol/L) also has no 
effect on other TRP channels (TRPC3, TRPC6 and TRPM7)93, 186. Based on the above 
results, 9-phenanthrol appears to be a specific and effective tool in studies of the 
functional roles of TRPM4 channels. However, Gonzales at el. only focused on the ion 
channels present in the vascular smooth muscle cells. It was recently reported by Garland 
et al. that 9-phenanthrol activates the intermediate conductance K+ (IKCa) channels in 
mesenteric arterial endothelial cells, hyperpolarizes smooth muscle and induces 
vasodilation at a relatively low concentration (3 µmol/L)94. Similar results were also 
obtained in cerebral parenchymal arterioles by our laboratory (unpublished data). The 
nonselective inhibitory effects of 9-phenanthrol were also reported on cerebral arterial 
myocytes TMEM16A channels187, which were proposed to be a newly discovered 
mediator of myogenic membrane depolarization and constriction, a role identical to that 
of TRPM4 channels. The IC50 of 9-phenanthrol on TMEM16A channels is 12 µmol/L, 
which is very close to the IC50 for TRPM4. All these off-target effects of 9-phenanthrol 
indicate that the use of 9-phenanthrol should be handled with more caution for further 
TRPM4 studies. Proper control experiments should be conducted to eliminate the 
possibility that the observed results might actually be attributed to the off-target effects.  
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1.5.4 TRPM4 distribution and function 
 
Using various molecular approaches, TRPM4 channel protein has been detected 
in a large number of tissues. In human, high levels of TRPM4 signal were detected in the 
heart, pancreas, placenta, and prostate, and lower levels of expression in the kidney, 
skeletal muscle, liver, intestines, thymus, and spleen121, 169. It has also been found in 
several hematopoietic cell lines, including T and B lymphocyte cell lines and monocyte 
cell lines169. In the central nervous system, expression and functional roles of TRPM4 
were identified in the hippocampal neurons, substantial nigra pars compacta, cerebral 
cortex, spinal cord motor neurons, and the pre-Bötzinger complex in the brainstem180, 188-
191. This channel is present in smooth muscle cells found in rat cerebral arteries and 
arterioles19, 34, rat and guinea pig urinary bladder and detrusor192, 193, rat aorta194, rat 
pulmonary arteries194, and monkey and human colon195. TRPM4 channels are implicated 
in numerous physiological processes in various systems, all of which include TRPM4-
mediated Na+ entry and membrane depolarization, followed by modulation of 
intracellular ions, mostly Ca2+. Previous studies have shown that TRPM4 channels are 
involved in insulin secretion from pancreatic β cells196, 197, immune response in T cells170, 
dendritic cells198 and mast cells199, respiratory rhythm genesis in the pre-Bötzinger 
complex in the brain stem200, cardiac conduction201 and hypertrophy175, 202 in various 
types of cardiac myocytes, and detrusor smooth muscle contraction in the urinary 
bladder192, 193. 
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1.5.5 TRPM4 function and regulation in vascular smooth muscle 
 
It has been well established that membrane potential is the major determinant of 
smooth muscle cell contractility. It is attributed to that L-type voltage-dependent calcium 
channel (VDCC) activity is highly dependent on membrane potential15. VDCCs are 
sharply activated at membrane potential between -50 mV to -30 mV15. Opening of 
VDCCs allows for Ca2+ rushing into the cells down its concentration gradient 
(extracellular: ~2 mmol/L Ca2+, intracellular: ~100 nmol/L Ca2+). Ca2+ then binds to 
calmodulin and activates myosin light chain kinase (MLCK), which further 
phosphorylates and activates myosin light chain, promotes myosin/actin interaction and 
smooth muscle contraction. It was reported by Knot at el. that along with a membrane 
potential changing from -58 mV to -23 mV, intracellular [Ca2+] increased from 126 ± 7 
nmol/L to 349 ± 12 nmol/L, and that cerebral arteries went from full dilation to maximum 
constriction15.  It was also well accepted that vascular smooth muscle membrane potential 
is regulated by intraluminal pressure. Specifically, elevation of intravascular pressure 
causes a graded membrane depolarization of smooth muscle cells in resistant arteries, and 
results in graded constriction, i.e. myogenic tone14, 15. As a prime example, in cerebral 
arteries, increase in vascular pressure from 10 to 100 mmHg leads to smooth muscle 
depolarization from -63 to -36 mV, [Ca2+]i elevation from 119 nmol/L to 245 nmol/L, and 
subsequent arterial constriction from 208 µm to 116 µm15. This is again indicative of the 
central role of membrane potential regulation in the mechanism of pressure-induced 
vasoconstriction, blood flow and cerebral autoregulation. Nevertheless, how the 
mechanical stimulus (membrane stretch) is translated into a biological response 
(membrane depolarization) is not fully understood at the time. 
 46 
As the key role of TRPM4 in regulating membrane potential has been defined in 
HEK cells121, 169 and in other systems170, it became the prime suspect to mediate 
myogenic depolarization in cerebral circulation. As first reported by Earley et al. that 
TRPM4 transcript and currents are present in cerebral pial arterial smooth muscle cells19. 
Those currents exhibited the hallmarks of TRPM4 channels, including Ca2+-dependence, 
unitary conductance, and ion permeability. Recently, TRPM4 transcript signals were also 
detected in the cerebral microcirculation34, particularly parenchymal arteriole smooth 
muscle. The functional significance of TRPM4 was assessed with both molecular and 
pharmacological approaches. Firstly, downregulation of the channel in vitro with ODNs 
effectively and selectively reduced TRPM4 mRNA levels and current occurrence, and 
inhibited pressure-induced membrane depolarization and vasoconstriction19. Next, 
administration of a commercially available TRPM4 small interfering RNA (siRNA) 
generated similar results; myogenic response is attenuated by TRPM4 siRNA compared 
to control203. Thirdly, a selective pharmacological blocker 9-phenanthrol elicited 
inhibitory effects not only on whole-cell TRPM4 currents, but myogenic depolarization 
and constriction93. All of the above studies provide compelling evidence that pressure-
induced membrane depolarization is primarily mediated by opening of TPRM4 channels. 
In order to evaluate the involvement of TRPM4 in a more physiological setting, 
Reading et al. adopted an in vivo suppression technique; ODNs were administered to the 
cerebral spinal fluid of the third cerebral ventricle of rats using osmotic pumps177. With 
RT-PCR, the expression level of TRPM4 was reduced by 7-day treatment with antisense 
ODNs. Functionally, myogenic constriction was decreased by 70% to 85% in cerebral 
arteries from antisense-treated compared to sense-treated rats. Moreover, cerebral blood 
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flow was also substantially greater in the TRPM4 antisense group than in the sense 
group177. Cerebral blood flow was measured over a range of mean arterial pressures177. 
These observations suggest that arteries lacking TRPM4 channel fail to respond properly 
to elevated arterial pressure, and therefore the arteries are more dilated and blood flow is 
greater. This also points to the physiological significance of TRPM4 as it contributes in 
vivo to myogenic response and cerebral blood flow regulation.  
Supporting evidence that TRPM4 is mechano-sensitive was first provided by 
Morita et al.. TRPM4-like currents were observed in isolated cerebral arterial myocytes 
using the on-cell patch configuration184. These channels exhibited unitary conductance of 
approximately 22 pS, and were permeable to Na+ and Cs+ and blocked by Gd3+. Their 
activity was highly dependent on [Ca2+]i. These are all very important fingerprints of 
TRPM4 channels. Interestingly, the authors demonstrated that these channels could be 
activated by applying negative pressures to the membrane, which mimicked the 
membrane stretch during increase in intraluminal pressure184. The open probability of 
these channels increased with increased negative pipette pressure, which is consistent 
with pressure-dependent depolarization and constriction observed in intact arteries184. 
However, whether TRPM4 channels are directly activated by membrane stretch, or 
stimulated by a stretch-sensitive upstream signaling needs further investigation. A recent 
work from Gonzales et al. provided some insights into the mechano-sensitivity and 
activation mechanisms of TRPM4102. First, using perforated whole-cell patch 
configuration, they observed that inward TRPM4 currents were augmented by membrane 
stretch generated by switching to a hypotonic bath solution, indicating that TRPM4 can 
be activated by mechano-stimulation102. However, what is unexpected in the research is 
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that the single TRPM4 currents in HEK cells overexpressing the channel protein failed to 
be activated by negative pressures102. As a comparison, TRPC6 channels transfected in 
HEK cells exhibited apparent stretch-activation102. These results indicate that TRPM4 
channels are not inherently mechano-sensitive, rather, they are activated by upstream 
signaling pathways that potentially involve TRPC6 channels.  
IP3 Ca
2+ release. As described in previous text that TRPM4 is a Ca2+-activated 
ion channel. Its activity is highly dependent on intracellular [Ca2+]. In experimental 
settings, previous studies have shown that this channel requires a Ca2+ concentration of 
10-100 µmol/L to activate as indicated by both whole-cell and inside-out patch 
recordings. This level of Ca2+ is much higher than global Ca2+ levels in vascular smooth 
muscle cells under normal conditions (~ 100 nmol/L).  Global Ca2+ increase through Ca2+ 
influx from VDCCs is unlikely to reach the µmol/L range, whereas local Ca2+ elevation 
resulting from Ca2+ release from the sarcoplasmic reticulum (SR) could be substantial 
enough to activate TRPM4 in proximity, a proposed mechanism similar to the well-
characterized BKCa channel activation by SR Ca
2+ release from ryanodine receptors. Ca2+ 
sparks can reach the levels of 1- to 100- µmol/L204. Using the perforated patch voltage-
clamp technique, Gonzales et al. reported that inward TRPM4 currents were not acutely 
affected by removal of extracellular Ca2+, suggesting the channel is not dependent on 
Ca2+ influx through VDCCs21. However, prolonged Ca2+-free condition eventually 
reduced TRPM4 activity (after a few minutes), suggesting extracellular Ca2+ is important 
for sustaining TRPM4 activation presumably through maintaining the SR Ca2+ stores. 
This hypothesis was supported by further observation that disrupting Ca2+ stores with 
cyclopiazonic acid (CPA) largely suppressed TRPM4 currents21. Moreover, the authors 
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showed that TRPM4 activity was not affected by blocking RyR function, rather, it was 
significantly inhibited by an IP3 blocker xestospongin C
21. This is the first demonstration 
that TRPM4 channels interact with IP3 receptors on the SR to mediate myogenic 
depolarization. This mechanism may be present not only in the vascular smooth muscle 
cells, but also in other systems. In fact, the coupling between TRPM4 and IP3 receptor 
has also been documented in the mouse preBötzinger complex, regulating respiratory 
rhythms200. 
PKC regulation. In expression systems, TRPM4 channels are under the regulation 
of PKC, which phosphorylates the channel and decreases the EC50 of [Ca
2+]-dependent 
channel activation174. Such a regulatory mechanism was also investigated in the native 
smooth muscle. Earley et al. reported that, in isolated cerebral arterial myocytes, the 
selective PKC activator phorbol 12-myristate 13-acetate (PMA) shifted the EC50 of [Ca
2+] 
for TRPM4 activation from 10 µmol/L to 5 µmol/L, which, to some extent, brought the 
required [Ca2+] to a more physiological level. Consistent with this observation, PMA also 
enhanced myogenic tone of isolated pial arteries. To demonstrate that this effect is 
mediated by TRPM4, TRPM4 antisense ODNs were utilized by the authors. It was shown 
that PMA depolarized smooth muscle cells from sense-treated arteries, but did not 
significantly influence the membrane potential of antisense-treated smooth muscle. 
Further, TRPM4 sense-treated arteries exhibited concentration-dependent constriction to 
PMA. Such effects were not observed in arteries exposed to antisense, which caused 
oscillatory diameter changes, and significantly attenuated contractile response to PMA. 
These results indicate that PKC-mediated smooth muscle depolarization and constriction 
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involve activation of TRPM4 channels. More recently, a novel mechanism regarding 
PKC and TRPM4 was investigated by Crnich et al.205. In cultured aortic smooth muscle 
cells (A7r5 cells), the surface expression of TRPM4 protein increased by approximately 3 
fold when cells were exposed to PMA205. This also applies to native vascular smooth 
muscle as PMA increased TRPM4 expression in intact cerebral arteries205. PMA-induced 
translocation of TRPM4 could be inhibited by a PKCδ blocker, but it is insensitive to 
PKCα and PKCβ modulators205. Additionally, molecular and pharmacological inhibition 
of PKCδ dramatically reduced TRPM4 expression on the plasma membrane, indicating 
PKCδ is required to sustain the expression and activity of TRPM4 channels. In agreement 
with this observation, siRNA targeted to PKCδ significantly attenuated pressure-induced 
depolarization and vasoconstriction of pial arteries205, demonstrating that PKC-induced 
contractile response is partially attributed to increased surface expression of TRPM4.  
TRPC6 coupling. As briefly mentioned previously in this chapter, TRPC6 rather 
than TRPM4 appears to be directly mechano-sensitive102. Since TRPM4 is critically 
involved in stretch-induced responses, this observation is very intriguing, as TRPC6 may 
potentially serve as an upstream signaling partner in order to activate TRPM4 channels. It 
has been proposed previously that TRPM4 and TRPC6 might be electrically coupled to 
facilitate myogenic constriction19. The rationale is that both channels have been shown to 
participate in myogenic tone development. In addition, TRPC6 is a Ca2+-permeable, non-
selective cation channel206. It was hypothesized that if TRPC6 and TRPM4 channels are 
in proximity, Ca2+ entry through TRPC6 could lead to Ca2+-dependent activation of 
TRPM4 channels, and subsequent excitation-contraction signaling. These channels could 
also form heteromultimers with novel biophysical characteristics. However, though 
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heteromultimerization between within the TRPC family has been reported125, such 
constructs have not been found between different TRP families. The interactions between 
TRPC6 and TRPM4 were investigated in much greater detail by Gonzales et al.102. The 
authors used in situ proximity ligation assay to show that these two channels are located 
within 40 nm of each other, supporting the proposal that TRPC6 is positioned to provide 
a Ca2+ source for TRPM4 activation102. Moreover, stretch-induced TRPM4 activation 
was inhibited by a nonselective TRPC6 blocker and TRPC6 inhibitory antibody, 
providing supporting evidence that TRPC6 and TRPM4 are functionally connected. 
Further, hypotonic solution-stimulated TRPM4 currents were also attenuated when cells 
were pre-incubated in TRPC6 inhibitory antibody102. These results all point to the 
possibility that Ca2+ influx through TRPC6 is necessary for stretch-induced, IP3 receptor-
involved, and Ca2+-mediated activation of TRPM4 in the cerebral arterial smooth muscle 
cells. On the other hand, Earley et al. have also provided compelling evidence that PLC 
plays an essential role in regulating TRPM4 activity. First of all, PLCγ1, among other 
isoforms, was found to co-localize with TRPM4102. Suppressing the expression PLCγ1 
with siRNA reduced TRPM4 activity, which could be partially rescued by administration 
of Bt-IP3
102. This finding demonstrated that PLC-induced TRPM4 activation occurs 
through modulation of IP3 levels. Consistent with this finding, PLCγ1 siRNA also 
significantly inhibited pressure-induced membrane depolarization and myogenic 
constriction102. Taken together, Gonzales et al. have revealed a complex signaling 
network mediating pressure-induced depolarization. By incorporating the major players, 
including PLC, IP3 receptor, TRPM4 and TRPC6, the stretch-induced responses appear to 
be a dual effect: pressure-induced PLCγ1 activation stimulates IP3 release, and stretch-
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activated TRPC6 mediates Ca2+ influx. As IP3 increases the sensitivity of IP3 receptors to 
cytosolic Ca2+, IP3 receptor work as central hub that receives excitatory signals from the 
two pathways and mediate Ca2+ release from the SR. Local Ca2+ elevation further 
activates TRPM4 channels, and leads to subsequent depolarization and myogenic 
response102.   
 
1.6 Purinergic Receptors in Vascular Function 
Purinergic receptors are a family of plasma membrane proteins that have been 
identified in almost all mammalian tissues207. They are involved in a large variety of 
cellular functions, including cytokine secretion208, cell proliferation208, vascular reactivity 
and remodeling209, apoptosis, neuromodulation41, and synaptic transmission and 
plasticity41. etc. Based on the molecular structure and signal transduction mechanisms, 
purinergic receptors are grouped into three major classes210: P1 (adenosine) receptors, G 
protein- (primarily Gs and Gi/o) coupled receptors that are activated by adenosine; P2X 
receptors, ligand-gated ion channel receptors that are primarily stimulated by ATP; P2Y 
receptors, G protein- (primarily Gq and G12/13) coupled receptors that show different 
sensitivities to various nucleotides, such as ATP, ADP, UTP and UDP. Purinergic 
receptors are widely expressed in almost all tissue of all mammalian species. Among the 
purinergic receptors, P1 receptors, including A1, A2A, A2B and A3 receptors, are present in 
brain, heart, liver, intestine and lungs, and involved in modulation of the cardiovascular, 
immune and central nervous system activity211. P2X receptors, including P2X1 to P2X7 
receptors, are mainly found in vascular smooth muscle, platelets, central nervous system 
and spinal cord211, and contribute to regulation of vascular reactivity and synaptic 
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transmission41. P2Y receptors, comprising P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, 
P2Y13, P2Y14 receptors, are abundantly expressed in vascular endothelial cells and 
smooth muscle cells to regulate vasodilation and constriction209; they also participate in 
platelet activation and aggregation, inflammation, and neuroimmune functions211.  
1.6.1 P2Y receptors in vascular function and mechanisms 
 
P2Y receptors have been widely detected in the endothelium and smooth muscle 
of numerous vascular beds, contributing to regulation of vascular tone, mediation of 
smooth muscle proliferation, and promotion of platelet aggregation209. P2Y receptors 
have different selectivities for endogenous agonists, which may be critical for fine-tuning 
of appropriate and accurate cellular responses. P2Y1 receptors are selectively activated 
by ADP and ATP; P2Y2 receptors are stimulated equipotently by UTP and ATP; P2Y4 
receptors have higher selectivity for UTP, whereas P2Y6 receptors are preferentially 
stimulated by UDP212. Upon physiological and pathological stimulation, these purines 
and pyrimidines are locally released from surrounding sympathetic nerves, myocytes, 
endothelial cells, erythrocytes, platelets and white blood cells, and act synergically on 
receptors in endothelial cells and smooth muscle cells to eventually regulate vessel 
contractile status212. 
Vascular smooth muscle. The major P2Y receptors detected in arterial myocytes 
are P2Y2, P2Y4 and P2Y6 receptors. They play a pivotal role in mediating agonist-
dependent or independent vasoconstriction in mesenteric arteries, cerebral arteries, 
pulmonary arteries, and renal arteries from different species212. P2Y receptor-mediated 
cellular signaling transduction mechanisms also vary significantly. For example, in 
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mesenteric arteries, P2Y2 and P2Y6 receptors are found in arterial smooth muscle. Juul 
et al. reported that UTP induced sustained depolarization, increased [Ca2+]i and 
constriction213. In comparison, ATP-induced depolarization and constriction were 
transient. Further, nucleotide-elicited [Ca2+]i elevation appeared to arise from both Ca
2+ 
release from the SR and Ca2+ entry through VDCCs, since transient [Ca2+]i increase was 
still detected in Ca2+-free medium213.  In contrast to the well-established signaling 
mechanisms of P2Y receptors through Gq protein- and PLC-dependent Ca
2+ modulation, 
Sauzeau et al. reported that P2Y1, P2Y2, P2Y4 and P2Y6 receptors are also coupled to 
RhoA-Rho kinase-dependent signaling pathways, which result in cytoskeleton 
reorganization and Ca2+ sensitization214.  In agreement of this finding, Luykenaar and 
colleagues found that inhibiting Rho kinase significantly attenuated UTP-induced 
responses29. However, rather than initiating a Ca2+-sensitization mechanism, UTP evoked 
Rho kinase-mediated inhibition of K+ channels, and subsequent depolarization and 
vasoconstriction29. P2Y receptors have also been shown to mediate pressure-induced 
vasoconstriction4. Brayden et al. demonstrated that P2Y2, P2Y4 and P2Y6 receptors are 
present in the intraparenchymal arterioles within the brain. Surprisingly, P2Y2 receptor 
activation has no effect on arteriolar diameter. By contrast, P2Y4 and P2Y6 receptors 
play a previously undiscovered role as mechanosensors and mediators of myogenic 
regulation in these vessels4. Possible contributions of P2Y6 receptors in myogenic control 
were reported previously in mouse mesenteric arteries16. Nevertheless, it was proposed 
and later demonstrated by another group that P2Y6 receptors were activated by pressure-
dependent local release of nucleotides via an antocrine/paracrine mechanism17. 
Comparatively, the observation that modulation of endogenous nucleotide activity had no 
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influence on myogenic responses but effectively altered exogenous nucleotide-induced 
vasoconstriction points to a convincing stretch-activation mechanism initiated by the P2Y 
receptors4. A follow-up mechanistic investigation by Li. et al. and thoroughly presented 
in Chapter 2 of this dissertation, revealed that P2Y receptors mediate mechano-activation 
of TRPM4 channels, and concomitant smooth muscle depolarization and contraction34. 
As P2Y receptors are coupled to the Rho signaling, we further investigated the role of 
this cellular mechanism in mediating pressure-induced and P2Y receptor-mediated 
activation of TRPM4 channels in parenchymal arteriolar myocytes. Chapter 3 focuses on 
testing this hypothesis.  
Vascular endothelium. P2 receptors are in fact more abundantly expressed in 
vascular endothelial cells than in smooth muscle cells. P2Y1 and P2Y2 receptors are 
involved in endothelium-dependent vasodilatory effects in various vascular beds209, 
which counterbalance the vasocontractile effects of purines and pyrimidines directly on 
smooth muscle, resulting in more complex control of vascular tone. Under disease 
conditions when endothelium is damaged, locally secreted nucleotides may act directly 
on smooth muscle purinergic receptors and lead to pathological vasospasm209. Upon 
stimulation by purines, endothelial cell activation leads to increase in endothelial [Ca2+]i 
and triggers several pathways, including NO215, prostacyclin216 and endothelial-derived 
hyperpolarizing factors (EDHF)217, that function in concert to eventually induce smooth 
muscle relaxation209.  Recent evidence from Crecelius et al. showed that the vasodilator 
responses to ATP were significantly attenuated by BaCl2, indicating that inward 
rectifying potassium (Kir) channels are also involved in P2Y receptor-mediated vascular 
hyperpolarization218. Interestingly. ATP release from endothelial cells is also regulated by 
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shear stress and hypotonicity219. Elevation in shear stress leads to increased local 
concentration of ATP, which triggers endothelial P2Y receptor activation and 
vasodilation.  
1.6.2 P2X receptors in vascular function and mechanisms 
 
P2X receptors are ionotropic receptors that are gated by ATP. They are non-
selective cation channels responsible for mediating various cellular processes, like 
smooth muscle contraction, platelet aggregation, macrophage activation, and numerous 
neuronal functions220.  
Vascular smooth muscle. P2X1 receptors are the most abundant P2X receptors in 
vascular smooth muscle209.  In accord with the expression profile, the dominance of 
P2X1 receptor in mediating currents in smooth muscle cells of rat mesenteric arteries was 
also confirmed221. Functionally, the use of P2X1-deficient mice further revealed that 
P2X1 is critically involved in sympathetic neurogenic vasoconstriction, which is 
mediated by neuronal release of ATP upon stimulation222. ATP-evoked activation of 
P2X1 receptors allows for calcium (and other anion) influx, leading to smooth muscle 
depolarization, Ca2+ entry through VDCCs and vasoconstriction209. In rat cerebral 
parenchymal arterioles in vivo, low concentrations of ATP produce a biphasic response 
including a transient contraction via P2X1 receptor activation in arterial smooth muscle 
followed by vasodilation due to endothelial P2Y receptor activation223.  
Vascular endothelium. Though P2X1, P2X2 and P2X4 subtypes are identified by 
immunostaining in the endothelium of rat mesenteric, middle cerebral and coronary 
arteries209, the functional significance of P2X receptors in vascular endothelial cells is 
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largely unknown. The most thoroughly characterized receptor is the P2X4 receptor, 
which was identified as crucial transducers in response to ATP released from shear 
stress-activated endothelial cells. Yamamoto et al. observed that stepwise increases in 
shear stress elicited a corresponding stepwise increase in [Ca2+]i in human umbilical vein 
endothelial cells. However, downregulation of P2X4 purinoceptors with selective 
antisense ODNs markedly diminished shear stress-induced Ca2+ influx into endothelial 
cells, indicating that this subtype of P2X receptor has a “shear-transducer” property 
through which the mechanical signal is perceived and potentially transformed into 
vasodilation in a physiological system224. Later, this laboratory continued the 
investigation into the physiological role of P2X4 receptors using P2X4 knockout mice.  
They found that P2X4-defient mice failed to respond to changes in blood flow with 
endothelial cell [Ca2+] increase and NO release normally observed in wild type mice225. 
Further, P2X-/- mice exhibited higher blood pressures and excreted smaller amounts of 
NO products in their urine. These findings imply that impaired, P2X-mediated and flow-
induced endothelial cell activation leads to significantly reduced NO release from 
endothelium and substantially blunted vasodilatory effects in smooth muscle225. This is 
suggestive that P2X4 receptors play a fundamental role in flow-induced 
mechanotransduction and regulation of vascular tone and blood pressure.   
1.6.3 P1 receptors in vascular function and mechanisms 
 
P1 receptors are G protein-coupled receptors that are activated by adenosine, 
hence the name adenosine receptors. All four types of P1 receptors (A1, A2A, A2B and A3) 
have been detected in the vasculature with a higher expression level of A2A and A2B 
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receptors209. A number of studies have shown that P1 receptors contribute to 
endothelium-mediated or endothelium-independent vasorelaxation, which plays a crucial 
role in decreasing tissue damage under pathological conditions, including hypoxia and 
vasospasm after subarachnoid hemorrhage209. It has been well-characterized that 
adenosine-induced vasodilation participates fundamentally in protective arterial dilations 
following hypoxia and ischemia209, 226.  
Vascular smooth muscle. Though the major role of adenosine receptors lies in 
endothelium-dependent mechanisms, they are also found in the vascular smooth muscle 
from rat and guinea pig aorta, rat and rabbit mesenteric arteries, porcine coronary arteries, 
rat cerebral arteries and guinea pig and rabbit pulmonary arteries209. In mesenteric 
arteries, earlier studies from Prentice et al. suggested that adenosine and other adenosine 
analogues evoked vasodilation through A2B receptors in arteries stripped to 
endothelium227.  In contrast to this study, a more recent publication from Wang and 
colleagues proposed an interesting mechanism in small mesenteric resistance arteries, 
which comprises the involvement of A2A receptors in adenosine-induced inhibition of 
store-operated Ca2+ entry, and a subsequent decrease in cytosolic Ca2+ levels and 
vasorelaxation228. It was also shown in several early studies that adenosine-triggered 
dilatory responses are partially mediated by ATP-sensitive K+ (KATP) channels in intact 
coronary arteries229-231. However, whether or not this is important in vascular smooth 
muscle is unclear. Hein et al. further illustrated using denuded coronary arterioles that 
glibencalmide (KATP channel blocker) abolished adenosine- as well as CGS21680 (A2A 
receptor agonist)-induced smooth muscle relaxation, indicating that smooth muscle KATP 
channels are coupled to A2A receptors to facilitate adenosine-stimulated dilation
232.  
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Vascular endothelium. All of the P1 receptors have been found in the endothelium 
from numerous vascular beds. However, A2A and A2B receptors appear to play a 
predominant role in endothelium-dependent dilator effects, which is mediated by 
endothelial release of NO209. Interestingly, it seems that upon adenosine activation, 
different P1 receptors trigger distinct signaling pathways, which, however, eventually 
lead to the same destination - NO release and vasodilation. Specifically, Ray and 
colleagues found that A1 receptor-initiated NO release requires extracellular Ca
2+, 
phospholipase A2 (PLA2), and endothelial KATP channel activation, whereas A2A-facilated 
NO release involves extracellular Ca2+ as well as small and intermediate conductance 
Ca2+-activated K+ (SKCa and IKCa) channels
233. The authors hypothesized two distinct 
mechanisms. First, they suggested that A1 receptor-mediated KATP activation results in 
K+ efflux, endothelium hyperpolarization, and increased driving force for Ca2+ influx. 
Increases in [Ca2+]i stimulate PLA2 to liberate arachidonic acid and stimulate 
cyclooxygenase to generate prostacyclin (PGI2), which acts on its endothelial receptors to 
evoke cAMP-PKA pathway that subsequently activates eNOS and produce NO233. The 
second mechanism starts with activation of A2A-coupled KCa channels, which also 
facilitates Ca2+ entry into endothelial cells, thereby eventually activating eNOS and NO 
release233. Though the mechanisms are still elusive, it is rather clear that [Ca2+] regulation 
in endothelial cells is crucial to P1 receptor-mediated NO release. In cerebral arteries, 
A2A receptors were found to mediate both hypoxia- and glutamate-induced vasodilation 
in the cerebral cortex234, 235, thus contributing essentially to regulation of cerebral blood 
flow. Additionally, A1 and A3 receptor transcript messages have also been detected on 
endothelial cells in rat pial and intraparechymal arterioles236. It was reported by Lin et al. 
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that an A1 receptor agonist effectively attenuated subarachnoid hemorrhage-induced 
vasospasm236, pointing to A1 receptors as potential therapeutic targets for hemorrhagic 
stroke and even other cerebral pathologies. In addition to vasodilation, it was also shown 
that A3 receptors are involved in endothelium-dependent contraction of aorta
237 based on 
the observation that A3 receptor agonist failed to contract aorta from A3 knockout mice, 
and that removing the endothelium abolished the contractile response237. Since different 
COX-1 inhibitors showed common attenuating effects on A3 receptor-mediate 
constriction, Ansari et al. revealed a novel mechanism that endothelial A3 receptors 
induce aorta constriction through a COX-1 signaling pathway237.  
 
1.7 G protein-Coupled Receptors as Mechanosensors 
The involvement of G protein-coupled receptors (GPCRs) in regulation of 
vascular tone has long been established. GPCRs comprise seven-transmembrane 
domains, and transduce the extracellular stimuli into cellular responses via intracellular 
signaling pathways. Typically, these mechanisms on a cellular level involve ligand 
binding to the GPCR, GPCR conformational change, activation of G protein (GDP-bound 
to GTP-bound) and Gα binding/activating downstream effectors. The intracellular 
signaling pathways are, to a large extent, dictated by the Gα subunit type, including Gαs, 
Gαq/11, Gα12/13, etc. In blood vessels, vascular tone is modulated by a variety of GPCRs 
that are present in smooth muscles and endothelial cells, and also in other cell types in the 
vicinity, such as neurons and astrocytes. It is widely accepted that GPCRs in vascular 
smooth muscle respond to neuronal and hormonal stimuli with contraction and relaxation 
of smooth muscle cells via the Gq protein (and G12/13 protein) signaling cascades or the Gs 
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pathway, respectively. For instance, the circulating hormone angiotensin II (Ang II) binds 
to Ang II (AT1) receptors and activates the Gq protein-associated signaling pathways that 
involve activation of phospholipase C (PLC), diacylglycerol (DAG), protein kinase C 
(PKC) and inositol trisphosphate (IP3), promotion of Ca
2+ release from the sarcoplasmic 
reticulum (SR) and Ca2+ influx through voltage-dependent calcium channels (VDCCs), 
and ultimately vasoconstriction. On the other hand, the neurotransmitter epinephrine 
stimulates the Gs protein-coupled β2 receptors in arterial smooth muscle, which 
subsequently causes activation of adenylyl cyclase, cAMP and PKA, concomitant 
reduction of cytosolic Ca2+ level and smooth muscle relaxation.  
It has already been suggested in this chapter that GPCRs are implicated in 
myogenic tone development; several downstream signaling effectors of GPCRs have 
been shown to participate in myogenic regulation. For example, phospholipase C (PLC) 
plays a key role in the genesis of myogenic responses via membrane depolarization and 
increased calcium influx238. A contribution of DAG in pressure-evoked vasoconstriction 
has also reported239. Additionally, PKC elicits substantial influence on various ion 
channels239, like TRPM420 and VDCCs240, that are clearly involved in myogenic control. 
These observations all point to an important contribution of GPCRs to the modulation of 
myogenic contractility. Since GPCRs are ligand-stimulated, it was postulated that the 
mechanical stretch imposed on the vascular wall resulting from an increase in 
intraluminal pressure might evoke local release of vasoactive substance, including 
peptides, amines, lipids and nucleotides, which in turn activates corresponding receptors 
in smooth muscle in an autocrine or paracrine manner, and causes vasoconstriction241.  In 
accord with this hypothesis, Harder et al. reported that in cerebral arteries, the formation 
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of an arachidonic acid metabolite 20-hydroxycosatetraenoic acid (20-HETE) is positively 
associated with elevation of intravascular pressure242.  20-HETE is a potent 
vasoconstrictor, which has been shown to activate both PKC-dependent pathways242 and 
Rho signaling cascades243.  Therefore, pressure-induced formation of 20-HETE from 
phospholipids significantly potentiates myogenic response and regulates cerebral blood 
flow242. Other reports observe that myogenic tone of mouse mesenteric arteries is 
attenuated by a P2Y6 receptor inhibitor16. The mechanism proposed by these authors is 
that P2Y6 receptors are activated by local UTP release from mesenteric arteries in 
response to pressure. This theory was corroborated by another laboratory. Kauffenstein et 
al. took advantage of the ectonucleotidase NTPDase1, a membrane-bound enzyme found 
abundantly expressed in vascular smooth muscle which hydrolyzes and inactivates 
extracellular nucleotides like UTP and UDP17. They found that the mesenteric arteries 
from NTPDase knockout mice exhibited enhanced pressure-evoked constriction, 
consistent with greater local concentrations of endogenously released nucleotides17. This 
effect was inhibited by a P2Y receptor antagonist, indicating that local release of 
nucleotides is essential for myogenic regulation via activating P2Y receptors in 
mesenteric arteries17.  
Recently, the classic perspective that GPCRs need to be stimulated by 
extracellular ligands has been challenged by evidence pointing to GPCRs as 
mechanosensors, which mediate myogenic response in an agonist-independent manner. It 
was first reported by Mederos Schnitzler et al. that angiotensin II AT1 receptors, along 
with several other Gq/11-coupled receptors, are mechanosensitive
18. In that study, they 
first demonstrated that TRPC6 channels are not directly activated by mechanical force 
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based on the observation that neither hypotonicity nor negative pressures on the cell 
membrane activated TRPPC6 currents in TRPC6-transfected HEK cells. However, when 
co-expressing TRPC6 with AT1 receptors, membrane stretch could markedly activate 
TRPC6 currents. Interestingly, these currents could be prevented by pretreating the cells 
with inhibitors of AT1 receptor (losartan and candesartan), suggesting it is AT1 receptors 
rather than TRPC6 channels that are directly associated with pressure sensing.  Similar 
results were obtained with several other Gq-coupled receptors, including H1 histamine 
and muscarinic receptors, but not with Gs-coupled receptors, such as β2 receptors. These 
experiments were conducted in an expression system, where theoretically endogenous 
agonists could not be synthetized or released. In other words, these Gq-coupled receptors 
were stimulated independently of their endogenous ligands18. In A7r5 cells derived from 
a vascular source (embryonic rat thoracic aorta), mechano-activity of TRPC6 channels 
was similarly tightly coupled to AT1 receptor activity. To test the possibility that Ang II 
is stored in these cells and evoked the AT1 receptors in an autocrine fashion, the authors 
inactivated Ang II with a neutralizing antibody and found it had no significant influence 
on hypotonicity-induced TRPC6 activation, strongly indicating that local ligands are not 
involved in the mechano-stimulation mechanism18. To further confirm the physiological 
relevance of their mechanosensitivity, the authors then switched to studying myogenic 
responses in isolated rat cerebral arteries. The AT1 receptor inhibitor losartan clearly 
inhibited cerebral artery myogenic vasoconstriction, suggesting that AT1 receptors are 
also important in sensing native smooth muscle membrane stretch. Moreover, the 
observation that the angiotensin-converting enzyme (ACE) inhibitor failed to affect the 
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losartan-sensitive myogenic activity provided definitive evidence that locally formed Ang 
II does not contribute to developing or maintaining myogenic tone18.  
Consistent with this study, recent work from Brayden et al. showed that 
purinergic receptors, particularly P2Y4 and P2Y6 receptors, contribute essentially to 
myogenic regulation in the cerebral microcirculation, which appears to be unrelated to 
local levels of nucleotides4. The major evidence was that myogenic tone of 
intraparenchymal arterioles was reduced by selective molecular suppression on either 
receptor. In addition, P2Y receptor inhibitors also attenuated pressure-induced 
constrictions of these vessels. Interestingly, administration of an exogenous 
ectonucleotidase, which effectively abrogated UTP-induced constriction, failed to 
modulate myogenic response. Similarly, application of an endogenous ectonucleotidase 
inhibitor, which potentiated UTP-induced contraction, also elicited no influence on 
pressure-induced tone, strongly suggesting that P2Y receptors in the penetrating 
arterioles are activated by mechanical stimulation and not by autocrine/paracrine 
mechanisms4. Since P2Y receptors are all Gq-coupled receptors, this finding is in 
agreement with the previous discovery by Mederos Schnitzler et al.. It is rather surprising 
to see that neither Ang II nor AT1 receptor antagonist modulated PA contractility. The 
explanation for this apparent shift of functional mechanosensors from brain surface 
arteries to penetrating arterioles is unknown, but it may in part be the unique environment 
where parenchymal arterioles are encased by neurons and astrocytes, and are intrinsically 
innervated2.  It may also be attributed to different receptor profiles5, distinct Ca2+ 
signaling6, and diverse intracellular mechanisms in regulation of vascular tone.  Chapter 3 
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of the dissertation will concentrate on an intracellular signaling mechanism that appears 
rather unique to the microvasculature.  
Extensive structural analysis on different GPCRs has established that ligand 
binding to GPCRs shifts the conformation of the receptors to an active state, which 
subsequently activates G protein signaling. Yet how GPCRs are activated mechanically 
in the absence of agonists is essentially unknown. In order for a membrane protein to be 
recognized as a mechanosensor, a few criteria should be strictly followed243. Firstly, the 
kinetics between the mechanical stimulation and a cellular response should be fast 
enough and comparable to already established ligand activation. Secondly, the extent of 
response should be closely related to the amplitude of mechanical stimulation. In short, 
bigger mechanical force should be able to evoke greater biological response in the same 
amount of time. Third, a conformational change of the protein should be detected upon 
machano-activation. Fourth, mechano-stimulation of the protein should be able to be 
attenuated by protein inhibitors or inverse agonists.  Finally, since mechanosensitivity is 
an intrinsic property of the protein, then purified protein inserted into an expression 
system should still be activated by stretch244.  Judging by these criteria, Gq-coupled 
receptors, as defined by Mederos y Schnitzler et al., are mechanosensitive. This group 
went one step further in terms of understanding the mechanism of mechano-activation 
and demonstrated that membrane stretch allows the receptor to shift to an active 
conformation, which effectively recruit β-arrestin-2 with very similar intensity as 
compared to agonist-induced conformational change and β-arrestin-2 binding. This 
finding suggests stretch does result in an activated conformation, which is sensitive to 
receptor antagonists18. However, whether or not ligand-activated and stretch-initiated 
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conformational changes are the same has to be resolved by analysis of crystal structures.  
Currently, there are two separate hypotheses regarding how GPCRs perceive membrane 
stretch244. The first one is a “tethered” theory that postulates a molecular spring anchoring 
to GPCR. Membrane stretch would dislocate the spring and force a conformational 
modification of the GPCR. The second one focuses on the altered lateral pressure profile, 
which translates membrane stretch into conformation changes of GPCRs. Unfortunately, 
the precise mechanistic model is still elusive. Clearly, a combination of molecular study, 
structural analysis and biophysical investigation will be required to clarify this novel 
mechanism.   
 
1.8 RhoA/ROCK signaling 
Recently, along with emerging evidence that inhibition of ROCK effectively 
attenuates agonist- and pressure-induced vasoconstriction, the physiological and 
pathological significance of smooth muscle ROCK and Ca2+-sensitization mechanisms 
has begun to receive more attention.  
1.8.1 RhoA/ROCK signaling in health and disease     
 
Physiological roles of RhoA/ROCK signaling pathway. With a cranial window 
approach to monitor vascular diameter of anesthetized rats, two ROCK inhibitors (Y-
27632 and HA1077) caused marked concentration-dependent dilations of basilar 
arteries22, pointing to a key role of ROCK to cerebral artery tone in vivo. Later, several 
studies showed Rho mediates different vasoactive agent-initiated contractile responses. 
For instance, vasoconstriction induced by endothelin-1 (ET-1) has been found to involve 
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Rho signaling in various beds. In rabbit basilar arteries, ET-1 enhanced RhoA activity 
and stimulated Y-27632-sensitive contraction245.  Rat internal pudendal and clitoral 
arteries are both sensitive to ET-1, which also signals through ROCK246. In porcine 
retinal arterioles, the ROCK inhibitor H-1152 effectively abolished ET-1-induced 
vasoconstriction247. Another potent ROCK inhibitor SAR407899 reduces constriction of 
rat renal arteries to ET-1248. Other Rho-mediated vasoconstrictor responses have also 
been investigated. Briefly, serotonin triggers constriction in bovine middle cerebral 
arteries249 and cerebral arteries250, both of which are sensitive to Rho inhibition. ROCK 
signaling also plays an important role in eliciting UTP-induced constriction in cerebral 
arteries28. In addition to these receptor ligands, vascular tone is also greatly influenced by 
changes in intraluminal pressure, and ROCK is tonically active to regulate this influence 
in several vascular beds. In cerebral arteries, Y-27632 and HA 1077 were reported to 
suppress pressure-induced tone in a Ca2+-independent fashion251, 252, supporting a 
significant role for RhoA/ROCK pathway in cerebral artery stretch-activated constriction 
mechanisms that augment smooth muscle calcium sensitivity. ROCK-regulated myogenic 
activity was also observed in rat tail small arteries253 and rabbit facial veins254, both of 
which dilated when exposed to Y-27632. 
Pathological roles of RhoA/ROCK signaling pathway. Along with increased focus 
on the physiological importance in vascular smooth muscle, ROCK is also receiving 
progressively more recognition in various cardiovascular diseases and as a therapeutic 
target. It is not surprising that this signaling pathway and subsequent hyper-
vasoconstriction has been rigorously studied in human and animal models of 
hypertension, cerebral and coronary vasospasm, and subarachnoid hemorrhage. In three 
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different models of hypertension (spontaneous hypertensive rats, renal hypertensive rats 
and deoxycorticosterone acetate (DOCA)-salt hypertensive rats), intravenous 
administration of Y-27632 effectively lowered blood pressure255, suggesting Rho/ROCK 
signaling contributes to blood pressure regulation in vivo and that it is augmented in 
hypertension. Other evidence include that vascular ROCK mRNA levels are elevated in 
the spontaneously hypertensive rat model256, and levels and activity of GTP-RhoA are 
increased in aortic smooth muscle from angiotensin II-induced hypertensive rats, 
spontaneously hypertensive rats, and L-NAME-treated rats257, 258. Vasodilator responses 
of basilar arteries to Y-27632 were observed in vivo in spontaneous hypertensive rats, 
and significantly augmented in normotensive rats that were pre-exposed to L-NAME22, 
indicating that ROCK activity is abnormally elevated in hypertension and cerebral 
circulation may be largely affected by this pathological alteration. In agreement with this 
proposal, isolated cerebral arteries from hypertensive rats were significantly more 
sensitive to the dilating effects of Y-27632 and HA-1077 than those from normotensive 
rats252, which, again, emphasizes on the elevated contribution of ROCK to the cerebral 
myogenic reactivity in hypertension.  
In the context of Rho in the cerebral circulation, several studies have reported its 
involvement in cerebral vasospasm after subarachnoid hemorrhage (SAH). Increased 
RhoA and ROCK mRNA levels were observed in rat basilar arteries of a rat double 
cisternal blood-injection SAH model259. Elevated ROCK and myosin light chain 
phosphorylation were also found in canine basilar arteries following SAH260. Further, 
enhanced ROCK activity was found to account for augmented contractile responses of 
cerebral arteries to serotonin after experimental SAH261. In SAH patients, a potent ROCK 
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inhibitor fasudil hydrochloride exhibited promising clinical results with alleviated 
cerebral vasospasm262. Relaxation of cerebral vasospasm by fasudil is accompanied by a 
decrease in myosin light chain phosphorylation, consistent with ROCK inhibition263, and 
it is now clinically used in Japan and China for treating this symptom264. 
1.8.2 RhoA/ROCK signaling mechanisms 
Ca2+ sensitization. Rho-mediated smooth muscle contraction happens primarily 
through increasing the calcium sensitivity of the contractile apparatus, whereby myosin 
light chain (MLC) can be highly activated even with much lower levels of intracellular 
[Ca2+]. It was initially accepted that, similar to striated muscle contraction, the force of 
smooth muscle contraction is exclusively dictated by the levels of cytosolic Ca2+. 
Elevation of [Ca2+]i enhances the binding of Ca
2+ to calmodulin (CaM), which 
subsequently stimulates myosin light chain kinase (MLCK) to phosphorylate MLC265. It 
was therefore widely accepted that the degree of MLC phosphorylation, tightly regulated 
by cytosolic Ca2+, is the essential factor that determines the extent to which smooth 
muscle contracts. However, several earlier studies with Ca2+ indicators observed that the 
[Ca2+]i does not always parallel to the degree of MLC phosphorylation and constriction. 
Constrictions induced by a variety of agonists are higher than depolarization (high K+)-
induced contraction, even with lower [Ca2+], a process called Ca2+ sensitization266, 267. It 
was later revealed that the calcium sensitivity of the contractile apparatus of smooth 
muscle, i.e. the levels of MLC phosphorylation, is regulated not only by MLCK but also 
by myosin light chain phosphatase (MLCP), which dephosphorylates and inactivates 
MLC independent of [Ca2+]i. Subsequent studies revealed that MLCP is physiologically 
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inhibited by the intracellular Rho signaling, which promotes contraction that is uncoupled 
to the changes in cytosolic Ca2+ levels268.  
Stimulation of the small GTPase Rho following activation of certain heterotrimeic 
G protein coupled receptors (GPCRs) or receptor tyrosine kinases, triggers the Ca2+ 
sensitization mechanism. Similar to other GTP binding proteins, the small GTPase Rho 
shows binding affinity for both GDP and GTP, and exhibits intrinsic GTPase activity. 
Rho continuously goes through the cycle of inactivated state (GDP-Rho) and active state 
(GTP-Rho), which is tightly regulated by various proteins. In myocytes under resting 
conditions, the inactive Rho GDP dissociation inhibitor (Rho GDI) binds to inactive 
GDP-Rho and stabilizes GDP-Rho in the cytosol. Activation of receptors leads, through 
activity of guanine nucleotide exchange factor (GEFs), to the GTP-GDP exchange 
reaction, whereby inactive GDP bound Rho is converted to active GTP-Rho. Rho GDI 
dissociates and RhoA-GTP is then targeted to the cell membrane through its C-terminal 
geranyl-geranylated tail and interacts its downstream effectors, one of which is ROCK. 
ROCK activation, in turn, phosphorylates the myosin phosphatase target subunit (MYPT-
1), the regulatory subunit of MLCP, and inhibits its activity. Suppressed MLCP activity 
leads to reduced dephosphorylation of MLC, resulting in increased MLC activity and 
promoting smooth muscle contraction255, 268.  Active Rho (GTP-Rho) is terminated by 
intrinsic and GTPase-activating proteins (GAPs)-induced GTPase activity of Rho and 
converted to inactive GDP-Rho.  
In addition to inhibiting MLCP, ROCK also directly phosphorylates MLC and 
activates myosin ATPase. Amano et al. were the first to report that isolated MLC is 
phosphorylated by ROCK in a cell-free system. In the same study, phosphorylation sites 
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on MLC by ROCK were investigated. It was found that the MLC kinase preferentially 
phosphorylates MLC at Ser-19, and surprisingly, ROCK phosphorylates MLC mainly at 
the exact same site and activates its MgATPase activity of myosin in a GTPRho-
dependent manner as an added mechanism to facilitate Ca2+-sensitization and smooth 
muscle contraction269. 
Ion channel regulation. Though Ca2+ sensitization accounts primarily for 
Rho/ROCK-mediated regulation of vasomotor activity, emerging evidence suggests that 
RhoA and ROCK can regulate smooth muscle contraction by controlling the activity of 
ion channels, mostly potassium channels.  
Several groups have reported that RhoA/ROCK-signaling regulates the activity 
and expression of voltage-dependent delayed rectifier potassium (Kv) channels in 
different systems. With co-immunoprecipitation, Cachero et al. were the first to show 
close association between RhoA and Kv1.2 in a native mammalian system. 
Overexpression of RhoA markedly reduced Kv1.2 basal currents in expression systems. 
Additionally, in HEK cells, M1 muscarinic receptor-initiated suppression of Kv1.2 
channel activity was prevented when RhoA was inhibited by the C3 exoenzyme, strongly 
suggesting that RhoA links the signal transduction from GPCRs to ion channels270. Later, 
the mechanisms through which RhoA suppresses Kv1.2 channels were investigated by 
Stirling et al.271.  They found that treating HEK-K cells with increasing concentrations of 
C3 exoenzyme (RhoA inhibitor) produced a concentration-dependent increase in steady-
state Kv1.2 levels at the cell surface. In addition, inhibition of RhoA showed a decrease in 
steady-state channel endocytosis. Also, activation of RhoA by stimulation of endogenous 
LPA receptors triggered Kv1.2 channel endocytosis, which was reversed by ROCK 
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inhibitor Y27632, strongly indicating that the level of Kv1.2 expression is modulated by 
RhoA/ROCK-dependent steady-state channel endocytosis. Further exploration of this 
mechanism revealed that LPA receptor activation elicits clathrin-dependent Kv1.2 
endocytosis and consequent attenuation of Kv1.2 currents. Furthermore, a dual role of 
ROCK was discovered as it inhibits the recycling of endocytosed channel back to the 
plasma membrane, which further ensures the reduction of Kv1.2 channel expression on 
the cell surface271. Studies of ROCK and delayed rectifier potassium channels were not 
limited to expression systems. Luykenaar et al. reported that, in rat cerebral arterial 
smooth muscle, two ROCK inhibitors (Y27632 and H1152) not only abolished the 
attenuating effects of uridine triphosphate (UTP) on Kv channel activity, but also 
suppressed UTP-induced vasoconstriction28. This group further deciphered the 
mechanism by which Rho/ROCK inhibits Kv channels, and found that ROCK inhibition 
prevents UTP-induced actin polymerization, and that disruption of actin cytoskeleton 
rescues UTP-induced suppression of Kv channel activity. In addition, both ROCK 
inhibition and cytoskeleton disruption suppress UTP-induced depolarization and 
constriction of cerebral arteries. Together, these observations indicate that UTP initiates 
ROCK-mediated remodeling of the actin cytoskeleton and consequently suppresses the 
Kv currents, thereby facilitating depolarization and constriction of cerebral arteries
29. This 
important finding provides physiological and mechanistic evidence that Rho-associated 
constriction happens partially through regulation of membrane potential and presumably 
intracellular [Ca2+]. 
Inward rectifying potassium channels (Kir2.1-2.3), which are also important 
regulators of membrane potential and cell excitability, are also negatively regulated by 
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RhoA. In HEK cells, cotransfection with the activated mutant of the Rho reduced Kir 
current density, while C3 exoenzyme (RhoA inhibitor) attenuated M1 muscarinic 
receptor-induced reduction of Kir2.1-Kir2.3 activity
26, 27. Interestingly, this effect does not 
appear to be mediated by ROCK since Y27632 did not block the inhibitory effects of 
carbachol on Kir2.1
30. Another ROCK-regulated potassium channel, the TASK1 (K2P3.1) 
two-pore-domain K+ channel, contributes to resting membrane potential in human 
pulmonary artery smooth muscle cells. Endothelin-1 inhibited TASK1-mediated IKN 
currents in human pulmonary artery myocytes, which was reversed by Y27632. Mutation 
of either one of the putative ROCK phosphorylation sites (Ser336 and Ser393) on TASK1 
essentially reversed the inhibition of endothelin-1 on the channel, revealing a mechanism 
whereby regulation of vascular TASK1 currents by endothelin-1 is mediated by 
activation of ROCK and direct channel phosphorylation272.  
Rho signaling has also been shown to regulate other ion channel activities. 
Staruschenko et al. reported that co-expression of constitutively active RhoA and 
epithelial Na+ channels (ENaC) markedly increased ENaC activity. Pretreating the cells 
overexpressing ENaC and RhoA with Y27632 significantly decreased RhoA-dependent 
ENaC activity. Further investigation into this mechanism revealed that 
phosphatidylinositol 4.5-bisphosphate (PIP2) is necessary for RhoA/ROCK-dependent 
ENaC activation25. Furthermore, it was reported that T-type calcium channels are 
regulated by Rho signaling as well. Lysophophatidic acid (LPA) significantly inhibits the 
peak current amplitudes of expressed rat Cav3.1 and Cav3.3 channels without affecting 
the voltage dependence of activation or inactivation. This inhibitory effect was sensitive 
to ROCK inhibitors (fasudil and Y27362) as well as RhoA inhibition (C3 exoenzyme), 
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indicating LPA-mediated activation of Rho leads to ROCK-mediated suppression of 
Cav3.1 channels
273.  
Together these studies indicate that in addition to Ca2+ sensitization, the 
RhoA/ROCK signaling pathway also regulates ion channel activity and can control 
smooth muscle contractility. The influence of this signaling on TRPM4 channels and its 
participation in arteriolar myogenic depolarization and constriction were the topic of 
studies described in chapter three of this dissertation.  
Stress fiber formation. Additional mechanisms by which Rho regulates smooth 
muscle contractility have been revealed. There is substantial evidence to support the 
notion that smooth muscle contraction and relaxation involve actin polymerization and 
depolymerization, respectively. For example, decreased G-actin content, or a rise in F- to 
G- actin ratio, consistent with the utilization of G-actin and increased polymerization, 
were observed in blood vessels exposed to vasoconstrictors, osmotic challenge, or 
increased intravascular pressure. It was also shown that disruption of actin filament 
pharmacologically would significantly affect force generation274. Several studies have 
shown that ROCK regulates actin dynamic, and thus modulates actin-myosin interactions. 
For instance, LIM kinase 1 and 2 are phosphorylated by ROCK at Thr508 and Thr505, 
respectively, resulting in increased cofilin phosphorylation at Ser3. Cofilin is an actin-
depolymerizing factor and regulates actin dynamics, and its activity is attenuated by 
phosphorylation275. Therefore, through inhibition of cofilin and stabilization of actin 
filaments, ROCK further contributes to regulation of smooth muscle contractility. 
Moreno-Dominguez et al. have assessed the contribution of dynamic reorganization of 
the actin cytoskeleton and thin filament regulation to the myogenic response and 
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serotonin-induced constriction of pressurized rat middle cerebral arteries. They reported 
that the ROCK inhibitor (H1152) significantly increased the level of G-actin and caused a 
loss of myogenic tone. Additionally, the involvement of cofilin, which was previously 
identified as a mediator of ROCK-dependent control of actin dynamics, in myogenic 
responses has been studied. The level of cofilin-S3 phosphorylation was substantially 
elevated by an increase in pressure, which was effectively inhibited by H1152, indicating 
that dynamic reorganization of the cytoskeleton involving increased actin polymerization 
in response to ROCK/cofilin contributes significantly to force generation in myogenic 
constriction of cerebral resistance arteries274.  
1.8.3 RhoA structure, regulation and substrates 
 
At least ten members of the Rho family of GTPases are present in the mammals: 
Rho (isoforms A-E, and G), Rac (isoforms 1 and 2), Cdc42 and TC10, where Rho, Rac1 
and Cdc42 have been most intensively characterized. Among them, RhoA, RhoB and 
RhoC share the same amino acid sequence and very similar cellular functions. Therefore, 
most of the studies on Rho were based on the investigation of the function and regulation 
of RhoA268.     
RhoA structure. As summarized by Huret and colleagues, Rho-GTP-binding 
proteins are comprised of an effector domain, four separate guanosine phosphate binding 
regions that span the length of the core structure, a hypervariable region and a CAAX box 
motif (C: cysteine, A: aliphatic residue; X: any amino acid). The effector domain 
(residues 26-45) changes conformation between the GTP bound and GDP bound states. 
All Rho proteins possess conserved residues at Gly14, Thr19, Phe30 and Gln93, which 
 76 
participate in binding, stabilization or regulation of GTP hydrolysis. The N-terminus 
region also contains switch 1 (residues 27-40) and switch 2 (residues 59-78) regions that 
change conformation between GTP-bound and GDP-bound states, and may mediate 
changes in effector region necessary for binding to downstream targets. The 
hypervariable region of Rho is made up of residues 173-189, and is the region with most 
diversity between individual Rho family members. The C-terminus of RhoA is essential 
for correct localization of the protein. It is post-translationally modified by prenylation of 
a conserved C-terminal cysteine and followed by methylation and proteolytic removal of 
the last three amino acids. These are essential processes as the prenyl group anchors 
RhoA into membrane and facilitates its stability, cell growth, transformation and 
cytoskeletal organization276. 
RhoA regulation. Rho GTPases can be regulated intrinsically and extrinsically. 
They behave as molecular switches that shuffle between active (GTP-bound) state and 
inactive (GDP-bound) state. This cycle is under the control of two regulatory proteins: 
guanine nucleotide-exchange factors (GEFs), which catalyze the exchange of GDP for 
GTP to activate Rho GTPases, and GTPase-activating proteins (GAPs), which potentiate 
the intrinsic GTPase activity and accelerate the inactivation of Rho by hydrolyzing GTP 
to GDP268. Moreover, in resting cells, RhoA can be sequestered in the cytoplasm by 
guanine nucleotide-dissociation inhibitors (GDIs), which interact with prenylated GDP-
bound Rho, allowing for translocation of Rho GTPases between membrane and cytosol276. 
It is well characterized that RhoA is stimulated by various agonists through 
coupling to heterotrimetic G proteins. Specifically, Gα12 and Gα13 are involved in 
numerous Rho-associated responses, such as stress fiber formation and cytoskeletal 
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alterations268. Agonists initially stimulate G-protein coupled receptor (GPCRs) on the 
plasma membrane, which in turn activate Gα12/13 proteins and subsequent Rho signaling. 
The GPCRs that have been shown to initiate Rho signaling include α-adrenergic277, 
muscarinic278, prostanoid279, purinergic214, endothelin245, thrombin280, vasopressin281, 
oxytoncin282, epidermal growth factor283 and angiotensin receptors284. Most of these 
receptors are also coupled to the Gq protein and activate phospholipase C (PLC)-
modulated responses.  
RhoA GTPases are not only regulated by endogenous stimulation, but also 
affected by bacterial toxins and exoenzymes that have been proved valuable for 
experimental investigations. The C3-exoenzyme and the Escherichia coli protein ENIN 
are the most widely used RhoA inhibitors285, 286. They are ADP-ribose transferases that 
ADP-ribosylate the Asn-41 residue of Rho, thus inactivating RhoA and downstream 
signaling287. The C3-exenzyme is highly selective for RhoA without any effect on Rac or 
Cdc42288, leading to its extensive experimental application. A less specific inhibitor, 
Clostridium difficile toxin B, is also used in several studies289. Its limited selectivity lies 
in that it glycosylates not only Thr-37 of RhoA, but also the counterparts (Thr-35) of Rac 
and Cdc42. Toxin B inhibits GTPases by glycosylating and blocking the residues that 
contribute to Mg2+ coordination, and thereby preventing the GTP/GDP exchange 
necessary for activation290.  Interestingly, a RhoA activator CN03 was recently developed 
in order for better understandings of the Rho pathways. It was developed based on the 
cytotoxic necrotizing factor 1 (CNF-1), which has been shown to activate Rho, Rac, and 
Cdc42 by deamidating Gln-63 to Glu-63, which significantly inhibits the intrinsic and 
GAP-activated GTPase activity of Rho, leaving these proteins constitutively active291. 
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Based on CNF-1, CN03 contains a covalently attached cell penetrating moiety, allowing 
for cell penetration within 2-4 hours in the culture media. The targeted action on RhoA 
with CN03 makes it a more attractive tool for the study of Rho GTPase signaling than the 
classic indirect activators, like LPA.    
1.8.4 ROCK structure, expression, regulation and substrates 
 
ROCK structure. ROCK is a serine/threonine kinase with a molecular mass of 
about 160 kDa, and it is a major downstream effector of the small GTPase RhoA. It is 
expressed in invertebrates (C elegans, Drosophila and mosquito) and in vertebrates 
(zebrafish, Xenopus, chicken, mouse, rat and human). ROCK consists of an amino-
terminal kinase domain that is followed by a potential coiled-coil forming region and 
other functional motifs at the carboxyl terminus. These motifs include a Rho-binding 
domain, and Pleckstrin homology (PH) domain, which has an internal cysteine-rich 
domain. These carboxy-terminal domains constitute an autoinhibitory region that reduces 
the kinase activity of ROCKs292. The Rho-binding domain (RBD) is located in the 
predicted coiled-coil region of ROCK, and it exhibits sequence homology to the Rho-
interaction domain of kinectin, which is a protein that regulates microtubule-based 
organelle motility. The coiled-coil region is thought to interact with other α-helical 
proteins, whereas the PH domain in the carboxyl terminus might participate in protein 
localization293.  
ROCK expression. There are two isoforms of ROCK encoded by two different 
genes have been identified: ROCK-1, also known as ROCK I, P160-ROCK, or ROKβ) 
and ROCK-2 (ROCK II or ROKα). Human ROCK-1 and ROCK-2 genes locate on 
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chromosome 18 (18q11.1) and chromosome 2 (2p24), respectively294. They are highly 
homologous, with an overall amino acid sequence identity of 65%. Identity in the RBD 
region is 58% and approaches 92% in the kinase domain295. ROCK-1 and ROCK-2 are 
ubiquitously expressed in mouse and rat tissues, with a preferential expression of ROCK-
2 in the brain and skeletal muscle, suggesting the protein might have a specialized role in 
these cell types. In terms of the cardiovascular system, both of the kinases are found in 
the heart and vascular smooth muscle. Additional studies on the localization of ROCK-2. 
using immunofluorescence techniques, show that ROCK-2 is primarily localized to the 
cytoplasm296. Another study supported this finding with cell-fractionation studies, which 
indicated that the main proportion of ROCK-2 is located in cytosol, whereas only a small 
proportion of ROCK-2 is found in the membrane fraction297. When active RhoA is 
overexpressed, ROCK-2 translocates from the cell cytoplasm to plasma membrane297. 
Moreover, some immunostaining of ROCK-2 is detected at the cell periphery and 
membrane of growing cells298. 
ROCK regulation. ROCK is endogenously activated/regulated by RhoA in an 
activated and GTP-bound form, thereby ROCK kinase activity is enhanced. Additionally, 
it was demonstrated by Feng et al. that ROCK can be markedly stimulated by lipids, 
including arachidonic acid and some acidic phospholipids299. Protein oligomerization 
might also regulate ROCK activity, presumably through amino-terminal 
transphosphorylation300. A recent study pointed out that ROCK is negatively regulated by 
other small GTP-binding proteins, including Gem and Rad301. Recently, another small 
GTPase, RhoE, was identified as an inhibitor of ROCK-1. It binds to the amino-terminal 
section of ROCK-1 and presumably physically interfere with the kinase activity302.  
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Interestingly, Gem and Rad associate with the cytoskeleton and RhoE relates with the 
Golgi, the proteins could therefore function at specific intracellular subdomains to 
modulate ROCK-mediated processes302. 
In order to manipulate ROCK activity for experimental purposes, several ROCK 
inhibitors were developed that show a relatively high degree of specificity over the past 
few years. The most widely used is Y-27632, which is very useful in assessing the 
cellular and functional roles of ROCK. Y-27632 has a very high selectivity for ROCK 
over other protein kinases, with an inhibitory constant (Ki) at 0.14 µmol/L and 26 µmol/L 
for PKC. An important feature of Y-27632 is that, though it competes with ATP for 
binding, it is highly effective in cells even with high ATP levels303. Other ROCK 
inhibitors include HA-1077 and another pyridine derivative, Wf-536. These compounds 
are non-isoform-selective ROCK inhibitors that target the ATP-dependent kinase 
domains and are therefore equipotent in terms of suppressing both ROCK-1 and ROCK-
2304. And because of the essential contributions of ROCK to various cardiovascular 
pathologies and inflammatory conditions, these compounds have gained favorable 
interest from the pharmaceutical industry for novel drug development. And excitingly, 
the active metabolite of HA-1077, hydroxyfasudil, has been approved in Japan and China 
for treating cerebral vasospasm after SAH. Animal studies of numerous cardiovascular 
disease models have shown that ROCK inhibitors are beneficial for diseases including 
atherosclerosis and arterial remodeling following vascular injury305, angiogenesis306, 
cerebral ischemia307, erectile dysfunction308, myocardial ischemia-reperfusion injury309, 
etc. A most recent inhibitor is H-1152P, which has a Ki of 0.012 µmol/L for ROCK-2, 
3.03 µmol/L for PKA, and 5.68 µmol/L for PKC. It is a more potent inhibitor than either 
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Y-27632 or HA-1077. Its effectiveness has been rigorously tested by large numbers of 
studies examining the roles of ROCK in vascular reactivity, stress fiber assembly and 
neurite extension.  
ROCK substrates. ROCK mediates a broad range of cellular responses. For 
instance, it regulates cell contractility and actin cytoskeleton by phosphorylating a variety 
of proteins, such as MLCP, LIM kinases, adducin, and ezrin-radixin-moesin (ERM) 
proteins. These proteins are also phosphorylated by other serine/threonine kinases 
including PKA, PKC and PKG. The consensus amino acid sequences for phosphorylation 
are R/KXS/T or R/KXXS/T (R: arginine, K: lysine, X: any amino acid, S: serine, T: 
threonine)304. ROCK-1 and ROCK-2 share the majority of the amino acid sequence in the 
kinase domain. Though substrate studies were conducted focusing on individual ROCK 
isoforms, for example, ROCK-2 on MLCP and ROCK-1 on LIMK, thus far there is no 
direct evidence that they phosphorylate different substrates. ROCK directly 
phosphorylates MLC at Ser-19, the same phosphorylation site for MLCK, and activates 
MLC269. The direct excitatory effects on MLC may be physiologically significant as it 
largely enhances smooth muscle contractility independent of changes in intracellular 
[Ca2+]i. Additionally, the phosphorylation and inhibition of MLCP by ROCK are very 
well established. The MLCP consists of three subunits: a catalytic subunit, a myosin 
phosphatase target subunit (MYPT), and a small non-catalytic subunit of unknown 
functions. Phosphorylation of residues in the carboxyl-terminal of MYPT results in 
inhibition of MLCP activity and a concomitant increase in phosphorylation of MLC and 
cell contraction310. ROCK-2 phosphorylates MYPT at Thr697, Ser854 and Thr855311. 
Furthermore, another major type of substrates for ROCK is LIM kinases. LIM kinases 1 
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and 2 are serine/threonine kinases that are involved in the regulation of actin-filament 
dynamics303. ROCK I phosphorylates LIMK1 at Thr508312 and LIMK2 at Thr505313, and 
potentiates the ability of LIMKs to phosphorylate cofilin, which in turn promotes actin 
assembly and polymerization. 
 
1.9 Protein Kinase C and Myogenic Tone 
Protein kinase C, also known as PKC, is a family of protein kinase enzymes that 
are involved in regulating the function of other proteins through phosphorylation. PKC 
plays important roles in Gq protein-initiated signal transduction. PKC has been found in 
numerous cell types and mediates cell-type specific effects. Expression of PKC in smooth 
muscle cells from arteries, bronchi, urinary bladder, uterus and the gastrointestinal tract is 
uniformly associated with smooth muscle contraction36, indicating that PKC positively 
regulates the excitation-contraction mechanism. This section briefly summarizes the 
functional involvement and signaling mechanisms of PKC in myogenic vasoconstriction. 
The crucial roles of PKC in myogenic tone development have been established by earlier 
studies based on the evidence that pharmacological inhibition of PKC significantly 
reduces myogenic response, and that PKC activators potentiate pressure-induced 
contraction. These observations were made in different types of vessels from different 
species, including rat cerebral arteries314, rat cremaster arteries315, rat skeletal muscle 
arterioles316, rat coronary arteries317, human coronary arterioels318 and human 
subcutaneous resistance arteries319. Following from these reports, mechanisms of PKC-
mediated mechanoactivation have been heavily investigated. Primarily, PKC-modulated 
proteins in vascular smooth muscle can be primary divided into two groups, including ion 
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channels that are essential for regulation of membrane potential and intracellular [Ca2+], 
and the contractile apparatus that is not dependent on increased cytosolic Ca2+ levels.  
1.9.1 PKC regulates membrane potential 
 
Several studies have reported that modulation of PKC activity is associated with 
changes in smooth muscle membrane potential and cytosolic [Ca2+]. In cerebral arteries, 
the PKC activator PMA depolarized smooth muscle cells by ~ 15 mV and concomitantly 
caused robust vasoconstriction20. In support of this finding, the PKC inhibitor 
chelerythrine reduced myocyte [Ca2+]i in pressurized porcine coronary arteries, which 
was, not surprisingly, coupled to attenuated vasoconstriction320. Increased cellular Ca2+ 
leads to activation of calmodulin and subsequent myosin light chain kinase activity, 
which gives rise to greater myosin-actin interaction and smooth muscle contraction. 
Therefore, regulation of membrane potential and [Ca2+]i  is a fundamental process 
underlying PKC-initiated responses. Several ion channels that are centrally implicated in 
modulation of smooth muscle membrane potential are shown to be regulated by PKC. 
TRPM4 channels. Regulation of TRPM4 by PKC was first reported by Nilius et 
al.. They found that phosphorylation of TRPM4 by PKC not only markedly enhanced the 
activation of TRPM4 currents by Ca2+ but also elevated the whole-cell current density 
recorded in HEK cells expressing TRPM4 channels174. Similarly, using native cerebral 
arterial myocytes, Earley et al. showed that TRPM4 currents were substantially elevated 
by the PKC activator PMA, confirming an excitatory influence of PKC on TRPM4 
activity20. Moreover, application of PMA increased TRPM4 Ca2+ sensitivity by way of 
decreasing the EC50 of [Ca
2+]i for TRPM4 activation
20. Further studies from this group 
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demonstrated that a particular isoform of PKC (PKCδ) is involved in maintaining 
localization of TRPM4 protein at the plasma membrane321. It was concluded from these 
observations that either inhibiting PKCδ pharmacologically or molecularly largely 
attenuated TRPM4 distribution on the membrane as well as whole-cell TRPM4 
currents321. As TRPM4 is an important depolarizing contributor in cerebral arterial19 and 
arteriolar34 smooth muscle, PKC, by activating TRPM4 channels, effectively augments 
myogenic Ca2+ entry through VDCCs and subsequent pressure-induced vasoconstriction. 
BKCa channels. BKCa channels are important regulators of membrane potential. 
During myogenic tone development, depolarization-mediated BKCa channel opening and 
K+ efflux function as negative feedback mechanisms to reduce the degree of excitation by 
pressure50. As PKC is tightly coupled to vasoconstriction, it is therefore not surprising to 
find that PKC phosphorylation inhibits BKCa channels in vascular smooth muscle
322-324. 
Subsequent molecular studies focusing on the phosphorylation sites on BKCa channels 
revealed a dynamic regulation of the channel by PKC activity. In this study, 
phosphorylation of Ser695 inhibited both basal BKCa channel open-state probability and 
stimulatory effects of PKG and PKA on BKCa channels
325. BKCa channels contribute not 
only to regulation of myogenic tone50 but also to modulating vasoactive substance-
induced contraction64, 65, and it is not surprising that modulation of BKCa activity by PKC 
during agonist-evoked vasoconstriction has been documented. As one example, Kunduri 
and coworkers reported that activation of adenosine (A1) receptor inhibits BKCa activity 
in a PKCα-dependent manner in aortic smooth muscle326. Thus, by reducing BKCa 
channel open probability, PKC potentiates vascular smooth muscle depolarization and 
vasoconstriction induced by various excitatory stimuli. 
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Kir channels. Smooth muscle Kir channels are critically involved in K
+-induced 
membrane hyperpolarization and vasodilation. This is a pivotal regulatory mechanism for 
vascular reactivity mediated by endothelium-derived hyperpolarizing factor (EDHF) and 
neuronal activation. Inhibition of Kir channels reduces Kir-mediated K
+ efflux and smooth 
muscle hyperpolarization. It has been shown by several studies that PKC can evoke a 
vasoconstrictor response by inhibiting Kir channels. This was first observed by 
Chrisoobolis et al. that K+ (5 to 15 mmol/L)-elicited vasodilation of rat basilar arteries 
was inhibited by PKC activation and augmented by PKC inhibition, indicating a 
suppressive influence of PKC on K+-induced responses327.  Further, Park and colleagues 
published two consecutive studies on rabbit coronary arteries to elucidate the contribution 
of PKC in vasoconstrictor-triggered inhibition of Kir channels
328, 329. They reported that 
both endothelin-1 (ET-1) and Ang II markedly inhibited Kir currents, and that pretreating 
cells with PKC inhibitors prevented this response. PKC stimulation reduced Kir activity 
in this study, further confirming the inhibitory effects PKC on Kir channels
328, 329. 
Interestingly, PKC-regulated Kir channels appear to be involved in a unique cellular 
function in cerebral arterial smooth muscle. Studies on the mechano-regulation of Kir 
channels by Wu et al. showed that Ba2+-sensitive Kir channels are unresponsive to various 
vasoconstrictors that are known to constrict and depolarize cerebral arteries. However, Kir 
currents were strongly attenuated by hyposmotic challenges, suggesting that Kir might be 
sensitive to mechanical stimuli330. In agreement of these electrophysiological results, the 
authors also observed substantial inhibition on membrane depolarization and tone by 
Ba2+ at a low intraluminal pressure, but much less effects were observed from Ba2+ at a 
high pressure, suggesting that Kir channel activity is sensitive to membrane stretch. 
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Moreover, PKC inhibition abolished hyposmotic challenge-induced suppression of Kir 
currents, indicating PKC plays an important role in mechano-regulated Kir activity in the 
cerebral circulation330.   
VDCCs. A common denominator of vascular tone regulation is intracellular Ca2+ 
alterations, and a fundamental ion channel involved in regulation of cytosolic [Ca2+] is 
the L-type voltage-dependent Ca2+ channel (VDCC). VDCCs are activated by membrane 
depolarization, and they facilitate Ca2+ influx, leading in turn to vasoconstriction. In 
many smooth muscle preparations, PKC has been shown to increase VDCC activity, thus 
posing an excitatory influence on smooth muscle reactivity. Chik et al. reported that 
pituitary adenylate cyclase activating protein (PACAP) causes an increase in VDCC 
activity in rat tail arterial smooth muscle cells, which was reduced by PKC inhibition and 
mimicked by PMA. Moreover, Cobine et al. showed that the PKC activator PDBu also 
enhanced L-type VDCC currents, which was abolished by different PKC inhibitors331. 
Using more advanced Ca2+-fluorescent imaging techniques, Navedo and coworkers 
illustrated that PKCα is required for basal persistent L-type VDCC activity in arterial 
myocytes332. Biochemical investigation into the activating mechanism of PKC on VDCC 
suggests that phosphorylation of residues on the NH2-terminus of the α-subunit relieves a 
tonic inhibitory control on channel activation333.  
In summary, the activating effects of PKC on smooth muscle electrical excitation 
are mediated by an array of pathways; PKC-stimulated activation of TRPM4 and 
inhibition of K+ channels cause membrane depolarization, which activates L-type 
VDCCs that are also potentiated by PKC, leading to enhanced Ca2+ influx and myogenic 
vasoconstriction.  
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1.9.2 PKC and Ca2+-sensitization 
 
With the development and utilization of Ca2+-sensitive fluorescent dyes, e.g., 
Fura-2, uncoupling between [Ca2+]i and the magnitude of myogenic contraction has been 
reported. This was first observed in hamster cheek pouch arterioles, where augmented 
myogenic response was tightly related to the magnitude of step increases in pressure by 
comparing 40-60 cm and 40-100 cm H20 step increases, yet cytosolic [Ca
2+] was not 
significantly different between the two step increases, clearly displaying an uncoupling 
between intracellular [Ca2+] and myogenic response. Subsequently, more evidence was 
obtained by different groups showing that stretch-evoked contraction is greater than that 
stimulated by high K+ at a given [Ca2+], indicating the existence of other signaling 
pathways to sensitize the contractile apparatus to Ca2+ 334, 335. It is widely accepted that 
the [Ca2+]i-tone relationship gives direct assessment of the Ca
2+ sensitivity. According to 
the work of Schubert et al. using rat tail arteries, the relationship between tone and [Ca2+] 
is much larger at 80 mmHg than at 10 mmHg, further confirming that stretch increases 
the sensitivity of the myofilament to Ca2+ in vascular myocytes253. Involvement of PKC 
in the Ca2+ sensitization mechanisms has been reported336-338. Karibe et al. found that 
pressure-dependent [Ca2+]i increase and vasoconstriction were not abolished by a VDCC 
blocker (nimodipine). However, application of a PKC inhibitor abolished myogenic tone 
without affecting cytosolic [Ca2+] increases in rat skeletal muscle arterial myocytes336. In 
agreement with this finding, Lagaud and coworkers found that, after using 60 mmol/L K+ 
bath solution to clamp membrane potential and [Ca2+]i, stepwise pressure increases 
evoked myogenic constriction without significant changes in [Ca2+]i
337. This appears to 
be an effective means to separate the Ca2+-dependent signaling from the Ca2+-
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sensitization mechanisms. Not surprisingly, these authors found that pressure-induced 
vasoconstriction on top of 60 mmol/L K+ was largely attenuated by the PKC inhibitor, 
which suggests that PKC is implicated in regulating Ca2+ sensitivity of the 
myofilament337. This mechanism is corroborated in several other studies which point out 
that PKC mediates smooth muscle Ca2+ sensitization by activating CPI-17, a 17-kDa 
polypeptide that specifically and potently diminishes myosin light chain phosphatase 
(MLCP) activity339-341, leading to smooth muscle contraction. PKC phosphorylates CPI-
17 at Thr-38 to enhance its potency for inhibition of MLCP340, 341. 
Taken together, PKC elicits an excitatory influence on myogenic behavior 
through synergistically activating two independent yet tightly associated pathways. On 
one hand, PKC potentiates membrane depolarization and Ca2+ entry through VDCCs to 
elevate cytosolic [Ca2+]; On the other hand, PKC modulates smooth muscle Ca2+-
sensitivity by indirectly inhibiting myosin light phosphatase and can enhance contraction 
in the absence of changes in [Ca2+]i. Both mechanisms ultimately lead to augmented 
responses to increased intravascular pressure.   
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Part III: Hypotheses 
1. P2Y4 and P2Y6 purinergic receptors activate TRPM4 channels to mediate 
pressure-induced depolarization and myogenic vasoconstriction in cerebral 
parenchymal arterioles.  
The overarching objective of this research project described in Chapter two was to 
determine the expression and functional roles of TRPM4 channels in myogenic 
regulation of cerebral PAs. Previously, our laboratory made an important discovery that 
P2Y4 and P2Y6 purinergic receptors mediate PA myogenic constriction4, presumably 
through regulation of smooth muscle membrane potential and intracellular [Ca2+]. 
Therefore, a central goal of this project was to explore the interactions of P2Y4/P2Y6 
receptors with TRPM4 channels in facilitating pressure-initiated depolarization and 
constriction of PAs. An array of techniques allowed for evaluation of TRPM4 channel 
expression in PAs, vascular reactivity, smooth muscle membrane potential, and TRPM4 
channel activity in PA myocytes. Predictions were that TRPM4 channels are expressed in 
PAs and that inhibiting this channel with either molecular or pharmacological tools 
would reduce myogenic responsiveness. Examinations of arteriolar tone and membrane 
potential of endothelium-denuded PAs indicated TRPM4 channels mediate P2Y4 and 
P2Y6 receptor ligand-stimulated depolarization and contraction. Direct measurements of 
channel activity provided definitive evidence that TRPM4 channels are regulated by P2Y 
receptor activity, further supporting the hypothesis that TRPM4 channels couple 
mechano-activation of P2Y receptors and myogenic vasoconstriction in cerebral PAs. 
Dysfunction of the cerebral microcirculation has been implicated in numerous 
cardiovascular and neurological pathologies, including subarachnoid hemorrhage 
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(SAH)10, hypertension13, vascular dementia12 and Alzheimer’s disease342. Thus, a more 
thorough understanding of the vasomotor control mechanisms in PAs, as revealed in the 
present work, may lead to development of novel therapeutic strategies in treating the 
microvascular diseases. 
2. RhoA/ROCK signaling contributes to pressure-induced, P2Y receptor-
mediated TRPM4 channel activation, myogenic depolarization and vasoconstriction 
in PA myocytes.  
Following from the interesting findings described in Chapter two, cellular 
mechanisms, specifically the signaling pathways that couple mechanical stretch to 
myogenic activation of TRPM4 channels, were explored (Chapter three). The initial 
focus was on the PLC-DAG-PKC pathway since all three signaling partners have been 
shown to participate in myogenic regulation of vascular tone in various vascular beds, 
particularly in cerebral arteries238, 239. Additionally, P2Y receptors have been reported to 
couple to the Gq protein, whose association with the PLC-PKC pathway has been well 
documented. More importantly, TRPM4 channels are regulated by PKC20, as 
demonstrated by previous research from our laboratory, which further increased the 
plausibility that this signaling cascade may play a key role in PA smooth muscle. 
Interestingly, diameter measurements showed that myogenic constriction was barely 
affected by PLC or PKC inhibition (see Chapter four), which is consistent with a recent 
study concerning the contractile mechanisms of pial and parenchymal arteries343. This is 
suggestive of a fundamental shift of intracellular signaling mechanisms in the 
microcirculation. The present study demonstrated that ROCK plays a role in myogenic 
mechanisms in PAs343. Although the mechanism of Rho-mediated constriction is 
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generally accepted as Ca2+ sensitization303, ROCK also contributes to 
electrical/mechanical coupling by regulation of ion channel activities and modulation of 
smooth muscle membrane potential25, 28. Therefore, the overall goal of these studies was 
to investigate the functional significance of Rho signaling in pressure-induced and P2Y 
receptor-mediated activation of TRPM4 channels in PA smooth muscle cells. A 
combination of techniques was employed, including measurements of arteriolar diameter, 
intracellular [Ca2+], membrane potential and TRPM4 channel activity.  Consistent with 
the hypothesis, our data demonstrated that inhibiting ROCK reduced both pressure-
induced and receptor ligand-initiated vascular and cellular responses, whereas activating 
RhoA exerted the opposite effects on TRPM4 activity, membrane potential and tone.  
This finding brings new appreciation of the RhoA/ROCK signaling in regulation of 
smooth muscle contraction, which may contribute to identification of new therapeutic 
targets for preventing and treating cerebral microvascular diseases. 
 
  
 92 
References for Literature Review 
 
1. Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral 
microvascular pressure. Circulation research. 1990;66:8-17 
2. Cipolla MJ. The cerebral circulation integrated systems physiology: From 
molecule to function. The cerebral circulation. San Rafael (CA); 2009. 
3. Filosa JA, Bonev AD, Straub SV, Meredith AL, Wilkerson MK, Aldrich RW, 
Nelson MT. Local potassium signaling couples neuronal activity to vasodilation 
in the brain. Nature neuroscience. 2006;9:1397-1403 
4. Brayden JE, Li Y, Tavares MJ. Purinergic receptors regulate myogenic tone in 
cerebral parenchymal arterioles. Journal of cerebral blood flow and metabolism : 
official journal of the International Society of Cerebral Blood Flow and 
Metabolism. 2013;33:293-299 
5. Cipolla MJ, Li R, Vitullo L. Perivascular innervation of penetrating brain 
parenchymal arterioles. Journal of cardiovascular pharmacology. 2004;44:1-8 
6. Dabertrand F, Nelson MT, Brayden JE. Acidosis dilates brain parenchymal 
arterioles by conversion of calcium waves to sparks to activate bk channels. 
Circulation research. 2012;110:285-294 
7. Cipolla MJ. The cerebral circulation. San Rafael (CA); 2009. 
8. Pantoni L. Cerebral small vessel disease: From pathogenesis and clinical 
characteristics to therapeutic challenges. The Lancet. Neurology. 2010;9:689-701 
9. Dabertrand F, Kroigaard C, Bonev AD, Cognat E, Dalsgaard T, Domenga-Denier 
V, Hill-Eubanks DC, Brayden JE, Joutel A, Nelson MT. Potassium 
channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a 
genetic model of small vessel disease. Proceedings of the National Academy of 
Sciences of the United States of America. 2015;112:E796-805 
10. Nystoriak MA, O'Connor KP, Sonkusare SK, Brayden JE, Nelson MT, Wellman 
GC. Fundamental increase in pressure-dependent constriction of brain 
parenchymal arterioles from subarachnoid hemorrhage model rats due to 
membrane depolarization. American journal of physiology. Heart and circulatory 
physiology. 2011;300:H803-812 
11. Cipolla MJ, Bullinger LV. Reactivity of brain parenchymal arterioles after 
ischemia and reperfusion. Microcirculation. 2008;15:495-501 
12. Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80:844-866 
13. Pires PW, Jackson WF, Dorrance AM. Regulation of myogenic tone and structure 
of parenchymal arterioles by hypertension and the mineralocorticoid receptor. 
American journal of physiology. Heart and circulatory physiology. 2015:ajpheart 
00168 02015 
14. Harder DR. Pressure-dependent membrane depolarization in cat middle cerebral 
artery. Circulation research. 1984;55:197-202 
15. Knot HJ, Nelson MT. Regulation of arterial diameter and wall [ca2+] in cerebral 
arteries of rat by membrane potential and intravascular pressure. The Journal of 
physiology. 1998;508 ( Pt 1):199-209 
16. Koltsova SV, Maximov GV, Kotelevtsev SV, Lavoie JL, Tremblay J, Grygorczyk 
R, Hamet P, Orlov SN. Myogenic tone in mouse mesenteric arteries: Evidence for 
 93 
p2y receptor-mediated, na(+), k (+), 2cl (-) cotransport-dependent signaling. 
Purinergic signalling. 2009;5:343-349 
17. Kauffenstein G, Drouin A, Thorin-Trescases N, Bachelard H, Robaye B, 
D'Orleans-Juste P, Marceau F, Thorin E, Sevigny J. Ntpdase1 (cd39) controls 
nucleotide-dependent vasoconstriction in mouse. Cardiovascular research. 
2010;85:204-213 
18. Mederos y Schnitzler M, Storch U, Meibers S, Nurwakagari P, Breit A, Essin K, 
Gollasch M, Gudermann T. Gq-coupled receptors as mechanosensors mediating 
myogenic vasoconstriction. The EMBO journal. 2008;27:3092-3103 
19. Earley S, Waldron BJ, Brayden JE. Critical role for transient receptor potential 
channel trpm4 in myogenic constriction of cerebral arteries. Circulation research. 
2004;95:922-929 
20. Earley S, Straub SV, Brayden JE. Protein kinase c regulates vascular myogenic 
tone through activation of trpm4. American journal of physiology. Heart and 
circulatory physiology. 2007;292:H2613-2622 
21. Gonzales AL, Amberg GC, Earley S. Ca2+ release from the sarcoplasmic 
reticulum is required for sustained trpm4 activity in cerebral artery smooth muscle 
cells. American journal of physiology. Cell physiology. 2010;299:C279-288 
22. Chrissobolis S, Sobey CG. Evidence that rho-kinase activity contributes to 
cerebral vascular tone in vivo and is enhanced during chronic hypertension: 
Comparison with protein kinase c. Circulation research. 2001;88:774-779 
23. Cipolla MJ, Sweet J, Chan SL, Tavares MJ, Gokina N, Brayden JE. Increased 
pressure-induced tone in rat parenchymal arterioles vs. Middle cerebral arteries: 
Role of ion channels and calcium sensitivity. J Appl Physiol (1985). 2014;117:53-
59 
24. De Silva TM, Ketsawatsomkron P, Pelham C, Sigmund CD, Faraci FM. Genetic 
interference with peroxisome proliferator-activated receptor gamma in smooth 
muscle enhances myogenic tone in the cerebrovasculature via a rho kinase-
dependent mechanism. Hypertension. 2015;65:345-351 
25. Staruschenko A, Nichols A, Medina JL, Camacho P, Zheleznova NN, Stockand 
JD. Rho small gtpases activate the epithelial na(+) channel. The Journal of 
biological chemistry. 2004;279:49989-49994 
26. Jones SV. Role of the small gtpase rho in modulation of the inwardly rectifying 
potassium channel kir2.1. Molecular pharmacology. 2003;64:987-993 
27. Rossignol TM, Jones SV. Regulation of a family of inwardly rectifying potassium 
channels (kir2) by the m1 muscarinic receptor and the small gtpase rho. Pflugers 
Archiv : European journal of physiology. 2006;452:164-174 
28. Luykenaar KD, Brett SE, Wu BN, Wiehler WB, Welsh DG. Pyrimidine 
nucleotides suppress kdr currents and depolarize rat cerebral arteries by activating 
rho kinase. American journal of physiology. Heart and circulatory physiology. 
2004;286:H1088-1100 
29. Luykenaar KD, El-Rahman RA, Walsh MP, Welsh DG. Rho-kinase-mediated 
suppression of kdr current in cerebral arteries requires an intact actin cytoskeleton. 
American journal of physiology. Heart and circulatory physiology. 
2009;296:H917-926 
 94 
30. de Boorder MJ, van der Grond J, van Dongen AJ, Klijn CJ, Jaap Kappelle L, Van 
Rijk PP, Hendrikse J. Spect measurements of regional cerebral perfusion and 
carbondioxide reactivity: Correlation with cerebral collaterals in internal carotid 
artery occlusive disease. Journal of neurology. 2006;253:1285-1291 
31. Ropper AH, Samuels MA, Adams RD, Victor M, Klein J. Adams and victor's 
principles of neurology. 2014:1 online resource 
32. Nishimura N, Schaffer CB, Friedman B, Lyden PD, Kleinfeld D. Penetrating 
arterioles are a bottleneck in the perfusion of neocortex. Proceedings of the 
National Academy of Sciences of the United States of America. 2007;104:365-370 
33. Chan SL, Sweet JG, Cipolla MJ. Treatment for cerebral small vessel disease: 
Effect of relaxin on the function and structure of cerebral parenchymal arterioles 
during hypertension. FASEB journal : official publication of the Federation of 
American Societies for Experimental Biology. 2013 
34. Li Y, Baylie RL, Tavares MJ, Brayden JE. Trpm4 channels couple purinergic 
receptor mechanoactivation and myogenic tone development in cerebral 
parenchymal arterioles. Journal of cerebral blood flow and metabolism : official 
journal of the International Society of Cerebral Blood Flow and Metabolism. 
2014;34:1706-1714 
35. Ainslie PN, Shaw AD, Smith KJ, Willie CK, Ikeda K, Graham J, Macleod DB. 
Stability of cerebral metabolism and substrate availability in humans during 
hypoxia and hyperoxia. Clinical science. 2014;126:661-670 
36. Bhagavan NV. Medical biochemistry. San Diego: Harcourt/Academic Press; 2002. 
37. Heistad DD, Marcus ML, Gross PM. Effects of sympathetic nerves on cerebral 
vessels in dog, cat, and monkey. The American journal of physiology. 
1978;235:H544-552 
38. Ainslie PN, Brassard P. Why is the neural control of cerebral autoregulation so 
controversial? F1000prime reports. 2014;6:14 
39. Hamel E. Perivascular nerves and the regulation of cerebrovascular tone. J Appl 
Physiol (1985). 2006;100:1059-1064 
40. Saito A, Lee TJ. Serotonin as an alternative transmitter in sympathetic nerves of 
large cerebral arteries of the rabbit. Circulation research. 1987;60:220-228 
41. Burnstock G. Introduction to purinergic signalling in the brain. Advances in 
experimental medicine and biology. 2013;986:1-12 
42. Busija DW, Heistad DD. Factors involved in the physiological regulation of the 
cerebral circulation. Reviews of physiology, biochemistry and pharmacology. 
1984;101:161-211 
43. Bagher P, Segal SS. Regulation of blood flow in the microcirculation: Role of 
conducted vasodilation. Acta physiologica. 2011;202:271-284 
44. Wagerle LC, Mishra OP. Mechanism of co2 response in cerebral arteries of the 
newborn pig: Role of phospholipase, cyclooxygenase, and lipoxygenase pathways. 
Circulation research. 1988;62:1019-1026 
45. Bayliss WM. On the local reactions of the arterial wall to changes of internal 
pressure. The Journal of physiology. 1902;28:220-231 
 95 
46. Schubert R, Brayden JE. Stretch-activated cation channels and the myogenic 
response of small arteries. In: Kamkin A, Kiseleva I, eds. Mechanosensitivity in 
cells and tissues. Moscow; 2005. 
47. Earley S, Brayden JE. Transient receptor potential channels in the vasculature. 
Physiological reviews. 2015;95:645-690 
48. Gonzales AL, Earley S. Regulation of cerebral artery smooth muscle membrane 
potential by ca(2)(+)-activated cation channels. Microcirculation. 2013;20:337-
347 
49. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels 
in arterial smooth muscle. The American journal of physiology. 1995;268:C799-
822 
50. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-
dependent potassium channels. Science. 1992;256:532-535 
51. Thorneloe KS, Chen TT, Kerr PM, Grier EF, Horowitz B, Cole WC, Walsh MP. 
Molecular composition of 4-aminopyridine-sensitive voltage-gated k(+) channels 
of vascular smooth muscle. Circulation research. 2001;89:1030-1037 
52. Albarwani S, Nemetz LT, Madden JA, Tobin AA, England SK, Pratt PF, Rusch 
NJ. Voltage-gated k+ channels in rat small cerebral arteries: Molecular identity of 
the functional channels. The Journal of physiology. 2003;551:751-763 
53. Chen TT, Luykenaar KD, Walsh EJ, Walsh MP, Cole WC. Key role of kv1 
channels in vasoregulation. Circulation research. 2006;99:53-60 
54. Plane F, Johnson R, Kerr P, Wiehler W, Thorneloe K, Ishii K, Chen T, Cole W. 
Heteromultimeric kv1 channels contribute to myogenic control of arterial 
diameter. Circulation research. 2005;96:216-224 
55. Mukai Y, Shimokawa H, Matoba T, Hiroki J, Kunihiro I, Fujiki T, Takeshita A. 
Acute vasodilator effects of hmg-coa reductase inhibitors: Involvement of pi3-
kinase/akt pathway and kv channels. Journal of cardiovascular pharmacology. 
2003;42:118-124 
56. Heaps CL, Bowles DK. Gender-specific k(+)-channel contribution to adenosine-
induced relaxation in coronary arterioles. J Appl Physiol (1985). 2002;92:550-558 
57. Waldron GJ, Cole WC. Activation of vascular smooth muscle k+ channels by 
endothelium-derived relaxing factors. Clinical and experimental pharmacology & 
physiology. 1999;26:180-184 
58. Park SW, Noh HJ, Sung DJ, Kim JG, Kim JM, Ryu SY, Kang K, Kim B, Bae YM, 
Cho H. Hydrogen peroxide induces vasorelaxation by enhancing 4-
aminopyridine-sensitive kv currents through s-glutathionylation. Pflugers Archiv : 
European journal of physiology. 2015;467:285-297 
59. Irvine JC, Favaloro JL, Kemp-Harper BK. No- activates soluble guanylate cyclase 
and kv channels to vasodilate resistance arteries. Hypertension. 2003;41:1301-
1307 
60. Aiello EA, Clement-Chomienne O, Sontag DP, Walsh MP, Cole WC. Protein 
kinase c inhibits delayed rectifier k+ current in rabbit vascular smooth muscle 
cells. The American journal of physiology. 1996;271:H109-119 
 96 
61. Benham CD, Bolton TB, Lang RJ, Takewaki T. Calcium-activated potassium 
channels in single smooth muscle cells of rabbit jejunum and guinea-pig 
mesenteric artery. The Journal of physiology. 1986;371:45-67 
62. Nelson MT. Ca(2+)-activated potassium channels and atp-sensitive potassium 
channels as modulators of vascular tone. Trends in cardiovascular medicine. 
1993;3:54-60 
63. Hu XQ, Xiao D, Zhu R, Huang X, Yang S, Wilson SM, Zhang L. Chronic 
hypoxia suppresses pregnancy-induced upregulation of large-conductance ca2+-
activated k+ channel activity in uterine arteries. Hypertension. 2012;60:214-222 
64. Ishikawa T, Hume JR, Keef KD. Modulation of k+ and ca2+ channels by 
histamine h1-receptor stimulation in rabbit coronary artery cells. The Journal of 
physiology. 1993;468:379-400 
65. Petkov GV, Nelson MT. Differential regulation of ca2+-activated k+ channels by 
beta-adrenoceptors in guinea pig urinary bladder smooth muscle. American 
journal of physiology. Cell physiology. 2005;288:C1255-1263 
66. Perez GJ, Bonev AD, Nelson MT. Micromolar ca(2+) from sparks activates 
ca(2+)-sensitive k(+) channels in rat cerebral artery smooth muscle. American 
journal of physiology. Cell physiology. 2001;281:C1769-1775 
67. Noma A. Atp-regulated k+ channels in cardiac muscle. Nature. 1983;305:147-148 
68. Ashcroft SJ, Ashcroft FM. Properties and functions of atp-sensitive k-channels. 
Cellular signalling. 1990;2:197-214 
69. Demion M, Bois P, Launay P, Guinamard R. Trpm4, a ca2+-activated 
nonselective cation channel in mouse sino-atrial node cells. Cardiovascular 
research. 2007;73:531-538 
70. Woo SK, Kwon MS, Ivanov A, Gerzanich V, Simard JM. The sulfonylurea 
receptor 1 (sur1)-transient receptor potential melastatin 4 (trpm4) channel. The 
Journal of biological chemistry. 2013;288:3655-3667 
71. Kitazono T, Heistad DD, Faraci FM. Role of atp-sensitive k+ channels in cgrp-
induced dilatation of basilar artery in vivo. The American journal of physiology. 
1993;265:H581-585 
72. Nelson MT, Huang Y, Brayden JE, Hescheler J, Standen NB. Arterial dilations in 
response to calcitonin gene-related peptide involve activation of k+ channels. 
Nature. 1990;344:770-773 
73. Dart C, Standen NB. Adenosine-activated potassium current in smooth muscle 
cells isolated from the pig coronary artery. The Journal of physiology. 
1993;471:767-786 
74. Jackson WF. Arteriolar tone is determined by activity of atp-sensitive potassium 
channels. The American journal of physiology. 1993;265:H1797-1803 
75. Jackson WF, Konig A, Dambacher T, Busse R. Prostacyclin-induced vasodilation 
in rabbit heart is mediated by atp-sensitive potassium channels. The American 
journal of physiology. 1993;264:H238-243 
76. Standen NB, Quayle JM, Davies NW, Brayden JE, Huang Y, Nelson MT. 
Hyperpolarizing vasodilators activate atp-sensitive k+ channels in arterial smooth 
muscle. Science. 1989;245:177-180 
 97 
77. Garland CJ, McPherson GA. Evidence that nitric oxide does not mediate the 
hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. 
British journal of pharmacology. 1992;105:429-435 
78. Koide M, Syed AU, Braas KM, May V, Wellman GC. Pituitary adenylate cyclase 
activating polypeptide (pacap) dilates cerebellar arteries through activation of 
large-conductance ca(2+)-activated (bk) and atp-sensitive (k atp) k (+) channels. 
Journal of molecular neuroscience : MN. 2014;54:443-450 
79. Taguchi H, Heistad DD, Kitazono T, Faraci FM. Atp-sensitive k+ channels 
mediate dilatation of cerebral arterioles during hypoxia. Circulation research. 
1994;74:1005-1008 
80. von Beckerath N, Cyrys S, Dischner A, Daut J. Hypoxic vasodilatation in isolated, 
perfused guinea-pig heart: An analysis of the underlying mechanisms. The 
Journal of physiology. 1991;442:297-319 
81. Loutzenhiser RD, Parker MJ. Hypoxia inhibits myogenic reactivity of renal 
afferent arterioles by activating atp-sensitive k+ channels. Circulation research. 
1994;74:861-869 
82. Dart C, Standen NB. Activation of atp-dependent k+ channels by hypoxia in 
smooth muscle cells isolated from the pig coronary artery. The Journal of 
physiology. 1995;483 ( Pt 1):29-39 
83. Samaha FF, Heineman FW, Ince C, Fleming J, Balaban RS. Atp-sensitive 
potassium channel is essential to maintain basal coronary vascular tone in vivo. 
The American journal of physiology. 1992;262:C1220-1227 
84. Imamura Y, Tomoike H, Narishige T, Takahashi T, Kasuya H, Takeshita A. 
Glibenclamide decreases basal coronary blood flow in anesthetized dogs. The 
American journal of physiology. 1992;263:H399-404 
85. Faraci FM, Heistad DD. Role of atp-sensitive potassium channels in the basilar 
artery. The American journal of physiology. 1993;264:H8-13 
86. Armstead WM. Role of atp-sensitive k+ channels in cgmp-mediated pial artery 
vasodilation. The American journal of physiology. 1996;270:H423-426 
87. Zaritsky JJ, Eckman DM, Wellman GC, Nelson MT, Schwarz TL. Targeted 
disruption of kir2.1 and kir2.2 genes reveals the essential role of the inwardly 
rectifying k(+) current in k(+)-mediated vasodilation. Circulation research. 
2000;87:160-166 
88. Edwards FR, Hirst GD, Silverberg GD. Inward rectification in rat cerebral 
arterioles; involvement of potassium ions in autoregulation. The Journal of 
physiology. 1988;404:455-466 
89. Quayle JM, McCarron JG, Brayden JE, Nelson MT. Inward rectifier k+ currents 
in smooth muscle cells from rat resistance-sized cerebral arteries. The American 
journal of physiology. 1993;265:C1363-1370 
90. Knot HJ, Zimmermann PA, Nelson MT. Extracellular k(+)-induced 
hyperpolarizations and dilatations of rat coronary and cerebral arteries involve 
inward rectifier k(+) channels. The Journal of physiology. 1996;492 ( Pt 2):419-
430 
 98 
91. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH. K+ is an 
endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998;396:269-
272 
92. Guinamard R, Demion M, Launay P. Physiological roles of the trpm4 channel 
extracted from background currents. Physiology. 2010;25:155-164 
93. Gonzales AL, Garcia ZI, Amberg GC, Earley S. Pharmacological inhibition of 
trpm4 hyperpolarizes vascular smooth muscle. American journal of physiology. 
Cell physiology. 2010;299:C1195-1202 
94. Garland CJ, Smirnov SV, Bagher P, Lim CS, Huang CY, Mitchell R, Stanley C, 
Pinkney A, Dora KA. Trpm4 inhibitor 9-phenanthrol activates endothelial cell 
intermediate conductance calcium-activated potassium channels in rat isolated 
mesenteric artery. British journal of pharmacology. 2015;172:1114-1123 
95. Smith AC, Parajuli SP, Hristov KL, Cheng Q, Soder RP, Afeli SA, Earley S, Xin 
W, Malysz J, Petkov GV. Trpm4 channel: A new player in urinary bladder 
smooth muscle function in rats. American journal of physiology. Renal physiology. 
2013;304:F918-929 
96. Albert AP, Large WA. Synergism between inositol phosphates and diacylglycerol 
on native trpc6-like channels in rabbit portal vein myocytes. The Journal of 
physiology. 2003;552:789-795 
97. Saleh SN, Albert AP, Peppiatt CM, Large WA. Angiotensin ii activates two 
cation conductances with distinct trpc1 and trpc6 channel properties in rabbit 
mesenteric artery myocytes. The Journal of physiology. 2006;577:479-495 
98. Welsh DG, Morielli AD, Nelson MT, Brayden JE. Transient receptor potential 
channels regulate myogenic tone of resistance arteries. Circulation research. 
2002;90:248-250 
99. Gonzalez-Cobos JC, Trebak M. Trpc channels in smooth muscle cells. Frontiers 
in bioscience : a journal and virtual library. 2010;15:1023-1039 
100. Inoue R, Okada T, Onoue H, Hara Y, Shimizu S, Naitoh S, Ito Y, Mori Y. The 
transient receptor potential protein homologue trp6 is the essential component of 
vascular alpha(1)-adrenoceptor-activated ca(2+)-permeable cation channel. 
Circulation research. 2001;88:325-332 
101. Soboloff J, Spassova M, Xu W, He LP, Cuesta N, Gill DL. Role of endogenous 
trpc6 channels in ca2+ signal generation in a7r5 smooth muscle cells. The Journal 
of biological chemistry. 2005;280:39786-39794 
102. Gonzales AL, Yang Y, Sullivan MN, Sanders L, Dabertrand F, Hill-Eubanks DC, 
Nelson MT, Earley S. A plcgamma1-dependent, force-sensitive signaling network 
in the myogenic constriction of cerebral arteries. Science signaling. 2014;7:ra49 
103. Gottlieb P, Folgering J, Maroto R, Raso A, Wood TG, Kurosky A, Bowman C, 
Bichet D, Patel A, Sachs F, Martinac B, Hamill OP, Honore E. Revisiting trpc1 
and trpc6 mechanosensitivity. Pflugers Archiv : European journal of physiology. 
2008;455:1097-1103 
104. Dietrich A, Mederos YSM, Gollasch M, Gross V, Storch U, Dubrovska G, Obst 
M, Yildirim E, Salanova B, Kalwa H, Essin K, Pinkenburg O, Luft FC, 
Gudermann T, Birnbaumer L. Increased vascular smooth muscle contractility in 
trpc6-/- mice. Molecular and cellular biology. 2005;25:6980-6989 
 99 
105. Albert AP, Pucovsky V, Prestwich SA, Large WA. Trpc3 properties of a native 
constitutively active ca2+-permeable cation channel in rabbit ear artery myocytes. 
The Journal of physiology. 2006;571:361-369 
106. Narayanan D, Bulley S, Leo MD, Burris SK, Gabrick KS, Boop FA, Jaggar JH. 
Smooth muscle cell transient receptor potential polycystin-2 (trpp2) channels 
contribute to the myogenic response in cerebral arteries. The Journal of 
physiology. 2013;591:5031-5046 
107. Sharif-Naeini R, Folgering JH, Bichet D, Duprat F, Lauritzen I, Arhatte M, Jodar 
M, Dedman A, Chatelain FC, Schulte U, Retailleau K, Loufrani L, Patel A, Sachs 
F, Delmas P, Peters DJ, Honore E. Polycystin-1 and -2 dosage regulates pressure 
sensing. Cell. 2009;139:587-596 
108. Hirst GD, Edwards FR. Sympathetic neuroeffector transmission in arteries and 
arterioles. Physiological reviews. 1989;69:546-604 
109. Nelson MT, Conway MA, Knot HJ, Brayden JE. Chloride channel blockers 
inhibit myogenic tone in rat cerebral arteries. The Journal of physiology. 
1997;502 ( Pt 2):259-264 
110. Doughty JM, Langton PD. Measurement of chloride flux associated with the 
myogenic response in rat cerebral arteries. The Journal of physiology. 
2001;534:753-761 
111. Bulley S, Neeb ZP, Burris SK, Bannister JP, Thomas-Gatewood CM, 
Jangsangthong W, Jaggar JH. Tmem16a/ano1 channels contribute to the 
myogenic response in cerebral arteries. Circulation research. 2012;111:1027-
1036 
112. Garty H, Palmer LG. Epithelial sodium channels: Function, structure, and 
regulation. Physiological reviews. 1997;77:359-396 
113. Jernigan NL, Drummond HA. Vascular enac proteins are required for renal 
myogenic constriction. American journal of physiology. Renal physiology. 
2005;289:F891-901 
114. Drummond HA. Betaenac is a molecular component of a vsmc 
mechanotransducer that contributes to renal blood flow regulation, protection 
from renal injury, and hypertension. Frontiers in physiology. 2012;3:341 
115. Kim EC, Ahn DS, Yeon SI, Lim M, Lee YH. Epithelial na+ channel proteins are 
mechanotransducers of myogenic constriction in rat posterior cerebral arteries. 
Experimental physiology. 2012;97:544-555 
116. Kim EC, Choi SK, Lim M, Yeon SI, Lee YH. Role of endogenous enac and trp 
channels in the myogenic response of rat posterior cerebral arteries. PloS one. 
2013;8:e84194 
117. Cosens DJ, Manning A. Abnormal electroretinogram from a drosophila mutant. 
Nature. 1969;224:285-287 
118. Ramsey IS, Delling M, Clapham DE. An introduction to trp channels. Annual 
review of physiology. 2006;68:619-647 
119. Rohacs T, Lopes CM, Michailidis I, Logothetis DE. Pi(4,5)p2 regulates the 
activation and desensitization of trpm8 channels through the trp domain. Nature 
neuroscience. 2005;8:626-634 
 100 
120. Walker RL, Hume JR, Horowitz B. Differential expression and alternative 
splicing of trp channel genes in smooth muscles. American journal of physiology. 
Cell physiology. 2001;280:C1184-1192 
121. Nilius B, Prenen J, Droogmans G, Voets T, Vennekens R, Freichel M, 
Wissenbach U, Flockerzi V. Voltage dependence of the ca2+-activated cation 
channel trpm4. The Journal of biological chemistry. 2003;278:30813-30820 
122. Liman ER. The ca2+-activated trp channels: Trpm4 and trpm5. In: Liedtke WB, 
Heller S, eds. Trp ion channel function in sensory transduction and cellular 
signaling cascades. Boca Raton (FL); 2007. 
123. Vennekens R, Hoenderop JG, Prenen J, Stuiver M, Willems PH, Droogmans G, 
Nilius B, Bindels RJ. Permeation and gating properties of the novel epithelial 
ca(2+) channel. The Journal of biological chemistry. 2000;276:3963-3969 
124. Yue L, Peng JB, Hediger MA, Clapham DE. Cat1 manifests the pore properties of 
the calcium-release-activated calcium channel. Nature. 2001;410:705-709 
125. Strubing C, Krapivinsky G, Krapivinsky L, Clapham DE. Trpc1 and trpc5 form a 
novel cation channel in mammalian brain. Neuron. 2001;29:645-655 
126. Xu H, Ramsey IS, Kotecha SA, Moran MM, Chong JA, Lawson D, Ge P, Lilly J, 
Silos-Santiago I, Xie Y, DiStefano PS, Curtis R, Clapham DE. Trpv3 is a 
calcium-permeable temperature-sensitive cation channel. Nature. 2002;418:181-
186 
127. Li M, Jiang J, Yue L. Functional characterization of homo- and heteromeric 
channel kinases trpm6 and trpm7. The Journal of general physiology. 
2006;127:525-537 
128. Reading SA, Earley S, Waldron BJ, Welsh DG, Brayden JE. Trpc3 mediates 
pyrimidine receptor-induced depolarization of cerebral arteries. American journal 
of physiology. Heart and circulatory physiology. 2005;288:H2055-2061 
129. Noorani MM, Noel RC, Marrelli SP. Upregulated trpc3 and downregulated trpc1 
channel expression during hypertension is associated with increased vascular 
contractility in rat. Frontiers in physiology. 2011;2:42 
130. Adebiyi A, Thomas-Gatewood CM, Leo MD, Kidd MW, Neeb ZP, Jaggar JH. An 
elevation in physical coupling of type 1 inositol 1,4,5-trisphosphate (ip3) 
receptors to transient receptor potential 3 (trpc3) channels constricts mesenteric 
arteries in genetic hypertension. Hypertension. 2012;60:1213-1219 
131. Xi Q, Adebiyi A, Zhao G, Chapman KE, Waters CM, Hassid A, Jaggar JH. Ip3 
constricts cerebral arteries via ip3 receptor-mediated trpc3 channel activation and 
independently of sarcoplasmic reticulum ca2+ release. Circulation research. 
2008;102:1118-1126 
132. Brueggemann LI, Markun DR, Henderson KK, Cribbs LL, Byron KL. 
Pharmacological and electrophysiological characterization of store-operated 
currents and capacitative ca(2+) entry in vascular smooth muscle cells. The 
Journal of pharmacology and experimental therapeutics. 2006;317:488-499 
133. Ng LC, Airey JA, Hume JR. The contribution of trpc1 and stim1 to capacitative 
ca(2+) entry in pulmonary artery. Advances in experimental medicine and biology. 
2010;661:123-135 
 101 
134. Ng LC, McCormack MD, Airey JA, Singer CA, Keller PS, Shen XM, Hume JR. 
Trpc1 and stim1 mediate capacitative ca2+ entry in mouse pulmonary arterial 
smooth muscle cells. The Journal of physiology. 2009;587:2429-2442 
135. Ng LC, O'Neill KG, French D, Airey JA, Singer CA, Tian H, Shen XM, Hume JR. 
Trpc1 and orai1 interact with stim1 and mediate capacitative ca(2+) entry caused 
by acute hypoxia in mouse pulmonary arterial smooth muscle cells. American 
journal of physiology. Cell physiology. 2012;303:C1156-1172 
136. Dietrich A, Kalwa H, Storch U, Mederos y Schnitzler M, Salanova B, Pinkenburg 
O, Dubrovska G, Essin K, Gollasch M, Birnbaumer L, Gudermann T. Pressure-
induced and store-operated cation influx in vascular smooth muscle cells is 
independent of trpc1. Pflugers Archiv : European journal of physiology. 
2007;455:465-477 
137. Earley S, Heppner TJ, Nelson MT, Brayden JE. Trpv4 forms a novel ca2+ 
signaling complex with ryanodine receptors and bkca channels. Circulation 
research. 2005;97:1270-1279 
138. Golovina VA, Platoshyn O, Bailey CL, Wang J, Limsuwan A, Sweeney M, Rubin 
LJ, Yuan JX. Upregulated trp and enhanced capacitative ca(2+) entry in human 
pulmonary artery myocytes during proliferation. American journal of physiology. 
Heart and circulatory physiology. 2001;280:H746-755 
139. Sweeney M, Yu Y, Platoshyn O, Zhang S, McDaniel SS, Yuan JX. Inhibition of 
endogenous trp1 decreases capacitative ca2+ entry and attenuates pulmonary 
artery smooth muscle cell proliferation. American journal of physiology. Lung 
cellular and molecular physiology. 2002;283:L144-155 
140. Yu Y, Sweeney M, Zhang S, Platoshyn O, Landsberg J, Rothman A, Yuan JX. 
Pdgf stimulates pulmonary vascular smooth muscle cell proliferation by 
upregulating trpc6 expression. American journal of physiology. Cell physiology. 
2003;284:C316-330 
141. Yang M, Zhao T, Lin J, Ju T, Zhang L. Inhibition of trpm7 attenuates rat aortic 
smooth muscle cell proliferation induced by angiotensin ii: Role of genistein. 
Journal of cardiovascular pharmacology. 2015;66:16-24 
142. Earley S, Gonzales AL, Crnich R. Endothelium-dependent cerebral artery dilation 
mediated by trpa1 and ca2+-activated k+ channels. Circulation research. 
2009;104:987-994 
143. Earley S, Gonzales AL, Garcia ZI. A dietary agonist of transient receptor 
potential cation channel v3 elicits endothelium-dependent vasodilation. Molecular 
pharmacology. 2010;77:612-620 
144. Senadheera S, Kim Y, Grayson TH, Toemoe S, Kochukov MY, Abramowitz J, 
Housley GD, Bertrand RL, Chadha PS, Bertrand PP, Murphy TV, Tare M, 
Birnbaumer L, Marrelli SP, Sandow SL. Transient receptor potential canonical 
type 3 channels facilitate endothelium-derived hyperpolarization-mediated 
resistance artery vasodilator activity. Cardiovascular research. 2012;95:439-447 
145. Zhang DX, Gutterman DD. Transient receptor potential channel activation and 
endothelium-dependent dilation in the systemic circulation. Journal of 
cardiovascular pharmacology. 2011;57:133-139 
 102 
146. Zhang DX, Mendoza SA, Bubolz AH, Mizuno A, Ge ZD, Li R, Warltier DC, 
Suzuki M, Gutterman DD. Transient receptor potential vanilloid type 4-deficient 
mice exhibit impaired endothelium-dependent relaxation induced by acetylcholine 
in vitro and in vivo. Hypertension. 2009;53:532-538 
147. Sonkusare SK, Bonev AD, Ledoux J, Liedtke W, Kotlikoff MI, Heppner TJ, Hill-
Eubanks DC, Nelson MT. Elementary ca2+ signals through endothelial trpv4 
channels regulate vascular function. Science. 2012;336:597-601 
148. Marrelli SP, O'Neil R G, Brown RC, Bryan RM, Jr. Pla2 and trpv4 channels 
regulate endothelial calcium in cerebral arteries. American journal of physiology. 
Heart and circulatory physiology. 2007;292:H1390-1397 
149. Kohler R, Heyken WT, Heinau P, Schubert R, Si H, Kacik M, Busch C, Grgic I, 
Maier T, Hoyer J. Evidence for a functional role of endothelial transient receptor 
potential v4 in shear stress-induced vasodilatation. Arteriosclerosis, thrombosis, 
and vascular biology. 2006;26:1495-1502 
150. Hartmannsgruber V, Heyken WT, Kacik M, Kaistha A, Grgic I, Harteneck C, 
Liedtke W, Hoyer J, Kohler R. Arterial response to shear stress critically depends 
on endothelial trpv4 expression. PloS one. 2007;2:e827 
151. Mendoza SA, Fang J, Gutterman DD, Wilcox DA, Bubolz AH, Li R, Suzuki M, 
Zhang DX. Trpv4-mediated endothelial ca2+ influx and vasodilation in response 
to shear stress. American journal of physiology. Heart and circulatory physiology. 
2010;298:H466-476 
152. Poblete IM, Orliac ML, Briones R, Adler-Graschinsky E, Huidobro-Toro JP. 
Anandamide elicits an acute release of nitric oxide through endothelial trpv1 
receptor activation in the rat arterial mesenteric bed. The Journal of physiology. 
2005;568:539-551 
153. Yang D, Luo Z, Ma S, Wong WT, Ma L, Zhong J, He H, Zhao Z, Cao T, Yan Z, 
Liu D, Arendshorst WJ, Huang Y, Tepel M, Zhu Z. Activation of trpv1 by dietary 
capsaicin improves endothelium-dependent vasorelaxation and prevents 
hypertension. Cell metabolism. 2010;12:130-141 
154. Chen L, Kassmann M, Sendeski M, Tsvetkov D, Marko L, Michalick L, Riehle M, 
Liedtke WB, Kuebler WM, Harteneck C, Tepel M, Patzak A, Gollasch M. 
Functional transient receptor potential vanilloid 1 and transient receptor potential 
vanilloid 4 channels along different segments of the renal vasculature. Acta 
physiologica. 2015;213:481-491 
155. Bratz IN, Dick GM, Tune JD, Edwards JM, Neeb ZP, Dincer UD, Sturek M. 
Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of 
the metabolic syndrome. American journal of physiology. Heart and circulatory 
physiology. 2008;294:H2489-2496 
156. Kirby BS, Bruhl A, Sullivan MN, Francis M, Dinenno FA, Earley S. Robust 
internal elastic lamina fenestration in skeletal muscle arteries. PloS one. 
2013;8:e54849 
157. Sullivan MN, Gonzales AL, Pires PW, Bruhl A, Leo MD, Li W, Oulidi A, Boop 
FA, Feng Y, Jaggar JH, Welsh DG, Earley S. Localized trpa1 channel ca2+ 
signals stimulated by reactive oxygen species promote cerebral artery dilation. 
Science signaling. 2015;8:ra2 
 103 
158. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. 
Physiological reviews. 2006;86:279-367 
159. Alvarez DF, King JA, Weber D, Addison E, Liedtke W, Townsley MI. Transient 
receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: A 
novel mechanism of acute lung injury. Circulation research. 2006;99:988-995 
160. Folkman J, Shing Y. Angiogenesis. The Journal of biological chemistry. 
1992;267:10931-10934 
161. Hamdollah Zadeh MA, Glass CA, Magnussen A, Hancox JC, Bates DO. Vegf-
mediated elevated intracellular calcium and angiogenesis in human microvascular 
endothelial cells in vitro are inhibited by dominant negative trpc6. 
Microcirculation. 2008;15:605-614 
162. Cheng HW, James AF, Foster RR, Hancox JC, Bates DO. Vegf activates 
receptor-operated cation channels in human microvascular endothelial cells. 
Arteriosclerosis, thrombosis, and vascular biology. 2006;26:1768-1776 
163. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, 
Daskalakis N, Kwan SY, Ebersviller S, Burchette JL, Pericak-Vance MA, Howell 
DN, Vance JM, Rosenberg PB. A mutation in the trpc6 cation channel causes 
familial focal segmental glomerulosclerosis. Science. 2005;308:1801-1804 
164. Vennekens R, Nilius B. Insights into trpm4 function, regulation and physiological 
role. Handbook of experimental pharmacology. 2007:269-285 
165. Grand T, Demion M, Norez C, Mettey Y, Launay P, Becq F, Bois P, Guinamard 
R. 9-phenanthrol inhibits human trpm4 but not trpm5 cationic channels. British 
journal of pharmacology. 2008;153:1697-1705 
166. Nilius B, Mahieu F, Prenen J, Janssens A, Owsianik G, Vennekens R, Voets T. 
The ca2+-activated cation channel trpm4 is regulated by phosphatidylinositol 4,5-
biphosphate. The EMBO journal. 2006;25:467-478 
167. Yamaguchi S, Tanimoto A, Otsuguro K, Hibino H, Ito S. Negatively charged 
amino acids near and in transient receptor potential (trp) domain of trpm4 channel 
are one determinant of its ca2+ sensitivity. The Journal of biological chemistry. 
2014;289:35265-35282 
168. Xu XZ, Moebius F, Gill DL, Montell C. Regulation of melastatin, a trp-related 
protein, through interaction with a cytoplasmic isoform. Proceedings of the 
National Academy of Sciences of the United States of America. 2001;98:10692-
10697 
169. Launay P, Fleig A, Perraud AL, Scharenberg AM, Penner R, Kinet JP. Trpm4 is a 
ca2+-activated nonselective cation channel mediating cell membrane 
depolarization. Cell. 2002;109:397-407 
170. Launay P, Cheng H, Srivatsan S, Penner R, Fleig A, Kinet JP. Trpm4 regulates 
calcium oscillations after t cell activation. Science. 2004;306:1374-1377 
171. Nilius B, Prenen J, Janssens A, Owsianik G, Wang C, Zhu MX, Voets T. The 
selectivity filter of the cation channel trpm4. The Journal of biological chemistry. 
2005;280:22899-22906 
172. Nilius B, Prenen J, Janssens A, Voets T, Droogmans G. Decavanadate modulates 
gating of trpm4 cation channels. The Journal of physiology. 2004;560:753-765 
 104 
173. Gonzales AL, Earley S. Endogenous cytosolic ca(2+) buffering is necessary for 
trpm4 activity in cerebral artery smooth muscle cells. Cell calcium. 2012;51:82-
93 
174. Nilius B, Prenen J, Tang J, Wang C, Owsianik G, Janssens A, Voets T, Zhu MX. 
Regulation of the ca2+ sensitivity of the nonselective cation channel trpm4. The 
Journal of biological chemistry. 2005;280:6423-6433 
175. Guinamard R, Demion M, Magaud C, Potreau D, Bois P. Functional expression 
of the trpm4 cationic current in ventricular cardiomyocytes from spontaneously 
hypertensive rats. Hypertension. 2006;48:587-594 
176. Giles RV, Tidd DM. Enhanced rnase h activity with 
methylphosphonodiester/phosphodiester chimeric antisense 
oligodeoxynucleotides. Anti-cancer drug design. 1992;7:37-48 
177. Reading SA, Brayden JE. Central role of trpm4 channels in cerebral blood flow 
regulation. Stroke; a journal of cerebral circulation. 2007;38:2322-2328 
178. Gerzanich V, Woo SK, Vennekens R, Tsymbalyuk O, Ivanova S, Ivanov A, Geng 
Z, Chen Z, Nilius B, Flockerzi V, Freichel M, Simard JM. De novo expression of 
trpm4 initiates secondary hemorrhage in spinal cord injury. Nature medicine. 
2009;15:185-191 
179. Uhl S, Mathar I, Vennekens R, Freichel M. Adenylyl cyclase-mediated effects 
contribute to increased isoprenaline-induced cardiac contractility in trpm4-
deficient mice. Journal of molecular and cellular cardiology. 2014;74:307-317 
180. Schattling B, Steinbach K, Thies E, Kruse M, Menigoz A, Ufer F, Flockerzi V, 
Bruck W, Pongs O, Vennekens R, Kneussel M, Freichel M, Merkler D, Friese 
MA. Trpm4 cation channel mediates axonal and neuronal degeneration in 
experimental autoimmune encephalomyelitis and multiple sclerosis. Nature 
medicine. 2012;18:1805-1811 
181. Serafini N, Dahdah A, Barbet G, Demion M, Attout T, Gautier G, Arcos-Fajardo 
M, Souchet H, Jouvin MH, Vrtovsnik F, Kinet JP, Benhamou M, Monteiro RC, 
Launay P. The trpm4 channel controls monocyte and macrophage, but not 
neutrophil, function for survival in sepsis. Journal of immunology. 
2012;189:3689-3699 
182. Michel AD, Xing M, Thompson KM, Jones CA, Humphrey PP. Decavanadate, a 
p2x receptor antagonist, and its use to study ligand interactions with p2x7 
receptors. European journal of pharmacology. 2006;534:19-29 
183. Fohr KJ, Wahl Y, Engling R, Kemmer TP, Gratzl M. Decavanadate displaces 
inositol 1,4,5-trisphosphate (ip3) from its receptor and inhibits ip3 induced ca2+ 
release in permeabilized pancreatic acinar cells. Cell calcium. 1991;12:735-742 
184. Morita H, Honda A, Inoue R, Ito Y, Abe K, Nelson MT, Brayden JE. Membrane 
stretch-induced activation of a trpm4-like nonselective cation channel in cerebral 
artery myocytes. Journal of pharmacological sciences. 2007;103:417-426 
185. Ullrich ND, Voets T, Prenen J, Vennekens R, Talavera K, Droogmans G, Nilius B. 
Comparison of functional properties of the ca2+-activated cation channels trpm4 
and trpm5 from mice. Cell calcium. 2005;37:267-278 
 105 
186. Kim BJ, Kim SY, Lee S, Jeon JH, Matsui H, Kwon YK, Kim SJ, So I. The role of 
transient receptor potential channel blockers in human gastric cancer cell viability. 
Canadian journal of physiology and pharmacology. 2012;90:175-186 
187. Burris SK, Wang Q, Bulley S, Neeb ZP, Jaggar JH. 9-phenanthrol inhibits 
recombinant and arterial myocyte tmem16a channels. British journal of 
pharmacology. 2015;172:2459-2468 
188. Mironov SL, Skorova EY. Stimulation of bursting in pre-botzinger neurons by 
epac through calcium release and modulation of trpm4 and k-atp channels. 
Journal of neurochemistry. 2011;117:295-308 
189. Kim YS, Kang E, Makino Y, Park S, Shin JH, Song H, Launay P, Linden DJ. 
Characterizing the conductance underlying depolarization-induced slow current in 
cerebellar purkinje cells. Journal of neurophysiology. 2013;109:1174-1181 
190. Mrejeru A, Wei A, Ramirez JM. Calcium-activated non-selective cation currents 
are involved in generation of tonic and bursting activity in dopamine neurons of 
the substantia nigra pars compacta. The Journal of physiology. 2011;589:2497-
2514 
191. Teruyama R, Sakuraba M, Kurotaki H, Armstrong WE. Transient receptor 
potential channel m4 and m5 in magnocellular cells in rat supraoptic and 
paraventricular nuclei. Journal of neuroendocrinology. 2011;23:1204-1213 
192. Parajuli SP, Hristov KL, Sullivan MN, Xin W, Smith AC, Earley S, Malysz J, 
Petkov GV. Control of urinary bladder smooth muscle excitability by the trpm4 
channel modulator 9-phenanthrol. Channels. 2013;7:537-540 
193. Smith AC, Hristov KL, Cheng Q, Xin W, Parajuli SP, Earley S, Malysz J, Petkov 
GV. Novel role for the transient potential receptor melastatin 4 channel in guinea 
pig detrusor smooth muscle physiology. American journal of physiology. Cell 
physiology. 2013;304:C467-477 
194. Yang XR, Lin MJ, McIntosh LS, Sham JS. Functional expression of transient 
receptor potential melastatin- and vanilloid-related channels in pulmonary arterial 
and aortic smooth muscle. American journal of physiology. Lung cellular and 
molecular physiology. 2006;290:L1267-1276 
195. Dwyer L, Rhee PL, Lowe V, Zheng H, Peri L, Ro S, Sanders KM, Koh SD. 
Basally activated nonselective cation currents regulate the resting membrane 
potential in human and monkey colonic smooth muscle. American journal of 
physiology. Gastrointestinal and liver physiology. 2011;301:G287-296 
196. Cheng H, Beck A, Launay P, Gross SA, Stokes AJ, Kinet JP, Fleig A, Penner R. 
Trpm4 controls insulin secretion in pancreatic beta-cells. Cell calcium. 
2007;41:51-61 
197. Marigo V, Courville K, Hsu WH, Feng JM, Cheng H. Trpm4 impacts on ca2+ 
signals during agonist-induced insulin secretion in pancreatic beta-cells. 
Molecular and cellular endocrinology. 2009;299:194-203 
198. Barbet G, Demion M, Moura IC, Serafini N, Leger T, Vrtovsnik F, Monteiro RC, 
Guinamard R, Kinet JP, Launay P. The calcium-activated nonselective cation 
channel trpm4 is essential for the migration but not the maturation of dendritic 
cells. Nature immunology. 2008;9:1148-1156 
 106 
199. Vennekens R, Olausson J, Meissner M, Bloch W, Mathar I, Philipp SE, Schmitz F, 
Weissgerber P, Nilius B, Flockerzi V, Freichel M. Increased ige-dependent mast 
cell activation and anaphylactic responses in mice lacking the calcium-activated 
nonselective cation channel trpm4. Nature immunology. 2007;8:312-320 
200. Crowder EA, Saha MS, Pace RW, Zhang H, Prestwich GD, Del Negro CA. 
Phosphatidylinositol 4,5-bisphosphate regulates inspiratory burst activity in the 
neonatal mouse prebotzinger complex. The Journal of physiology. 
2007;582:1047-1058 
201. Kruse M, Schulze-Bahr E, Corfield V, Beckmann A, Stallmeyer B, Kurtbay G, 
Ohmert I, Schulze-Bahr E, Brink P, Pongs O. Impaired endocytosis of the ion 
channel trpm4 is associated with human progressive familial heart block type i. 
The Journal of clinical investigation. 2009;119:2737-2744 
202. Guinamard R, Bois P. Involvement of transient receptor potential proteins in 
cardiac hypertrophy. Biochimica et biophysica acta. 2007;1772:885-894 
203. Earley S. Trpm4 channels in smooth muscle function. Pflugers Archiv : European 
journal of physiology. 2013 
204. Nelson MT, Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, Lederer WJ. 
Relaxation of arterial smooth muscle by calcium sparks. Science. 1995;270:633-
637 
205. Crnich R, Amberg GC, Leo MD, Gonzales AL, Tamkun MM, Jaggar JH, Earley 
S. Vasoconstriction resulting from dynamic membrane trafficking of trpm4 in 
vascular smooth muscle cells. American journal of physiology. Cell physiology. 
2010;299:C682-694 
206. Trebak M, Vazquez G, Bird GS, Putney JW, Jr. The trpc3/6/7 subfamily of cation 
channels. Cell calcium. 2003;33:451-461 
207. North RA. Molecular physiology of p2x receptors. Physiological reviews. 
2002;82:1013-1067 
208. Burnstock G, Knight GE. Cellular distribution and functions of p2 receptor 
subtypes in different systems. International review of cytology. 2004;240:31-304 
209. Burnstock G, Ralevic V. Purinergic signaling and blood vessels in health and 
disease. Pharmacological reviews. 2014;66:102-192 
210. Abbracchio MP, Burnstock G. Purinoceptors: Are there families of p2x and p2y 
purinoceptors? Pharmacology & therapeutics. 1994;64:445-475 
211. Burnstock G. Purine and pyrimidine receptors. Cellular and molecular life 
sciences : CMLS. 2007;64:1471-1483 
212. Wang L, Karlsson L, Moses S, Hultgardh-Nilsson A, Andersson M, Borna C, 
Gudbjartsson T, Jern S, Erlinge D. P2 receptor expression profiles in human 
vascular smooth muscle and endothelial cells. Journal of cardiovascular 
pharmacology. 2002;40:841-853 
213. Juul B, Plesner L, Aalkjaer C. Effects of atp and utp on [ca2+]i, membrane 
potential and force in isolated rat small arteries. Journal of vascular research. 
1992;29:385-395 
214. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Vaillant N, Gadeau AP, 
Desgranges C, Scalbert E, Chardin P, Pacaud P, Loirand G. P2y(1), p2y(2), 
p2y(4), and p2y(6) receptors are coupled to rho and rho kinase activation in 
 107 
vascular myocytes. American journal of physiology. Heart and circulatory 
physiology. 2000;278:H1751-1761 
215. You J, Johnson TD, Marrelli SP, Mombouli JV, Bryan RM, Jr. P2u receptor-
mediated release of endothelium-derived relaxing factor/nitric oxide and 
endothelium-derived hyperpolarizing factor from cerebrovascular endothelium in 
rats. Stroke; a journal of cerebral circulation. 1999;30:1125-1133 
216. Robertson PL, Ar D, Goldstein GW. Phosphoinositide metabolism and 
prostacyclin formation in retinal microvascular endothelium: Stimulation by 
adenine nucleotides. Experimental eye research. 1990;50:37-44 
217. Malmsjo M, Chu ZM, Croft K, Erlinge D, Edvinsson L, Beilin LJ. P2y receptor-
induced edhf vasodilatation is of primary importance for the regulation of 
perfusion pressure in the peripheral circulation of the rat. Acta physiologica 
Scandinavica. 2002;174:301-309 
218. Crecelius AR, Kirby BS, Luckasen GJ, Larson DG, Dinenno FA. Atp-mediated 
vasodilatation occurs via activation of inwardly rectifying potassium channels in 
humans. The Journal of physiology. 2012;590:5349-5359 
219. Bodin P, Bailey D, Burnstock G. Increased flow-induced atp release from isolated 
vascular endothelial cells but not smooth muscle cells. British journal of 
pharmacology. 1991;103:1203-1205 
220. Kaczmarek-Hajek K, Lorinczi E, Hausmann R, Nicke A. Molecular and 
functional properties of p2x receptors--recent progress and persisting challenges. 
Purinergic signalling. 2012;8:375-417 
221. Lewis CJ, Evans RJ. Lack of run-down of smooth muscle p2x receptor currents 
recorded with the amphotericin permeabilized patch technique, physiological and 
pharmacological characterization of the properties of mesenteric artery p2x 
receptor ion channels. British journal of pharmacology. 2000;131:1659-1666 
222. Vial C, Evans RJ. P2x(1) receptor-deficient mice establish the native p2x receptor 
and a p2y6-like receptor in arteries. Molecular pharmacology. 2002;62:1438-
1445 
223. Dietrich HH, Horiuchi T, Xiang C, Hongo K, Falck JR, Dacey RG, Jr. 
Mechanism of atp-induced local and conducted vasomotor responses in isolated 
rat cerebral penetrating arterioles. Journal of vascular research. 2009;46:253-264 
224. Yamamoto K, Korenaga R, Kamiya A, Ando J. Fluid shear stress activates ca(2+) 
influx into human endothelial cells via p2x4 purinoceptors. Circulation research. 
2000;87:385-391 
225. Yamamoto K, Sokabe T, Matsumoto T, Yoshimura K, Shibata M, Ohura N, 
Fukuda T, Sato T, Sekine K, Kato S, Isshiki M, Fujita T, Kobayashi M, 
Kawamura K, Masuda H, Kamiya A, Ando J. Impaired flow-dependent control of 
vascular tone and remodeling in p2x4-deficient mice. Nature medicine. 
2006;12:133-137 
226. Auchampach JA. Adenosine receptors and angiogenesis. Circulation research. 
2007;101:1075-1077 
227. Prentice DJ, Payne SL, Hourani SM. Activation of two sites by adenosine 
receptor agonists to cause relaxation in rat isolated mesenteric artery. British 
journal of pharmacology. 1997;122:1509-1515 
 108 
228. Wang S, Zhang Y, Wier WG, Yu X, Zhao M, Hu H, Sun L, He X, Wang Y, 
Wang B, Zang W. Role of store-operated ca(2+) entry in adenosine-induced 
vasodilatation of rat small mesenteric artery. American journal of physiology. 
Heart and circulatory physiology. 2009;297:H347-354 
229. Akatsuka Y, Egashira K, Katsuda Y, Narishige T, Ueno H, Shimokawa H, 
Takeshita A. Atp sensitive potassium channels are involved in adenosine a2 
receptor mediated coronary vasodilatation in the dog. Cardiovascular research. 
1994;28:906-911 
230. Niiya K, Uchida S, Tsuji T, Olsson RA. Glibenclamide reduces the coronary 
vasoactivity of adenosine receptor agonists. The Journal of pharmacology and 
experimental therapeutics. 1994;271:14-19 
231. Randall MD. The involvement of atp-sensitive potassium channels and adenosine 
in the regulation of coronary flow in the isolated perfused rat heart. British 
journal of pharmacology. 1995;116:3068-3074 
232. Hein TW, Belardinelli L, Kuo L. Adenosine a(2a) receptors mediate coronary 
microvascular dilation to adenosine: Role of nitric oxide and atp-sensitive 
potassium channels. The Journal of pharmacology and experimental therapeutics. 
1999;291:655-664 
233. Ray CJ, Marshall JM. The cellular mechanisms by which adenosine evokes 
release of nitric oxide from rat aortic endothelium. The Journal of physiology. 
2006;570:85-96 
234. Coney AM, Marshall JM. Role of adenosine and its receptors in the vasodilatation 
induced in the cerebral cortex of the rat by systemic hypoxia. The Journal of 
physiology. 1998;509 ( Pt 2):507-518 
235. Iliff JJ, D'Ambrosio R, Ngai AC, Winn HR. Adenosine receptors mediate 
glutamate-evoked arteriolar dilation in the rat cerebral cortex. American journal 
of physiology. Heart and circulatory physiology. 2003;284:H1631-1637 
236. Lin CL, Su YF, Dumont AS, Shih HC, Lieu AS, Howng SL, Lee KS, Kwan AL. 
The effect of an adenosine a1 receptor agonist in the treatment of experimental 
subarachnoid hemorrhage-induced cerebrovasospasm. Acta neurochirurgica. 
2006;148:873-879; discussion 879 
237. Ansari HR, Nadeem A, Tilley SL, Mustafa SJ. Involvement of cox-1 in a3 
adenosine receptor-mediated contraction through endothelium in mice aorta. 
American journal of physiology. Heart and circulatory physiology. 
2007;293:H3448-3455 
238. Jarajapu YP, Knot HJ. Role of phospholipase c in development of myogenic tone 
in rat posterior cerebral arteries. American journal of physiology. Heart and 
circulatory physiology. 2002;283:H2234-2238 
239. Slish DF, Welsh DG, Brayden JE. Diacylglycerol and protein kinase c activate 
cation channels involved in myogenic tone. American journal of physiology. 
Heart and circulatory physiology. 2002;283:H2196-2201 
240. Luke T, Maylor J, Undem C, Sylvester JT, Shimoda LA. Kinase-dependent 
activation of voltage-gated ca2+ channels by et-1 in pulmonary arterial myocytes 
during chronic hypoxia. American journal of physiology. Lung cellular and 
molecular physiology. 2012;302:L1128-1139 
 109 
241. Kauffenstein G, Laher I, Matrougui K, Guerineau NC, Henrion D. Emerging role 
of g protein-coupled receptors in microvascular myogenic tone. Cardiovascular 
research. 2012;95:223-232 
242. Harder DR, Narayanan J, Gebremedhin D. Pressure-induced myogenic tone and 
role of 20-hete in mediating autoregulation of cerebral blood flow. American 
journal of physiology. Heart and circulatory physiology. 2011;300:H1557-1565 
243. Randriamboavonjy V, Busse R, Fleming I. 20-hete-induced contraction of small 
coronary arteries depends on the activation of rho-kinase. Hypertension. 
2003;41:801-806 
244. Mederos y Schnitzler M, Storch U, Gudermann T. At1 receptors as 
mechanosensors. Current opinion in pharmacology. 2011;11:112-116 
245. Miao L, Dai Y, Zhang J. Mechanism of rhoa/rho kinase activation in endothelin-
1- induced contraction in rabbit basilar artery. American journal of physiology. 
Heart and circulatory physiology. 2002;283:H983-989 
246. Allahdadi KJ, Hannan JL, Tostes RC, Webb RC. Endothelin-1 induces 
contraction of female rat internal pudendal and clitoral arteries through et(a) 
receptor and rho-kinase activation. The journal of sexual medicine. 2010;7:2096-
2103 
247. Potts LB, Ren Y, Lu G, Kuo E, Ngo E, Kuo L, Hein TW. Constriction of retinal 
arterioles to endothelin-1: Requisite role of rho kinase independent of protein 
kinase c and l-type calcium channels. Investigative ophthalmology & visual 
science. 2012;53:2904-2912 
248. Grisk O, Schluter T, Reimer N, Zimmermann U, Katsari E, Plettenburg O, Lohn 
M, Wollert HG, Rettig R. The rho kinase inhibitor sar407899 potently inhibits 
endothelin-1-induced constriction of renal resistance arteries. Journal of 
hypertension. 2012;30:980-989 
249. Nishikawa Y, Doi M, Koji T, Watanabe M, Kimura S, Kawasaki S, Ogawa A, 
Sasaki K. The role of rho and rho-dependent kinase in serotonin-induced 
contraction observed in bovine middle cerebral artery. The Tohoku journal of 
experimental medicine. 2003;201:239-249 
250. El-Yazbi AF, Johnson RP, Walsh EJ, Takeya K, Walsh MP, Cole WC. Pressure-
dependent contribution of rho kinase-mediated calcium sensitization in serotonin-
evoked vasoconstriction of rat cerebral arteries. The Journal of physiology. 
2010;588:1747-1762 
251. Gokina NI, Park KM, McElroy-Yaggy K, Osol G. Effects of rho kinase inhibition 
on cerebral artery myogenic tone and reactivity. J Appl Physiol (1985). 
2005;98:1940-1948 
252. Jarajapu YP, Knot HJ. Relative contribution of rho kinase and protein kinase c to 
myogenic tone in rat cerebral arteries in hypertension. American journal of 
physiology. Heart and circulatory physiology. 2005;289:H1917-1922 
253. Schubert R, Kalentchuk VU, Krien U. Rho kinase inhibition partly weakens 
myogenic reactivity in rat small arteries by changing calcium sensitivity. 
American journal of physiology. Heart and circulatory physiology. 
2002;283:H2288-2295 
 110 
254. Dubroca C, You D, Levy BI, Loufrani L, Henrion D. Involvement of rhoa/rho 
kinase pathway in myogenic tone in the rabbit facial vein. Hypertension. 
2005;45:974-979 
255. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, 
Yamagami K, Inui J, Maekawa M, Narumiya S. Calcium sensitization of smooth 
muscle mediated by a rho-associated protein kinase in hypertension. Nature. 
1997;389:990-994 
256. Mukai Y, Shimokawa H, Matoba T, Kandabashi T, Satoh S, Hiroki J, Kaibuchi K, 
Takeshita A. Involvement of rho-kinase in hypertensive vascular disease: A novel 
therapeutic target in hypertension. FASEB journal : official publication of the 
Federation of American Societies for Experimental Biology. 2001;15:1062-1064 
257. Seasholtz TM, Zhang T, Morissette MR, Howes AL, Yang AH, Brown JH. 
Increased expression and activity of rhoa are associated with increased DNA 
synthesis and reduced p27(kip1) expression in the vasculature of hypertensive rats. 
Circulation research. 2001;89:488-495 
258. Seko T, Ito M, Kureishi Y, Okamoto R, Moriki N, Onishi K, Isaka N, Hartshorne 
DJ, Nakano T. Activation of rhoa and inhibition of myosin phosphatase as 
important components in hypertension in vascular smooth muscle. Circulation 
research. 2003;92:411-418 
259. Miyagi Y, Carpenter RC, Meguro T, Parent AD, Zhang JH. Upregulation of rho a 
and rho kinase messenger rnas in the basilar artery of a rat model of subarachnoid 
hemorrhage. Journal of neurosurgery. 2000;93:471-476 
260. Sato M, Tani E, Fujikawa H, Kaibuchi K. Involvement of rho-kinase-mediated 
phosphorylation of myosin light chain in enhancement of cerebral vasospasm. 
Circulation research. 2000;87:195-200 
261. Watanabe Y, Faraci FM, Heistad DD. Activation of rho-associated kinase during 
augmented contraction of the basilar artery to serotonin after subarachnoid 
hemorrhage. American journal of physiology. Heart and circulatory physiology. 
2005;288:H2653-2658 
262. Tachibana E, Harada T, Shibuya M, Saito K, Takayasu M, Suzuki Y, Yoshida J. 
Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following 
subarachnoid haemorrhage. Acta neurochirurgica. 1999;141:13-19 
263. Nakamura K, Nishimura J, Hirano K, Ibayashi S, Fujishima M, Kanaide H. 
Hydroxyfasudil, an active metabolite of fasudil hydrochloride, relaxes the rabbit 
basilar artery by disinhibition of myosin light chain phosphatase. Journal of 
cerebral blood flow and metabolism : official journal of the International Society 
of Cerebral Blood Flow and Metabolism. 2001;21:876-885 
264. Nakashima S, Tabuchi K, Shimokawa S, Fukuyama K, Mineta T, Abe M. 
Combination therapy of fasudil hydrochloride and ozagrel sodium for cerebral 
vasospasm following aneurysmal subarachnoid hemorrhage. Neurologia medico-
chirurgica. 1998;38:805-810; discussion 810-801 
265. Kamm KE, Stull JT. The function of myosin and myosin light chain kinase 
phosphorylation in smooth muscle. Annual review of pharmacology and 
toxicology. 1985;25:593-620 
 111 
266. Borman MA, MacDonald JA, Muranyi A, Hartshorne DJ, Haystead TA. Smooth 
muscle myosin phosphatase-associated kinase induces ca2+ sensitization via 
myosin phosphatase inhibition. The Journal of biological chemistry. 
2002;277:23441-23446 
267. Himpens B, Casteels R. Different effects of depolarization and muscarinic 
stimulation on the ca2+/force relationship during the contraction-relaxation cycle 
in the guinea pig ileum. Pflugers Archiv : European journal of physiology. 
1990;416:28-35 
268. Fukata Y, Amano M, Kaibuchi K. Rho-rho-kinase pathway in smooth muscle 
contraction and cytoskeletal reorganization of non-muscle cells. Trends in 
pharmacological sciences. 2001;22:32-39 
269. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, 
Kaibuchi K. Phosphorylation and activation of myosin by rho-associated kinase 
(rho-kinase). The Journal of biological chemistry. 1996;271:20246-20249 
270. Cachero TG, Morielli AD, Peralta EG. The small gtp-binding protein rhoa 
regulates a delayed rectifier potassium channel. Cell. 1998;93:1077-1085 
271. Stirling L, Williams MR, Morielli AD. Dual roles for rhoa/rho-kinase in the 
regulated trafficking of a voltage-sensitive potassium channel. Molecular biology 
of the cell. 2009;20:2991-3002 
272. Seyler C, Duthil-Straub E, Zitron E, Gierten J, Scholz EP, Fink RH, Karle CA, 
Becker R, Katus HA, Thomas D. Task1 (k(2p)3.1) k(+) channel inhibition by 
endothelin-1 is mediated through rho kinase-dependent phosphorylation. British 
journal of pharmacology. 2012;165:1467-1475 
273. Iftinca M, Hamid J, Chen L, Varela D, Tadayonnejad R, Altier C, Turner RW, 
Zamponi GW. Regulation of t-type calcium channels by rho-associated kinase. 
Nature neuroscience. 2007;10:854-860 
274. Moreno-Dominguez A, El-Yazbi AF, Zhu HL, Colinas O, Zhong XZ, Walsh EJ, 
Cole DM, Kargacin GJ, Walsh MP, Cole WC. Cytoskeletal reorganization evoked 
by rho-associated kinase- and protein kinase c-catalyzed phosphorylation of 
cofilin and heat shock protein 27, respectively, contributes to myogenic 
constriction of rat cerebral arteries. The Journal of biological chemistry. 
2014;289:20939-20952 
275. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, Obinata T, 
Ohashi K, Mizuno K, Narumiya S. Signaling from rho to the actin cytoskeleton 
through protein kinases rock and lim-kinase. Science. 1999;285:895-898 
276. Huret JL, Ahmad M, Arsaban M, Bernheim A, Cigna J, Desangles F, Guignard 
JC, Jacquemot-Perbal MC, Labarussias M, Leberre V, Malo A, Morel-Pair C, 
Mossafa H, Potier JC, Texier G, Viguie F, Yau Chun Wan-Senon S, Zasadzinski 
A, Dessen P. Atlas of genetics and cytogenetics in oncology and haematology in 
2013. Nucleic acids research. 2013;41:D920-924 
277. Maruyama Y, Nishida M, Sugimoto Y, Tanabe S, Turner JH, Kozasa T, Wada T, 
Nagao T, Kurose H. Galpha(12/13) mediates alpha(1)-adrenergic receptor-
induced cardiac hypertrophy. Circulation research. 2002;91:961-969 
278. Takahashi N, Shiomi H, Kushida N, Liu F, Ishibashi K, Yanagida T, Shishido K, 
Aikawa K, Yamaguchi O. Obstruction alters muscarinic receptor-coupled 
 112 
rhoa/rho-kinase pathway in the urinary bladder of the rat. Neurourology and 
urodynamics. 2009;28:257-262 
279. Ito K, Shimomura E, Iwanaga T, Shiraishi M, Shindo K, Nakamura J, Nagumo H, 
Seto M, Sasaki Y, Takuwa Y. Essential role of rho kinase in the ca2+ 
sensitization of prostaglandin f(2alpha)-induced contraction of rabbit aortae. The 
Journal of physiology. 2003;546:823-836 
280. van Nieuw Amerongen GP, van Delft S, Vermeer MA, Collard JG, van Hinsbergh 
VW. Activation of rhoa by thrombin in endothelial hyperpermeability: Role of 
rho kinase and protein tyrosine kinases. Circulation research. 2000;87:335-340 
281. Forti FL, Armelin HA. Vasopressin triggers senescence in k-ras transformed cells 
via rhoa-dependent downregulation of cyclin d1. Endocrine-related cancer. 
2007;14:1117-1125 
282. Tahara M, Morishige K, Sawada K, Ikebuchi Y, Kawagishi R, Tasaka K, Murata 
Y. Rhoa/rho-kinase cascade is involved in oxytocin-induced rat uterine 
contraction. Endocrinology. 2002;143:920-929 
283. Kakiashvili E, Dan Q, Vandermeer M, Zhang Y, Waheed F, Pham M, Szaszi K. 
The epidermal growth factor receptor mediates tumor necrosis factor-alpha-
induced activation of the erk/gef-h1/rhoa pathway in tubular epithelium. The 
Journal of biological chemistry. 2011;286:9268-9279 
284. Kimura K, Eguchi S. Angiotensin ii type-1 receptor regulates rhoa and rho-
kinase/rock activation via multiple mechanisms. Focus on "angiotensin ii induces 
rhoa activation through shp2-dependent dephosphorylation of the rhogap p190a in 
vascular smooth muscle cells". American journal of physiology. Cell physiology. 
2009;297:C1059-1061 
285. Boquet P. Bacterial toxins inhibiting or activating small gtp-binding proteins. 
Annals of the New York Academy of Sciences. 1999;886:83-90 
286. Sugai M, Hashimoto K, Kikuchi A, Inoue S, Okumura H, Matsumoto K, Goto Y, 
Ohgai H, Moriishi K, Syuto B, et al. Epidermal cell differentiation inhibitor adp-
ribosylates small gtp-binding proteins and induces hyperplasia of epidermis. The 
Journal of biological chemistry. 1992;267:2600-2604 
287. Fujihara H, Walker LA, Gong MC, Lemichez E, Boquet P, Somlyo AV, Somlyo 
AP. Inhibition of rhoa translocation and calcium sensitization by in vivo adp-
ribosylation with the chimeric toxin dc3b. Molecular biology of the cell. 
1997;8:2437-2447 
288. Gong MC, Iizuka K, Nixon G, Browne JP, Hall A, Eccleston JF, Sugai M, 
Kobayashi S, Somlyo AV, Somlyo AP. Role of guanine nucleotide-binding 
proteins--ras-family or trimeric proteins or both--in ca2+ sensitization of smooth 
muscle. Proceedings of the National Academy of Sciences of the United States of 
America. 1996;93:1340-1345 
289. Lucius C, Arner A, Steusloff A, Troschka M, Hofmann F, Aktories K, Pfitzer G. 
Clostridium difficile toxin b inhibits carbachol-induced force and myosin light 
chain phosphorylation in guinea-pig smooth muscle: Role of rho proteins. The 
Journal of physiology. 1998;506 ( Pt 1):83-93 
 113 
290. Wei Y, Zhang Y, Derewenda U, Liu X, Minor W, Nakamoto RK, Somlyo AV, 
Somlyo AP, Derewenda ZS. Crystal structure of rhoa-gdp and its functional 
implications. Nature structural biology. 1997;4:699-703 
291. Flatau G, Lemichez E, Gauthier M, Chardin P, Paris S, Fiorentini C, Boquet P. 
Toxin-induced activation of the g protein p21 rho by deamidation of glutamine. 
Nature. 1997;387:729-733 
292. Amano M, Chihara K, Nakamura N, Kaneko T, Matsuura Y, Kaibuchi K. The 
cooh terminus of rho-kinase negatively regulates rho-kinase activity. The Journal 
of biological chemistry. 1999;274:32418-32424 
293. Riento K, Ridley AJ. Rocks: Multifunctional kinases in cell behaviour. Nature 
reviews. Molecular cell biology. 2003;4:446-456 
294. Loirand G, Guerin P, Pacaud P. Rho kinases in cardiovascular physiology and 
pathophysiology. Circulation research. 2006;98:322-334 
295. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S. Rock-i and 
rock-ii, two isoforms of rho-associated coiled-coil forming protein 
serine/threonine kinase in mice. FEBS letters. 1996;392:189-193 
296. Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M, Nakano T, 
Okawa K, Iwamatsu A, Kaibuchi K. Rho-associated kinase, a novel 
serine/threonine kinase, as a putative target for small gtp binding protein rho. The 
EMBO journal. 1996;15:2208-2216 
297. Leung T, Manser E, Tan L, Lim L. A novel serine/threonine kinase binding the 
ras-related rhoa gtpase which translocates the kinase to peripheral membranes. 
The Journal of biological chemistry. 1995;270:29051-29054 
298. Kimura K, Fukata Y, Matsuoka Y, Bennett V, Matsuura Y, Okawa K, Iwamatsu 
A, Kaibuchi K. Regulation of the association of adducin with actin filaments by 
rho-associated kinase (rho-kinase) and myosin phosphatase. The Journal of 
biological chemistry. 1998;273:5542-5548 
299. Feng J, Ito M, Kureishi Y, Ichikawa K, Amano M, Isaka N, Okawa K, Iwamatsu 
A, Kaibuchi K, Hartshorne DJ, Nakano T. Rho-associated kinase of chicken 
gizzard smooth muscle. The Journal of biological chemistry. 1999;274:3744-3752 
300. Chen XQ, Tan I, Ng CH, Hall C, Lim L, Leung T. Characterization of rhoa-
binding kinase rokalpha implication of the pleckstrin homology domain in 
rokalpha function using region-specific antibodies. The Journal of biological 
chemistry. 2002;277:12680-12688 
301. Ward Y, Yap SF, Ravichandran V, Matsumura F, Ito M, Spinelli B, Kelly K. The 
gtp binding proteins gem and rad are negative regulators of the rho-rho kinase 
pathway. The Journal of cell biology. 2002;157:291-302 
302. Riento K, Guasch RM, Garg R, Jin B, Ridley AJ. Rhoe binds to rock i and 
inhibits downstream signaling. Molecular and cellular biology. 2003;23:4219-
4229 
303. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle 
myosin ii: Modulated by g proteins, kinases, and myosin phosphatase. 
Physiological reviews. 2003;83:1325-1358 
304. Liao JK, Seto M, Noma K. Rho kinase (rock) inhibitors. Journal of 
cardiovascular pharmacology. 2007;50:17-24 
 114 
305. Mallat Z, Gojova A, Sauzeau V, Brun V, Silvestre JS, Esposito B, Merval R, 
Groux H, Loirand G, Tedgui A. Rho-associated protein kinase contributes to early 
atherosclerotic lesion formation in mice. Circulation research. 2003;93:884-888 
306. Kishore R, Qin G, Luedemann C, Bord E, Hanley A, Silver M, Gavin M, Yoon 
YS, Goukassian D, Losordo DW. The cytoskeletal protein ezrin regulates ec 
proliferation and angiogenesis via tnf-alpha-induced transcriptional repression of 
cyclin a. The Journal of clinical investigation. 2005;115:1785-1796 
307. Toshima Y, Satoh S, Ikegaki I, Asano T. A new model of cerebral 
microthrombosis in rats and the neuroprotective effect of a rho-kinase inhibitor. 
Stroke; a journal of cerebral circulation. 2000;31:2245-2250 
308. Bivalacqua TJ, Champion HC, Usta MF, Cellek S, Chitaley K, Webb RC, Lewis 
RL, Mills TM, Hellstrom WJ, Kadowitz PJ. Rhoa/rho-kinase suppresses 
endothelial nitric oxide synthase in the penis: A mechanism for diabetes-
associated erectile dysfunction. Proceedings of the National Academy of Sciences 
of the United States of America. 2004;101:9121-9126 
309. Bao W, Hu E, Tao L, Boyce R, Mirabile R, Thudium DT, Ma XL, Willette RN, 
Yue TL. Inhibition of rho-kinase protects the heart against ischemia/reperfusion 
injury. Cardiovascular research. 2004;61:548-558 
310. Hudson CA, Heesom KJ, Lopez Bernal A. Phasic contractions of isolated human 
myometrium are associated with rho-kinase (rock)-dependent phosphorylation of 
myosin phosphatase-targeting subunit (mypt1). Molecular human reproduction. 
2012;18:265-279 
311. Kawano Y, Fukata Y, Oshiro N, Amano M, Nakamura T, Ito M, Matsumura F, 
Inagaki M, Kaibuchi K. Phosphorylation of myosin-binding subunit (mbs) of 
myosin phosphatase by rho-kinase in vivo. The Journal of cell biology. 
1999;147:1023-1038 
312. Ohashi K, Nagata K, Maekawa M, Ishizaki T, Narumiya S, Mizuno K. Rho-
associated kinase rock activates lim-kinase 1 by phosphorylation at threonine 508 
within the activation loop. The Journal of biological chemistry. 2000;275:3577-
3582 
313. Sumi T, Matsumoto K, Nakamura T. Specific activation of lim kinase 2 via 
phosphorylation of threonine 505 by rock, a rho-dependent protein kinase. The 
Journal of biological chemistry. 2001;276:670-676 
314. Osol G, Laher I, Cipolla M. Protein kinase c modulates basal myogenic tone in 
resistance arteries from the cerebral circulation. Circulation research. 
1991;68:359-367 
315. Liu J, Hill MA, Meininger GA. Mechanisms of myogenic enhancement by 
norepinephrine. The American journal of physiology. 1994;266:H440-446 
316. Bakker EN, Kerkhof CJ, Sipkema P. Signal transduction in spontaneous 
myogenic tone in isolated arterioles from rat skeletal muscle. Cardiovascular 
research. 1999;41:229-236 
317. Dessy C, Matsuda N, Hulvershorn J, Sougnez CL, Sellke FW, Morgan KG. 
Evidence for involvement of the pkc-alpha isoform in myogenic contractions of 
the coronary microcirculation. American journal of physiology. Heart and 
circulatory physiology. 2000;279:H916-923 
 115 
318. Miller FJ, Jr., Dellsperger KC, Gutterman DD. Myogenic constriction of human 
coronary arterioles. The American journal of physiology. 1997;273:H257-264 
319. Coats P, Johnston F, MacDonald J, McMurray JJ, Hillier C. Signalling 
mechanisms underlying the myogenic response in human subcutaneous resistance 
arteries. Cardiovascular research. 2001;49:828-837 
320. Korzick DH, Laughlin MH, Bowles DK. Alterations in pkc signaling underlie 
enhanced myogenic tone in exercise-trained porcine coronary resistance arteries. J 
Appl Physiol (1985). 2004;96:1425-1432 
321. Garcia ZI, Bruhl A, Gonzales AL, Earley S. Basal protein kinase cdelta activity is 
required for membrane localization and activity of trpm4 channels in cerebral 
artery smooth muscle cells. Channels. 2011;5:210-214 
322. Minami K, Fukuzawa K, Nakaya Y. Protein kinase c inhibits the ca(2+)-activated 
k+ channel of cultured porcine coronary artery smooth muscle cells. Biochemical 
and biophysical research communications. 1993;190:263-269 
323. Schubert R, Noack T, Serebryakov VN. Protein kinase c reduces the kca current 
of rat tail artery smooth muscle cells. The American journal of physiology. 
1999;276:C648-658 
324. Taguchi K, Kaneko K, Kubo T. Protein kinase c modulates ca2+-activated k+ 
channels in cultured rat mesenteric artery smooth muscle cells. Biological & 
pharmaceutical bulletin. 2000;23:1450-1454 
325. Zhou XB, Wulfsen I, Utku E, Sausbier U, Sausbier M, Wieland T, Ruth P, Korth 
M. Dual role of protein kinase c on bk channel regulation. Proceedings of the 
National Academy of Sciences of the United States of America. 2010;107:8005-
8010 
326. Kunduri S, Dick G, Nayeem M, Mustafa S. Adenosine a receptor signaling 
inhibits bk channels through a pkcalpha-dependent mechanism in mouse aortic 
smooth muscle. Physiological reports. 2013;1 
327. Chrissobolis S, Sobey CG. Inhibitory effects of protein kinase c on inwardly 
rectifying k+- and atp-sensitive k+ channel-mediated responses of the basilar 
artery. Stroke; a journal of cerebral circulation. 2002;33:1692-1697 
328. Park WS, Han J, Kim N, Youm JB, Joo H, Kim HK, Ko JH, Earm YE. 
Endothelin-1 inhibits inward rectifier k+ channels in rabbit coronary arterial 
smooth muscle cells through protein kinase c. Journal of cardiovascular 
pharmacology. 2005;46:681-689 
329. Park WS, Kim N, Youm JB, Warda M, Ko JH, Kim SJ, Earm YE, Han J. 
Angiotensin ii inhibits inward rectifier k+ channels in rabbit coronary arterial 
smooth muscle cells through protein kinase calpha. Biochemical and biophysical 
research communications. 2006;341:728-735 
330. Wu BN, Luykenaar KD, Brayden JE, Giles WR, Corteling RL, Wiehler WB, 
Welsh DG. Hyposmotic challenge inhibits inward rectifying k+ channels in 
cerebral arterial smooth muscle cells. American journal of physiology. Heart and 
circulatory physiology. 2007;292:H1085-1094 
331. Cobine CA, Callaghan BP, Keef KD. Role of l-type calcium channels and pkc in 
active tone development in rabbit coronary artery. American journal of physiology. 
Heart and circulatory physiology. 2007;292:H3079-3088 
 116 
332. Navedo MF, Amberg GC, Nieves M, Molkentin JD, Santana LF. Mechanisms 
underlying heterogeneous ca2+ sparklet activity in arterial smooth muscle. The 
Journal of general physiology. 2006;127:611-622 
333. Shistik E, Ivanina T, Blumenstein Y, Dascal N. Crucial role of n terminus in 
function of cardiac l-type ca2+ channel and its modulation by protein kinase c. 
The Journal of biological chemistry. 1998;273:17901-17909 
334. D'Angelo G, Davis MJ, Meininger GA. Calcium and mechanotransduction of the 
myogenic response. The American journal of physiology. 1997;273:H175-182 
335. Yeon DS, Kim JS, Ahn DS, Kwon SC, Kang BS, Morgan KG, Lee YH. Role of 
protein kinase c- or rhoa-induced ca(2+) sensitization in stretch-induced 
myogenic tone. Cardiovascular research. 2002;53:431-438 
336. Karibe A, Watanabe J, Horiguchi S, Takeuchi M, Suzuki S, Funakoshi M, Katoh 
H, Keitoku M, Satoh S, Shirato K. Role of cytosolic ca2+ and protein kinase c in 
developing myogenic contraction in isolated rat small arteries. The American 
journal of physiology. 1997;272:H1165-1172 
337. Lagaud G, Gaudreault N, Moore ED, Van Breemen C, Laher I. Pressure-
dependent myogenic constriction of cerebral arteries occurs independently of 
voltage-dependent activation. American journal of physiology. Heart and 
circulatory physiology. 2002;283:H2187-2195 
338. Wesselman JP, Spaan JA, van der Meulen ET, VanBavel E. Role of protein 
kinase c in myogenic calcium-contraction coupling of rat cannulated mesenteric 
small arteries. Clinical and experimental pharmacology & physiology. 
2001;28:848-855 
339. Eto M, Ohmori T, Suzuki M, Furuya K, Morita F. A novel protein phosphatase-1 
inhibitory protein potentiated by protein kinase c. Isolation from porcine aorta 
media and characterization. Journal of biochemistry. 1995;118:1104-1107 
340. Kitazawa T, Eto M, Woodsome TP, Brautigan DL. Agonists trigger g protein-
mediated activation of the cpi-17 inhibitor phosphoprotein of myosin light chain 
phosphatase to enhance vascular smooth muscle contractility. The Journal of 
biological chemistry. 2000;275:9897-9900 
341. Kitazawa T, Takizawa N, Ikebe M, Eto M. Reconstitution of protein kinase c-
induced contractile ca2+ sensitization in triton x-100-demembranated rabbit 
arterial smooth muscle. The Journal of physiology. 1999;520 Pt 1:139-152 
342. Vinters HV, Wang ZZ, Secor DL. Brain parenchymal and microvascular amyloid 
in alzheimer's disease. Brain pathology. 1996;6:179-195 
343. Cipolla MJ, Chan SL, Sweet J, Tavares MJ, Gokina N, Brayden JE. Postischemic 
reperfusion causes smooth muscle calcium sensitization and vasoconstriction of 
parenchymal arterioles. Stroke; a journal of cerebral circulation. 2014;45:2425-
2430 
 
 
  
 117 
CHAPTER 2: JOURNAL ARTICLE 
 
TRPM4 channels couple purinergic receptor activation and myogenic 
tone development in cerebral parenchymal arterioles 
Yao Li, B.S. Rachael L. Baylie, Ph.D. Matthew J. Tavares, B.S.  
Joseph E. Brayden, Ph.D. 
Department of Pharmacology, College of Medicine, University of Vermont, 
Burlington, Vermont, USA 
 
Correspondence:   
Joseph E. Brayden 
Department of Pharmacology 
89 Beaumont Avenue 
Given Building 
Burlington, VT  05405  USA 
 
FAX: (802) 656-4523 
Telephone: (802) 656-1985 
Email:  joe.brayden@uvm.edu 
 
Running headline: TRPM4 couples P2Y receptors and myogenic tone 
  
 118 
Abstract 
Cerebral parenchymal arterioles (PAs) play a critical role in assuring appropriate blood 
flow and perfusion pressure within the brain. PAs are unique in contrast to upstream pial 
arteries, as defined by their critical roles in neurovascular coupling, distinct sensitivities 
to chemical stimulants, and enhanced myogenic tone development.  The objective of the 
present study was to reveal some of the unique mechanisms of myogenic tone regulation 
in the cerebral microcirculation. Here we report that in vivo suppression of TRPM4 
channel expression, or inhibition of TRPM4 channels with 9-phenanthrol substantially 
reduced myogenic tone of isolated PAs, supporting a key role of TRPM4 channels in PA 
myogenic tone development. Further, downregulation of TRPM4 channels inhibited 
vasoconstriction induced by the specific P2Y4 and P2Y6 receptor ligands (UTPγS and 
UDP) by 37% and 42%, respectively. In addition, 9-phenanthrol substantially attenuated 
purinergic ligand-induced membrane depolarization and constriction of PAs, and 
inhibited ligand-evoked TRPM4 channel activation in isolated PA myocytes. In concert 
with our previous work showing the essential contributions of P2Y4 and P2Y6 receptors 
to myogenic regulation of PAs, the current results point to TRPM4 channels as an 
important link between mechanosensitive P2Y receptor activation and myogenic 
constriction of cerebral parenchymal arterioles. 
Keywords 
Cerebral arteriole, myogenic tone, P2Y-receptor, TRPM4, vasoconstriction 
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Introduction 
While the regulation of vascular tone in cerebral pial arteries has been intensely 
investigated, mechanistic studies of the intracerebral vessels branching from the surface 
arteries, i.e. the cerebral parenchymal arterioles (PAs), are uncommon, despite the fact 
that the PAs have unique functional roles and properties. PAs contribute to as much as 
40% of cerebrovascular resistance and play a key role in regulating local blood flow 
within the brain1. By maintaining appropriate local perfusion pressure, PAs serve to 
protect downstream capillaries from the potential damaging effects of high intravascular 
pressure1. When these small arterioles branch from pial arteries to perfuse the cerebral 
cortex, they enter a unique environment where surrounding astrocytes and neurons 
modulate vascular diameter and blood flow through a process called neurovascular 
coupling2, 3.  In addition, compared to pial arteries, the distinct features of PAs involve 
different responses to vasoconstrictors4, 5, altered ion channel function6, and enhanced 
myogenic responsiveness2. It is therefore likely that some of the fundamental contractile 
mechanisms in PA smooth muscle are unique as well. Since PAs are major sites of 
cerebral small vessel diseases (SVD)7, a better understanding of vascular tone regulation 
in PAs may reveal potential therapeutic targets for treatment of cerebral microvascular 
diseases.    
As one of the essential processes that modulate vascular tone, myogenic reactivity 
represents the ability of small arteries and arterioles to constrict and reduce their diameter 
in response to increased intravascular pressure. Myogenic regulation ensures that blood 
flow remains relatively constant despite moment-to-moment fluctuations in arterial 
pressure. In the brain, myogenic tone is an essential contributor to cerebral 
 120 
autoregulation. Mechanisms of myogenic tone development have been extensively 
studied and it is well established that vascular smooth muscle cells respond to increased 
intraluminal pressure via membrane depolarization8, calcium entry through voltage-
dependent calcium channels and subsequent vasoconstriction9. However, the signaling 
pathways responsible for pressure-induced membrane depolarization have not been fully 
elucidated. Prior research in our laboratory demonstrated a critical role of transient 
receptor potential (TRP) channels, specifically TRPM4, in this mechanism involving 
monovalent cation influx (mainly Na+) and membrane depolarization in the smooth 
muscle cells of cerebral pial arteries10. Further studies of this channel revealed that it is 
regulated by protein kinase C (PKC) and Ca2+ release from the sarcoplasmic reticulum11, 
12. However, neither the significance nor the regulation of TRPM4 channels has been 
investigated in the PAs.  
Another recent finding from our laboratory indicates the essential contribution of 
G protein-coupled receptors (GPCRs), specifically P2Y4 and P2Y6 purinergic receptors, 
to myogenic responsiveness of PAs via mechanosensitive receptor activation, which 
triggers vascular smooth muscle contraction5, similar to a proposed role for angiotensin II 
receptors in pial arteries13. Following from this novel finding, a major goal of the current 
study was to explore the possible interactions between TRPM4 channels and P2Y 
receptors. We hypothesized that P2Y4 and P2Y6 receptors regulate TRPM4 channel 
activity to mediate pressure-induced depolarization and myogenic vasoconstriction in 
cerebral PAs. The results of the present study support this hypothesis by demonstrating 
that downregulation of TRPM4 channel expression or pharmacologically blocking 
TRPM4 channels substantially attenuates pressure- and P2Y receptor ligand-induced 
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vascular and cellular responses, indicating a key role of TRPM4 channels in the P2Y 
receptor-mediated myogenic regulation of cerebral PAs. 
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Materials and Methods 
Animals 
All protocols and experimental procedures used in this research project were approved by 
the University of Vermont Institutional Animal Care and Use Committee. Male, Sprague-
Dawley rats (15 to 20 weeks old; Charles River Laboratories, Saint Constant, QC, 
Canada) were used for all experiments.  
 
Suppression of TRPM4 Channels in vivo 
Antisense and sense oligodeoxynucleotides (ODNs) were designed based on the 
published rat TRPM4 sequence (RGD: 620244). Antisense ODN sequences were: 
TRPM4 AS-1, 5’-GTGTGCACCGCGGTACCCCG-3’; TRPM4 AS-2, 5’-
GCCCTCATGAATCCCAGTAA-3’. Control animals were treated with sense ODNs: 
TRPM4 S-1, 5’-CGGGGTACCGCGGTGCACAC-3’; TRPM4 S-2, 5’-
TTACTGGGATTCATGAGGGC-3’. The last four bases on the 5’ and 3’ ends were 
phosphorothioated to limit ODN degradation. All ODNs were synthesized by Integrated 
DNA Technologies Inc. (San Diego, CA, USA). ODNs were dissolved in bicarbonate-
free artificial cerebral spinal fluid solution (in mmmol/L): 130 NaCl, 3 KCl, 2 
CaCl2·2H2O, 1 MgCl2, 3 Na2HPO4·12H2O, 0.45 NaH2PO4·H2O. Rats were initially 
anesthetized by isoflurane (5%) in an induction chamber and then maintained on 
isoflurane (2-3%) inhaled via a nose cone. A small (0.5-1.5 cm) longitudinal, midline 
incision was centered over the foramen magnum, and the neck muscle was dissected until 
the dura was visualized. ODNs (100 µL, 0.8 mmol/L) were injected through the dura into 
the cisterna magna (day 0) using an insulin syringe with a 31-gauge needle. Muscle and 
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skin were then sutured and the rat was placed on a heating pad until recovery from 
anesthesia. Twenty-four hours later (day 1), a second injection of ODNs solution (100 
µL, 0.8 mmol/L) was delivered by repeating the above procedure. Buprenorphine (0.01 
mg/kg) was injected every 12 h (for 36 h) as an analgesic. Rats were euthanized on day 2 
for further experimental procedures.   
 
Tissue Preparation 
Rats were euthanized by an overdose of sodium pentobarbital (120 mg/kg, intraperitoneal 
injection) followed by exsanguination. The brain was rapidly removed and placed in cold 
(4 °C) MOPS buffered physiological salt solution (PSS) (in mmol/L): 3 MOPS, 145 
NaCl, 5 KCl, 1 MgSO4, 2.5 CaCl2, 1 KH2PO4, 2 sodium pyruvate, 5 glucose, 1% albumin 
from bovine serum, pH 7.4. Middle cerebral arteries (MCAs) and attached parenchymal 
arterioles (PAs) were isolated from the brain as previously described14 and transferred to 
a small volume of MOPS buffered PSS for further experimental use. 
 
RT-PCR for TRPM4 Channel Message 
Total RNA was prepared from isolated cerebral pial and parenchymal arteries using RNA 
STAT-60 total RNA isolation reagent (Tel-test inc., Friendswood, TX, USA). First-strand 
cDNA for pial and parenchymal arteries was prepared from 1320 ng total RNA, and 620 
ng total RNA, respectively, using the Qiagen (Valencia, CA, USA) Sensiscript Reverse 
Transcriptase kit. Semi-quantitative PCR was performed using HotStarTaq DNA 
Polymerase (Qiagen). Amplification of the same templates for glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) served as internal control, and TRPC6 channel 
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transcript expression served to indicate the specificity of TRPM4 antisense ODNs. PCR 
reactions were hot started at 94°C for 15 minutes and exposed to 38 cycles of 94°C for 60 
s, 60°C for 60 s, and 72°C for 60 s, followed by final extension at 72°C for 10 minutes. 
All reaction products were resolved on 1.8% agarose gels. Primer sequences are listed in 
Table 1. 
 
Pressure Myography 
Parenchymal arteriolar segments were cannulated on glass pipettes in an arteriograph 
chamber (Living Systems, Burlington, VT, USA) containing a bicarbonate-buffered 
artificial cerebral spinal fluid (aCSF) of the following composition (in mmol/L): 136 
NaCl, 3 KCl, 15 NaHCO3, 1.25 NaH2PO4, 1 MgCl2, 4 glucose, 2 CaCl2 (temperature 37 
°C and pH 7.3). For most experiments, in order to eliminate endothelial responses to P2Y 
receptor agonists, arterioles were stripped of endothelium by passing air bubbles through 
the arteriolar lumen. Arterioles were pressurized at 5 mmHg (with no flow), and 
superfused with warmed (37 °C), gassed (20% O2/5% CO2/balance N2) aCSF. As an 
initial check of tissue viability, arterioles were reversibly constricted with the 
thromboxane receptor activator U46619 (100 nmol/L) (Enzo Life Sciences Inc., 
Farmingdale, NY, USA). Vessels were rejected for study if constrictions to U46619 were 
less than a 60% decrease in diameter. In experiments where myogenic constriction was 
not desired, e.g. agonist-induced vasoconstriction, intraluminal pressure was controlled at 
3-5 mmHg. In experiments where steady myogenic tone was desired, PAs were 
pressurized to 40 mmHg. After steady myogenic tone developed, PAs were exposed to 
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IKCa and SKCa channel activator NS 309 (1 µmol/L). Absence of a dilator response to NS 
309 indicated successful endothelial cell removal.  
 
Membrane Potential 
Arterioles were cannulated as described above and pressurized to 5 mmHg. The 
endothelium was removed from all vessels to eliminate any contribution of endothelial 
components to membrane potential. Nimodipine (300 nmol/L) (Calbiochem, San Diego, 
CA, USA) was included in aCSF prior to membrane potential measurements to prevent 
excessive vessel movement. Smooth muscle membrane potential was measured by 
insertion of a sharp glass microelectrode (~200 MΩ resistance when filled with 0.5 mol/L 
KCl) into the vessel wall. The criteria for successful impalement were 1) an abrupt 
negative potential deflection upon entry, 2) a stable membrane potential for at least 30s, 
and 3) an abrupt positive potential deflection to 0 mV upon electrode withdrawal. 
Measurements were made with an electrometer (World Precision Instruments) and 
recorded via computer with AxoScope and Dataq software. 
 
Single Cell Isolation 
Arterioles were placed in a cell isolation solution containing (in mmol/L): 55 NaCl, 80 
Na Glutamate, 5.6 KCl, 2 MgCl2, 10 HEPES, 10 Glucose, (pH 7.3). Arteriolar segments 
were initially incubated in 0.5 mg/ml papain (Worthington Biochemical Corp. Lakewood, 
NJ, USA) and 1.0 mg/ml dithioerythritol for 12 min at 37 °C and then in 1.0 mg/ml 
collagenase type F for 10 mins at 37 °C. The digested segments were washed three times 
in ice-cold cell isolation solution and incubated on ice for 30 min. Digested arterioles 
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were triturated to liberate smooth muscle cells and stored in ice-cold cell isolation 
solution for use. Smooth muscle cells were studied within 5 h following isolation. 
 
Patch Clamp Recordings 
Isolated smooth muscle cells were placed into a recording chamber and allowed to adhere 
to glass coverslips for 20 minutes at room temperature. Whole cell currents were 
recorded with an AxoPatch 200B amplifier (Axon instruments) equipped with an Axon 
CV 2032wBU headstage (Molecular Devices). Recording electrodes (3-5 MΩ) were 
pulled from boroscilicate glass (Sutter Instrument, Navato, CA, USA). Gigaohm seals 
were obtained in bath solution of the following composition (in mmol/L): 134 NaCl, 6 
KCl, 1 MgCl2, 2 CaCl2, 10 HEPES and 10 glucose, pH 7.4. The pipette solution 
contained (in mmol/L): 85 K-aspartate, 1 MgCl2, 30 KCl, 10 NaCl, 10 HEPES, 5 μmol/L 
EGTA with pH adjusted to 7.2 with KOH. Nystatin (200 μg/ml) was included in the 
pipette solution to perforate the cell membrane. Perforation was deemed acceptable when 
series resistance was less than 50 MΩ. Currents were filtered at 1 kHz, sampled at 2 kHz, 
and stored for subsequent analysis. Clampex and Clampfit version 9.2 (Molecular 
Devices) were utilized for data acquisition and analysis, respectively. For all experiments, 
membrane potential was held at -70 mV, and all recordings were performed at room 
temperature (22 °C). TRPM4 channel activity was calculated as the sum of the open 
probability (NPo) of multiple open states of 1.75 pA. This value was based on the 
reported unitary conductance of TRPM4 (25 pS). NPo was calculated using the following 
equation:  
    NPo = [(t j · j)/T]
J=1
N
å  
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where Po is the open state probability, tj is time spent (in seconds) with j = 1,2,…,N 
channels open. N is maximum number of channels observed, and T is duration of 
measurement. 
 
Chemical and Reagents 
Buffer reagents, dissociation enzymes, nystatin, UDP and 9-phenanthrol were purchased 
from Sigma-Aldrich (St Louis, MO, USA). UTPγS was purchased from Tocris 
(Minneapolis, MN, USA). Nimodipine was dissolved in DMSO to a final solvent 
concentration of 0.1%. All other compounds were dissolved in the appropriate salt 
solution.  
 
Statistical Analysis 
Values are expressed as Mean ± SEM, and n indicates the number of animals. Myogenic 
tone under different conditions was typically normalized as percentage tone, and 
calculated as follows: 
% Tone = [(Passive diameter – Constricted diameter)/Passive diameter]×100, 
where “Passive diameter” is the diameter in Ca2+-free aCSF. 
 
For P2Y receptor agonist responses, constrictions were expressed as percent of the 
maximum contraction induced by the thromboxane receptor activator U46619 (100 
nmo/L). Dilation to NS309 (1 µmol/L) was calculated as percent of maximum dilation as 
follows:  
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Dilation (% maximum) = [Change in diameter/(Passive diameter-Initial 
diameter)]×100. 
Student’s t-test was used to compare two experimental groups. One way ANOVA 
analysis of variance followed by Tukey multiple comparison test was used in the 
comparison of multiple groups. Mean values were considered significantly different at p 
≤ 0.05.  
     
  
 129 
Results 
Inhibition of TRPM4 channels reduces pressure-induced vasoconstriction of 
parenchymal arterioles. 
Previous studies have shown that TRPM4 channels are involved in pressure-induced 
(myogenic) membrane depolarization and constriction of pial arteries. However, the roles 
of these channels in PAs have not been investigated. Therefore, we first determined the 
presence of TRPM4 channel message in parenchymal arteriolar extracts. In agreement 
with previous studies examining the localization of TRPM4 channels in cerebral pial 
arteries, TRPM4 message was detected in PAs (Figure 1A). Next, to explore the 
functional significance of TRPM4 channels, we tested the effects of suppressing TRPM4 
expression on myogenic responses of PAs. Exposure of PAs to TRPM4 antisense 
oligodeoxynucleotides (ODNs) in vivo effectively reduced the expression level of 
TRPM4 channels as indicated by semi-quantitative PCR (Figure 1B). Control 
experiments on cerebral pial arteries also showed a significant reduction on TRPM4 
mRNA level in the TRPM4 antisense group (Supplementary Figure 1). As an additional 
control, we also assessed the effects of TRPM4 antisense on TRPC6 expression level, 
which was previously shown to contribute to myogenic tone development in cerebral pial 
arteries. TRPC6 message level was not affected by TRPM4 antisense (Supplementary 
Figure 1).  
Functional assessment of contractility revealed that PAs exposed in vivo to 
TRPM4 antisense ODNs developed 59%, 55% and 39% less myogenic tone at 20, 40 and 
60 mmHg, respectively, compared with PAs in the sense group (Figure 1C, 1D, 1E).  In 
control tests, we found no significant difference in endothelial cell K+ channel function 
 130 
between TRPM4 sense and antisense-treated PAs, which was indicated by the similar 
dilator responses to NS 309 (1 µmol/L), an activator of small and intermediate 
conductance Ca2+-activiated K+ (SKCa and IKCa) channels (Figure 1F). In parallel 
pharmacological studies, we found that 9-phenanthrol, which specifically inhibits 
TRPM4 channels, substantially attenuated pressure-induced tone of endothelium-denuded 
PAs, with an IC50 of 27.9 μmol/L (Figure 2A, 2B). Thus, the results of both a genetic and 
a pharmacological approach indicated that TRPM4 channels are involved in the 
development of myogenic tone in cerebral PAs.   
 
Inhibition of TRPM4 channels suppresses P2Y purinergic receptor ligand-evoked 
vasoconstriction and membrane depolarization of parenchymal arterioles. 
Interestingly, previous studies from our laboratory have demonstrated the significant 
contributions of P2Y4 and P2Y6 purinergic receptors to myogenic responses of PAs 
through coupling of membrane stretch to vasoconstriction, which is primarily mediated 
by calcium entry through voltage-gated calcium (Cav) channels(5). Since TRPM4 
channels are also implicated in the myogenic constriction of PAs, presumably through 
depolarization and activation of Cav channels, it is logical to hypothesize that TRPM4 
channels are involved in the coupling between activation of mechano-sensitive P2Y 
receptors and pressure-evoked vasoconstriction of PAs. 
To establish a possible link between P2Y receptors and TRPM4 channels, we first 
examined the effects of suppressing TRPM4 expression on the contractile responses of 
endothelium-denuded PAs to P2Y4 and P2Y6 receptor ligands. We found that the 
selective P2Y4 receptor agonist UTPγS (3 μmol/L) triggered 37% less constriction in the 
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TRPM4 antisense-treated PAs than sense-treated PAs. Similarly, constrictions induced by 
the P2Y6 receptor ligand UDP (3 μmol/L) were 42% lower in PAs from the antisense 
group (Figure 3A). Control tests revealed no significant difference between sense and 
antisense groups in the constrictions evoked by the thromboxane receptor ligand U46619 
(100 nmol/L) (Figure 3B). In parallel, we explored the effects of pharmacologically 
blocking TRPM4 channels on the constrictor responses.  We found that the TRPM4 
channel antagonist 9-phenanthrol (10 μmol/L) inhibited UTPγS (0.5 μmol/L) and UDP 
(0.5 μmol/L)-induced constriction of denuded PAs by 44% and 57%, respectively (Figure 
4A, 4B). Since there was no inhibitory effect of 9-phenanthrol (10 µmol/L) on 
vasoconstriction induced by elevation of bath K+ (30 mmol/L K+-aCSF) (Supplementary 
Figure 2), these results suggest a key role of TRPM4 channels in P2Y receptor-mediated 
contractile responses of PAs.  
The proposed link between P2Y receptor activation, TRPM4 channels, and 
constriction of PAs implies that activation of P2Y receptors should induce a 
depolarization of PA myocytes that is inhibited by TRPM4 channel block. Thus, in the 
next series of experiments, we measured smooth muscle membrane potential using 
intracellular microelectrodes before and after the administration of P2Y receptor ligands, 
in the absence and presence of 9-phenanthrol. At 5 mmHg, PA smooth muscle cells 
depolarized from -43 ± 1 mV to -25 ± 1 mV in response to UTPγS (0.5 µmol/L). 
Subsequent administration of 9-phenanthrol (10 µmol/L) reversed the depolarization to -
40 ± 2 mV. Similarly, UDP (0.5 µmol/L) depolarized PA smooth muscle from a resting 
potential of -42 ± 1 mV to -33 ± 1 mV, which did not occur in the presence of 10 µmol/L 
9-phenanthrol (-47 ± 2 mV) (Figure 5A, 5B). These findings clearly demonstrate that 
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TRPM4 channels participate in P2Y4 and P2Y6 receptor-mediated membrane 
depolarization and vasoconstriction of PAs. The critical importance of P2Y receptor-
induced membrane depolarization in the vasomotor response of PAs is strongly 
reinforced by the observation that inhibition of voltage-dependent calcium (Cav) channels 
in these arterioles abolished P2Y receptor-mediated vasoconstrictor responses 
(Supplementary Figure 3). 
 
Activation of P2Y receptors potentiates TRPM4 channel activity in parenchymal 
arteriolar smooth muscle cells. 
In a final series of experiments, direct coupling between P2Y receptors and TRPM4 
channels was assessed using the nystatin-perforated whole cell patch clamp technique. 
The P2Y4 receptor specific ligand UTPγS (0.5 µmol/L) enhanced TRPM4 channel open 
probability by about 3 fold, which was reversed by blocking TRPM4 channels with 9-
phenanthrol (30 µmol/L) (Figure 6A, 6B). Due to the somewhat transient nature of UDP 
current activation, the sequence of administering UDP and 9-phenanthrol was reversed in 
order to determine the effects of TRPM4 channel block. In the absence of 9-phenanthrol, 
the P2Y6 receptor agonist UDP (0.5 µmol/L) elicited a nearly 5-fold increase in TRPM4 
channel activity, which was absent in cells pre-treated with 9-phenanthrol (Figure 6C, 
6D, 6E). These results indicate that TRPM4 channels are regulated by P2Y4 and P2Y6 
receptor activity, further supporting the hypothesis that coupling between P2Y receptors 
and TRPM4 channels is critical in the development of myogenic tone in PAs.  
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Discussion 
Here, we investigated the expression and functional roles of smooth muscle TRPM4 
channels in cerebral intraparenchymal arterioles. The major findings of the present study 
are 1) TRPM4 channels are expressed in rat parenchymal arterioles; 2) administration of 
TRPM4 antisense oligodeoxynucleotides (ODNs) in vivo effectively reduced TRPM4 
expression in both pial and parenchymal arteries, and inhibited myogenic tone and P2Y 
purinergic receptor agonist-evoked vasoconstriction of PAs; 3) the specific TRPM4 
channel blocker 9-phenanthrol reduced myogenic responses, and purinergic ligand-
stimulated depolarization and vasoconstriction; 4) purinergic ligands strongly activated 9-
phenanthrol-sensitive TRPM4 currents in isolated PA smooth muscle cells. Given that 
P2Y4 and P2Y6 receptors have been demonstrated to be important contributors of PA 
myogenic vasoconstriction(5), collectively these results indicate that TRPM4 channels 
are involved in P2Y purinergic receptor-mediated myogenic responses of cerebral PAs. 
 
TRPM4 Channel Presence and Function in Parenchymal Arteriole 
Myogenic tone development is a process by which arterial pressure regulates vascular 
diameter in order to maintain constant blood flow. The mechanisms underlying the 
myogenic response are not entirely clear. However, the primary roles of membrane 
potential and voltage-dependent Ca2+ (Cav) channels have been established.  It is clear 
that increased intraluminal pressure is sensed by vascular smooth muscle cells, which 
subsequently depolarizes the cell membrane potential and increases the open probability 
of Cav channels, resulting in Ca
2+ influx into smooth muscle cells and vasoconstriction9. 
Nevertheless, how a mechanical signal (i.e. membrane stretch) is converted to a cellular 
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response (i.e. membrane depolarization) remains obscure. Previous studies from our 
laboratory focused on the roles of transient receptor potential channels and demonstrated 
that both TRPM4 and TRPC6 channels are involved in myogenic tone development of 
cerebral pial arteries. This work concluded that smooth muscle TRPM4 and TRPC6 
channels are activated by increased intravascular pressure and mediate cation influx, 
which leads to membrane depolarization and vasoconstriction10, 15. Subsequently, other 
depolarizing contributors implicated in this mechanism have been reported in cerebral 
pial arteries, including TRPP2 channels16, epithelial Na+ channels (ENaC)17 and TMEM-
16A chloride channels18, which further emphasize the significance of membrane potential 
regulation in myogenic tone development in cerebral arteries.     
Interestingly, compared to pial arteries, downstream parenchymal arterioles (PAs) 
are considerably more sensitive to mechanical forces. Specifically, we found that PA 
smooth muscle is more depolarized and more constricted compared to pial arteries over 
the same range of intraluminal pressures2, 14, suggesting reduced contribution of 
hyperpolarizing influence (primarily K+ channels) and/or enhanced activity of 
depolarizing factors on the smooth muscle. For instance, it has been shown that at normal 
pH (7.4), PAs display little activity of large-conductance Ca2+-activated K+ (BKCa) 
channels6. On the other hand, a more depolarized membrane potential may be partially 
attributed to enhanced depolarizing influences. The TRPM4 channel is a very promising 
candidate for this role.  However, neither the significance nor the regulation of TRPM4 
channels in PAs has been studied in any detail. The present study provides the first 
evidence that TRPM4 channels are centrally involved in myogenic tone development of 
PAs. In agreement with previous studies testing the presence of TRPM4 in cerebral pial 
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arteries, transcripts of this channel were also detected in PAs, suggesting a similar 
functional role in the myogenic response. Consistent with our initial hypothesis, we found 
that knocking down TRPM4 channels significantly inhibited the myogenic 
responsiveness of PAs. The present study validated the efficacy of a new technique that 
introduces antisense ODNs in vivo targeted against the TRPM4 gene. Given that 
subarachnoid cerebral spinal fluid (CSF) rapidly flows into the brain parenchyma along 
the outside of cortical surface arteries and penetrating arterioles19, intracisternally 
injected antisense ODNs had physical access to parenchymal smooth muscle cells and 
effectively reduced TRPM4 channel message in the present study. One important 
advantage of this approach is that it allows for acute (48-hour) message knockdown, 
which largely limits the possibility of compensatory pathways being upregulated. In the 
present study, this approach reduced PA myogenic vasoconstriction by 40 to 60%. 
However, one of our previous studies showed 70 to 85% reduction in pial artery 
myogenic tone following TRPM4 knockdown20 using another in vivo approach (osmotic 
mini pumps). One possible explanation for this apparent smaller effect on PAs is that the 
overall amount of antisense ODNs introduced into rat brain was less in the present study 
(~160 nmoles) compared to the previous publication (~ 350 nmoles)20, which might result 
in reduced channel suppression. Another possibility is that TRPM4 channels play a 
somewhat less prominent role in the cerebral parenchymal arterioles than in the surface 
arteries. It is likely that other depolarizing pathways, perhaps including other TRP 
channels (TPRC3, TRPC6 and/or TRPP2), exist and function in parallel with TRPM4 to 
facilitate membrane potential depolarization. Although the involvement of other TRP 
channels in this response has not yet been resolved for PAs, results of the present study 
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will provide a better understanding of the diversity and functional significance of various 
TRP channels in vascular smooth muscle. 
9-Phenanthrol was used as an alternative tool to confirm the involvement of 
TRPM4 in myogenic regulation. This selective TRPM4 channel blocker21 elicited 
concentration-dependent inhibition of pressure-induced tone in endothelium-denuded 
arterioles, supporting an essential role of smooth muscle TRPM4 channels in the 
coupling of mechanical stimulation and vasoconstriction in PAs. The specificity of 9-
phenanthrol has been tested by various groups.  9-phenanthrol does not inhibit TRPM5 
channels22. At a concentration of 30 µmol/L, which almost completely blocks TRPM4 
activity, 9-phenanthrol does not alter the activity of ion channels in smooth muscle cells 
that are involved in modulation of vascular tone (Cav channels, BKCa channels, voltage-
gated K+ channels, inward rectifying K+ channels)21; it has no effect on other TRP 
channels (TRPC3, TRPC6 and TRPM7)21, 23. In the present study, 10 µmol/L 9-
phenanthrol was used on isolated arterioles. Control experiments showed no inhibition of 
9-phenanthrol at this concentration on membrane depolarization (30 mmol/L K+-aCSF)-
induced vasoconstriction (Supplementary Figure 2). Thus, 9-phenanthrol appears to be a 
specific and very useful tool in studies of the functional roles of TRPM4 ion channels. 
 
P2Y4 and P2Y6 Receptors Are Coupled to TRPM4 Channels to Mediate Myogenic 
Constriction in Parenchymal Arterioles. 
Purinergic signaling plays an important role in control of vascular contractility in a 
variety of blood vessels24. Although different vessels in various species express distinct 
purinergic regulatory mechanisms, it is rather clear that vascular tone is under the control 
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of both the dilator effects of endothelial purinergic receptors and contractile responses of 
smooth muscle-associated purinergic signaling. In rat cerebral arteries, P2Y1 and P2Y2 
receptors are located on endothelial cells and mediate endothelium-dependent 
vasodilation25, whereas P2Y2, P2Y4 and P2Y6 receptors are abundantly expressed in 
smooth muscle and mediate vasoconstriction in response to purine and pyrimidine 
stimulation5, 26.  
Several earlier studies have explored the possible contributions of pyrimidine 
receptors in myogenic regulation. For instance, P2Y6 receptors likely play an important 
role in mouse mesenteric arteries27, as the P2Y6 antagonist (MRS2567) inhibits 
myogenic vasoconstriction of these blood vessels28. Moreover, recent findings from our 
laboratory revealed the central involvement of P2Y4 and P2Y6 receptors in myogenic 
tone development of cerebral PAs5. Interestingly, rather than endogenous release of 
nucleotides from local sources as was reported for systemic arteries27, pressure-induced 
activation of these receptors in the PAs appeared to be caused by direct 
mechanoactivation, since neither potentiation nor suppression of ectonucleotidase activity 
has any effect on the myogenic behavior of PAs5. This observation is in fact consistent 
with a previous study on cerebral pial arteries that myogenic tone is mediated by 
mechanosensitive G protein-coupled receptors (GPCRs). In that study, an inverse agonist 
of angiotensin II (Ang II) receptor attenuated myogenic responses by 50%. Further, 
because pretreatment of isolated pial arteries with an angiotensin I converting enzyme 
(ACE) inhibitor had no effect on myogenic tone development, it was proposed that 
myogenic vasoconstriction is facilitated by direct mechanical activation of Ang II 
receptors13. 
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The mechanisms of direct mechanoactivation of GPCRs (Ang II receptors, P2Y 
receptors, etc.) are not clear. Presently, a few possibilities have been proposed as to how 
GPCRs perceive mechanical force and initiate a conformational alteration to an active 
state. First, a “tethered” model has been proposed suggesting that intra- and/or 
extracellular anchorage to other proteins acts as a molecular spring to activate GPCRs 
upon membrane stretch. Second, a so-called “membrane” model proposes that the altered 
lateral pressure profile at the protein/phospholipid bilayer boundary can directly force a 
conformational change of the GPCRs29. Additional mechanisms including the 
interactions between receptors and cytoskeletal elements to facilitate stimulation of 
GPCRs have also been presented30. Clearly, identification of the specific mechanisms 
involved in GPCR regulation of myogenic tone will require deeper and more detailed 
biochemical and biophysical investigations. 
A major finding of the present study is that TRPM4 channels are regulated by 
P2Y4 and P2Y6 receptors, providing the first direct evidence that TRPM4 channels are 
associated with mechano-sensitive GPCRs, and this coupling is essential for pressure-
evoked responses of the cerebral PAs. Knocking down TRPM4 channels or blocking 
them with 9-phenanthrol significantly inhibited the constrictor responses to both UTPγS 
and UDP (specific P2Y4 and P2Y6 receptor ligands). Consistent with the functional 
studies, 9-phenanthrol also attenuated ligand-induced membrane potential depolarization. 
Furthermore, activation of these receptors largely enhanced TRPM4-like spontaneous 
inward currents in isolated smooth muscle cells. The properties of these currents were 
consistent with previously reported transient inward cation currents (TICCs) in cerebral 
artery myocytes12. Additionally, the currents are sensitive to 9-phenanthrol, indicating 
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these are TRPM4 currents. Though regulation of this channel by protein kinase C (PKC) 
and Ca2+ release from the endoplasmic reticulum has been previously reported11, 12, the 
present study provides the first evidence that this channel is a downstream effector of 
Gq/11-coupled receptor signaling, and that this mechanism plays an crucial role in 
myogenic regulation of vascular contractility. Involvement of other TRP channels in 
GPCR signaling has been previously proposed. For example, TRPC3 was demonstrated 
to mediate pyrimidine receptor-induced depolarization of rat pial arteries31 and TRPC6 
was proposed to participate in angiotensin II receptor-mediated vasoconstriction in 
response to mechanical stimuli13. Together with the present findings, it is clear that the 
vasomotor mechanisms in resistance arteries involve multiple players, including different 
GPCRs, various TRP channels and possibly distinct signaling pathways. Though the 
mechanisms are not fully elucidated, the present study provides important insights 
regarding contractile signaling in the smooth muscle of the cerebral penetrating arterioles.   
     
Regulation of TRPM4 Channels upon Myogenic Stimulation  
Previous studies in cerebral arteries have demonstrated that TRPM4 channel activity is 
regulated by PKC: activation of PKC increases the sensitivity of TRPM4 to intracellular 
Ca2+11. Moreover, Ca2+ release from the sarcoplasmic reticulum (SR) through inositol 
trisphosphate (IP3) receptors is required for sustained TRPM4 activity
12. Both findings 
suggest that TRPM4 channels may be physically associated with GPCR signaling 
partners to mediate myogenic regulation in smooth muscle cells. Furthermore, there is 
abundant evidence in support of a role of GPCR downstream signaling mechanisms in 
myogenic tone development. For instance, phospholipase C (PLC) plays a key role in the 
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genesis of myogenic responses via membrane depolarization and increased calcium 
influx32. Contribution of diacylglycerol (DAG) in pressure-evoked vasoconstriction has 
also been reported in cerebral arteries33. Additionally, PKC exerts substantial influence 
on various ion channels in smooth muscle of different vascular beds, including Cav
34, 
Kv
35 and TRPM411 channels, which are clearly involved in myogenic regulation. 
Moreover, IP3 receptors and intracellular levels of IP3 have been demonstrated to 
correlate with mechanical stimulation of arteries or arterioles36. Since P2Y4 and P2Y6 
are associated with Gq/11 protein signaling, PLC-DAG-PKC and IP3 are logical candidate 
pathways that couple mechano-stimulation of purinergic receptors to activation of 
TRPM4 channels in PA smooth muscle.  
In addition to Gq/11 protein signaling, P2Y receptors are also coupled to the Rho-
associated protein kinase (ROCK) pathway37. Interestingly, correlation between ROCK 
signaling and myogenic responses has been investigated in various vascular beds, 
including rat cerebral arteries38. Although Ca2+ sensitization through inhibiting myosin 
light chain phosphatase is generally accepted as a major mechanism of ROCK-associated 
myogenic vasoconstriction38, it has also been shown that ROCK regulates the activity of 
various ion channels, including Cav and Kv channels
39, 40. Additionally, ROCK-mediated 
modulation of membrane potential40 serves as further evidence that ROCK signaling 
contributes to the depolarizing mechanisms within smooth muscle, suggesting a possible 
role of ROCK in myogenic activation of TRPM4 channels. Understanding the relative 
contributions of these pathways may reveal therapeutic targets that can be manipulated in 
clinical settings.  
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Conclusion 
The current results demonstrate that TRPM4 channels contribute substantially to P2Y4 
and P2Y6 receptor-mediated myogenic tone development of cerebral intraparenchymal 
arterioles. A more thorough understanding of the vasomotor mechanisms within the brain 
may contribute to the development of novel medical approaches and revealing new 
therapeutic targets that could help patients with cerebral microvascular diseases. 
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Figures 
 
 
Figure 1. Effects of in vivo suppression of TRPM4 channels on myogenic tone of 
parenchymal arterioles. (A) RT-PCR indicates the presence of TRPM4 channel message 
in cerebral pial arteries and parenchymal arterioles. (product size: 148 bp)  (B) Semi-
quantitative PCR reveals a substantial reduction of TRPM4 expression level in cerebral 
parenchymal arterioles from rats exposed to TRPM4 antisense versus sense 
oligodeoxynucleotides (ODNs). Sense or antisense ODN-treated PAs from three animals 
were pooled to assess relative message abundance. Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used to demonstrate uniformity of reaction conditions 
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between the two groups. NT denotes reactions performed without DNA template. (C-E) 
Myogenic constriction in response to step-increased intraluminal pressure was 
significantly reduced in arterioles exposed to TRPM4 antisense ODNs (D) than sense 
ODNs (C). n=3 for both groups. * p < 0.05, **** p < 0.0001 versus sense group. (F) NS 
309-mediated, endothelium-dependent vasodilations of TRPM4-sense and TRPM4-
antisense treated arteries.  n=3 for both groups. 
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Figure 2. Effects of 9-phenanthrol on myogenic tone of endothelium-denuded 
parenchymal arterioles. (A) 9-phenanthrol substantially reduces myogenic constriction of 
PAs held at 40 mmHg. Lack of dilatory effects of NS309 (1 µmol/L) indicates successful 
endothelium removal. (B) Summary data of 9-phenanthrol concentration/response 
relationship in PAs held at 40 mmHg. IC50=27.9 µmol/L. n=6 at each concentration. 
  
A B
 149 
 
Figure 3. Effects of in vivo TRPM4 channel suppression on P2Y4- and P2Y6- specific 
ligand-induced vasoconstriction in endothelium-denuded parenchymal arterioles. (A) 
TRPM4 antisense ODNs significantly suppress vasoconstriction induced by specific 
P2Y4 receptor ligand (UTPγS: 3 µmol/L), and specific P2Y6 receptor ligand (UDP: 3 
µmol/L). n=3 for both groups. ** p < 0.01 versus sense group. (B) There is no significant 
difference in U46619 (100 nmol/L)-triggered vasoconstriction between PAs exposed to 
TRPM4 sense and antisense ODNs. n=3 for both groups. 
  
A B 
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Figure 4. 9-Phenanthrol (10 µmol/L) significantly reduces (A) P2Y4 receptor agonist 
(UTPγS: 0.5 µmol/L, n=6) and (B) P2Y6 receptor agonist (UDP: 0.5 µmol/L, n=6)-
induced vasoconstriction in endothelium-denuded parenchymal arterioles. ** p < 0.01 
versus response without 9-phenanthrol. 
  
A 
B 
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Figure 5. Effects of P2Y receptor ligands and 9-phenanthrol on parenchymal arteriolar 
smooth muscle membrane potential (Em). (A) 9-Phenanthrol inhibits P2Y4 receptor 
agonist (UTPγS: 0.5 µM)-induced depolarization in endothelium-denuded parenchymal 
arterioles. n=6, **** p < 0.0001 versus control and UTPγS. (B) The presence of 9-
Phenanthrol attenuates the depolarization triggered by P2Y6 receptor ligand (UDP: 0.5 
µM) in endothelium-denuded parenchymal arterioles. n=7, **** p < 0.0001 versus 
control and UDP. 
  
B 
A 
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Figure 6. Effects of P2Y receptor ligands and 9-phenanthrol on TRPM4 channel activity 
in isolated parenchymal arteriolar smooth muscle cells. (A, B) UTPγS (0.5 µmol/L) 
significantly increases TRPM4 channel open probability and 9-phenanthrol (30 µmol/L) 
inhibits UTPγS-activated TRPM4 currents. n=11 for control, n=7 for UTPγS, and n=4 for 
UTPγS + 9-phenanthrol.  ** p < 0.01 versus control and response without 9-phenanthrol. 
(C-E) UDP (0.5 µmol/L) triggers substantial increase in TRPM4 channel activity in the 
absence of 9-phenanthrol (C), but significantly less activation in the presence of 9-
UTPγS  
2 mins 
5 pA 
9-phenanthrol  
5 pA 
2 mins 
UDP 
5 pA 
2 mins 
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phenanthrol (30 µmol/L) (D). n=10 for control group, n=5 for UDP and UDP + 9-
phenanthrol groups. *** p < 0.001 versus control, ** p < 0.01 versus response without 9-
phenanthrol.   
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Table 1. Primer information for PCR studies examining TRPM4 channel transcript 
expression  
Target Sequences Product Size 
TRPM4F 5’-AGTTGAGTTCCCCCTGGACT-3’ 148 bp 
TRPM4R 5’-AATTCCAGTCCCTCCCACTC-3’  
GAPDHF 5’-GACAGCCGCATCTTCTTGTG-3’ 210 bp 
GAPDHR 5’-TGAACTTGCCGTGGGTAG AG-3’  
TRPC6F 5’-GTGCCAAGTCCAAAGTCCCTGC-3’ 315 bp 
TRPC6R 5’-CTGGGCCTGCAGTACGTATC-3’  
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Supplementary Figure 1. Semi-quantitative PCR indicates a substantial reduction of 
TRPM4 expression level in cerebral pial arteries from rats exposed to TRPM4 antisense 
versus sense oligodeoxynucleotides (ODNs). Lack of effects on TRPC6 expression level 
indicates specificity of TRPM4 antisense ODNs. Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used to demonstrate uniformity of reaction conditions 
between the two groups. NT denotes reactions performed without DNA template. 
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Supplementary Figure 2. 9-phenanthrol (10 µmol/L) has no significant effect on 
membrane depolarization (30 mM K+-aCSF)-induced vasoconstriction of endothelium-
denuded parenchymal arterioles. n = 3. 
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Supplementary figure 3. Effects of the voltage-dependent calcium (Cav) channel 
inhibitor nimodipine on P2Y4 and P2Y6 receptor-mediated constriction of endothelium-
denuded parenchymal arterioles. (A), Representative recording showing block of UTPγS 
(0.5 µM)-induced vasoconstriction by nimodipine (300 nM). (B), Summary data showing 
nimodipine (300 nM) inhibition of P2Y4 receptor agonist (UTPγS: 0.5 µM, n=4) and 
P2Y6 receptor agonist (MRS2693: 1 µM, n=4)-induced vasoconstriction of PAs. ** p < 
0.01 versus response without nimodipine, *** p < 0.001 versus response without 
nimodipine. 
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Abstract 
Cerebral arterioles contribute critically to regulation of local and global blood flow within 
the brain.  Dysfunction of these blood vessels is implicated in numerous cardiovascular 
diseases.  However, treatments are limited due to incomplete understanding of 
fundamental control mechanisms at this level of circulation. Emerging evidence points to 
a key role of Rho-associated protein kinase (ROCK) in regulation of microvascular 
contractility. This study sought to decipher the mechanisms of ROCK-mediated 
myogenic vasoconstriction in cerebral parenchymal arterioles (PAs). Here we report that 
the ROCK inhibitor H1152 strongly attenuated pressure-induced constriction, cytosolic 
[Ca2+] increases, and depolarization of isolated PAs. Further, the RhoA activator CN03 
potentiated PA myogenic constriction and depolarization, indicating important 
involvement of RhoA/ROCK signaling in myogenic excitation-contraction mechanisms. 
Because of the well-established role of TRPM4 in pressure-induced depolarization, 
possible modulatory effects of ROCK on TRPM4 currents were explored using patch 
clamp electrophysiology. TRPM4 currents were suppressed by H1152 and enhanced by 
CN03. Finally, H1152 elevated the apparent [Ca2+]-threshold for TRPM4 activation, 
suggesting that ROCK activates TRPM4 by increasing its Ca2+-sensitivity. Our results 
support a novel mechanism whereby ROCK-mediated myogenic vasoconstriction occurs 
primarily through activation of TRPM4 channels, smooth muscle depolarization and 
cytosolic [Ca2+] increases in cerebral arterioles.  
 
Keywords 
 Cerebral arteriole, depolarization, myogenic, Rho kinase, TRPM4  
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Introduction 
Cerebral blood flow is precisely regulated through the vasomotor activity of surface pial 
arteries and penetrating arterioles. As a prime example, arterioles within the brain 
parenchyma contribute to as much as 40% of cerebrovascular resistance, playing a crucial 
role in global cerebral autoregulation1. Furthermore, these parenchymal arterioles (PAs) 
modulate local blood flow via dilation in response to increased neuronal activity, in the 
process known as neurovascular coupling2.  Compared to upstream pial arteries, PAs 
exhibit unique functional properties and anatomical structure. Notably, distinct 
vasoconstrictor responses3, 4, altered ion channel functions5 and diverse Ca2+ signaling 
events5 in PA smooth muscle all strongly suggest that mechanisms of vascular tone 
regulation might also be quite different from the signaling pathways in the pial vessels. 
Structurally, in contrast to the ramifying and anastomotic networks formed by surface 
arteries and capillaries, the topology of the PA network is more one-dimensional6. This 
creates a “bottleneck” effect in the cerebral microcirculation, which renders PAs and 
surrounding brain tissue especially vulnerable to changes in local blood flow6. 
Accordingly, arteriolar dysfunction is implicated in numerous cerebral vascular 
pathologies, including cerebral and coronary small vessel diseases7, ischemic and 
hemorrhagic stroke8, 9, hypertension10, and vascular dementia11. However, effective 
measures for disease prevention and treatment are limited due to incomplete 
understanding of the factors and mechanisms that regulate these blood vessels. 
Myogenic tone represents one of most fundamental functions of resistance arteries 
in maintaining a relatively constant blood flow despite moment-to-moment fluctuations 
of arterial pressures. In the brain, myogenic tone sets the arteries and arterioles at a 
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partially constricted background so that blood flow can be tightly regulated by 
extracellular stimuli, particularly vasodilatory signals from neurovascular coupling and 
endothelial cell activation. Myogenic tone also contributes to controlling appropriate 
perfusion pressure and protecting downstream capillaries. The primary mechanism 
underlying pressure-induced vasoconstriction involves smooth muscle membrane 
depolarization and subsequent Ca2+ entry through voltage-dependent calcium channels 
(VDCCs)12. Yet how an extracellular mechanical stimulus is converted into intracellular 
membrane depolarization is not fully understood. Interestingly, compared to pial arteries, 
myogenic response plays a more prominent role in regulating PA reactivity, since these 
blood vessels exhibit significantly enhanced pressure-evoked depolarization8, 
intracellular [Ca2+] increase13, and contraction13 versus pial arteries over the same range 
of vascular pressures. Hence, elucidating the mechano-stimulated cellular pathways is 
particularly important for the cerebral microcirculation. Previous studies from our 
laboratory have provided important inroads in this area. P2Y4 and P2Y6 receptors appear 
to be mechanosensors in PAs and mediate myogenic responses in a ligand-independent 
manner4. TRPM4 channels couple the mechanoactivation of P2Y4 and P2Y6 receptors to 
membrane depolarization and vasoconstriction in PAs14. However, the intracellular 
signaling cascades that mediate the stretch-induced, P2Y receptor-mediated activation of 
TRPM4 remain unknown.  
Emerging evidence points to the dynamic role of the RhoA/Rho associated 
protein kinase (ROCK) pathway in regulating cerebrovascular function, including 
myogenic control9, 15, 16. Though it is generally accepted that ROCK promotes contraction 
by inhibiting myosin light chain phosphatase, i.e. via “Ca2+ sensitization” mechanisms17, 
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recent findings have revealed that ROCK also regulates ion channel activity, including 
activation of epithelial Na+ channels (ENaC)18 and inhibition of voltage-dependent K+ 
(Kv) channels which modulates smooth muscle membrane potential
19, suggesting ROCK 
may be involved in electromechanical coupling pathways. Following from these 
interesting findings, a major goal of the current study was to explore the roles of 
RhoA/ROCK signaling in myogenic reactivity of PAs. We hypothesized that 
RhoA/ROCK signaling mediates stretch activation of TRPM4 channels in the brain 
microcirculation. The results from this work support this hypothesis by demonstrating 
that pressure-induced and P2Y receptor agonist-triggered effects on TRPM4 activity, 
membrane potential, cytosolic [Ca2+] and vascular tone are all attenuated by ROCK 
inhibition and potentiated by RhoA activation, revealing a previously underappreciated 
contribution of ROCK signaling to myogenic regulation through depolarization and Ca2+-
dependent pathways. 
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Materials and Methods 
Animals  
All animal procedures were approved by the Institutional Animal Care and Use 
Committee at the University of Vermont and performed in accordance with the National 
Institutes of Health Policy on the care and use of laboratory animals. Male, Sprague-
Dawley rats (15 to 20 weeks old; Charles River Laboratories, Saint Constant, QC, 
Canada) were used for all experiments. 
 
Tissue Preparation  
Rats were euthanized by an overdose of sodium pentobarbital (120 mg/kg, intraperitoneal 
injection) followed by exsanguination. The brain was rapidly removed and placed in cold 
(4 °C) MOPS buffered physiological salt solution (PSS) (in mmol/L): 3 MOPS, 145 
NaCl, 5 KCl, 1 MgSO4, 2.5 CaCl2, 1 KH2PO4, 2 sodium pyruvate, 5 glucose, 1% albumin 
from bovine serum, pH 7.4. Middle cerebral arteries (MCAs) and attached parenchymal 
arterioles (PAs) were isolated from the brain as previously described20 and transferred to 
a small volume of MOPS buffered PSS for further experimental use. 
 
Pressure Myography  
Parenchymal arteriolar segments were cannulated on glass pipettes in an arteriograph 
chamber (Living Systems, Burlington, VT, USA) containing a bicarbonate-buffered 
artificial cerebral spinal fluid (aCSF) of the following composition (in mmol/L): 136 
NaCl, 3 KCl, 15 NaHCO3, 1.25 NaH2PO4, 1 MgCl2, 4 glucose, 2 CaCl2 (temperature 37 
°C and pH 7.3). In order to eliminate endothelial responses to P2Y receptor agonists, 
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arterioles were stripped of endothelium by passing air bubbles through the arteriolar 
lumen. PAs were initially pressurized at 3 mmHg (with no flow), and superfused with 
warmed (37 °C), gassed (20% O2/5% CO2/balance N2) aCSF. As an initial check of tissue 
viability, arterioles were reversibly constricted with the thromboxane receptor activator 
U46619 (100 nmol/L) (Enzo Life Sciences Inc., Farmingdale, NY, USA). Vessels were 
rejected for study if constrictions to U46619 were less than a 60% decrease in diameter. 
In experiments where myogenic constriction was not desired, e.g. agonist-induced 
vasoconstriction, intraluminal pressure was controlled at 3 mmHg. In experiments where 
steady myogenic tone was desired, PAs were pressurized to 40 mmHg. After myogenic 
tone developed, PAs were exposed to the IKCa and SKCa channel activator NS309 (1 
µmol/L), which mediates endothelium-dependent vasodilator responses in these 
arterioles21. Absence of dilation by NS309 indicated successful endothelial cell removal.  
 
Membrane Potential Measurements 
The endothelium was removed from all vessels to eliminate any contribution of 
endothelial components to membrane potential. Arterioles were cannulated as described 
above and pressurized to 3 mmHg. In these experiments, the myosin light chain kinase 
inhibitor wortmannin (800 nmol/L) was included in aCSF prior to membrane potential 
measurements to prevent excessive vessel movement. Smooth muscle membrane 
potential was measured by repeated insertion of a sharp glass microelectrode (~200 MΩ 
resistance when filled with 0.5 mol/L KCl) into the vessel wall. The criteria for 
successful impalement were 1) an abrupt negative potential deflection upon entry, 2) a 
stable membrane potential for at least 30s, and 3) an abrupt positive potential deflection 
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to 0 mV upon electrode withdrawal. Measurements were made with an electrometer 
(World Precision Instruments, Sarasota, FL, USA) and recorded via computer with 
AxoScope and Dataq software. At least three repeated impalements were made and the 
average membrane potential was calculated under each pharmacological treatment for 
every PA. 
 
RhoA Activation of Isolated PAs  
MCAs with PAs attached were isolated as previously described20 and incubated with the 
selective RhoA activator CN03 (1 µg/mL, equivalent to 8.5 nmol/L) (Cytoskeleton, Inc., 
Denver, CO, USA) for 3 hours in 2 ml DMEM/F-12 (serum-free) culture medium (37 
°C). Control arterioles were incubated for 3 hours in DMEM/F-12 culture medium in the 
absence of CN03. Myogenic tone and membrane potential were then assessed as 
described above. 
 
Intracellular Ca2+ Concentration Measurements  
Freshly isolated PAs were cannulated on glass micropipettes and the endothelium was 
removed as described above. Cannulated arterioles were initially pressurized to 5 mmHg 
and equilibrated in aCSF for 1h, and then loaded with the ratiometric Ca2+-sensitive dye 
fura-2 [acetoxymethyl ester (AM) membrane-permeant form] by incubating in aCSF 
containing fura-2 AM (5 µmol/L) (Invitrogen, Carlsbad, CA, USA) with pluronic acid 
(0.1%) (Invitrogen) for 1 hour at room temperature (~22 °C). The myograph chamber 
was mounted on a Nikon TE2000-S inverted fluorescence microscope. Arterioles were 
washed with aCSF 3 times and de-esterification of fura-2 AM occurred by superfusing 
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with warmed (37 °C), gassed (20% O2/5% CO2/balance N2) aCSF for 20 mins before 
recording. Bath pH was closely monitored and maintained at 7.30-7.35. 
For pressure-response tests, studies were performed in which intravascular 
pressure was increased to 10, 20, 30 and 40 mmHg. Fluorescence ratio was obtained from 
the background-corrected ratio of the 510 nm emission from arterioles alternately excited 
at 340 and 380 nm with hardware and software developed by IonOptix (Milton, MA, 
USA). [Ca2+]i was estimated using the following equation: [Ca
2+]i = Kd × β × (R – 
Rmin)/(Rmax – R).  Rmin and Rmax, the ratios of emission signals under Ca2+-free and Ca2+-
saturated conditions, respectively, were measured from a separate set of ionomycin-
treated arterioles, and β was determined as the ratio of F380 intensities at Rmin and Rmax. 
Calibration values were pooled for calculation of intracellular [Ca2+] using an apparent 
dissociation constant (Kd) of 282 nmol/L of fura-2 for Ca
2+.  
 
Single Cell Isolation 
Arterioles were placed in a cell isolation solution containing (in mmol/L): 55 NaCl, 80 
Na Glutamate, 5.6 KCl, 2 MgCl2, 10 HEPES, 10 Glucose, (pH 7.3). Arteriolar segments 
were initially incubated in 0.5 mg/ml papain (Worthington Biochemical Corp. Lakewood, 
NJ, USA) and 1.0 mg/ml dithioerythritol for 11 min at 37 °C and then in 1.0 mg/ml 
collagenase type F for 13 mins at 37 °C. The digested segments were washed three times 
in ice-cold cell isolation solution and incubated on ice for 30 mins. Digested arterioles 
were triturated to liberate smooth muscle cells and stored in ice-cold cell isolation 
solution prior to use. Smooth muscle cells were studied within 5 h following isolation. 
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Patch Clamp Recordings  
General Methods. Isolated smooth muscle cells were placed into a recording chamber 
and allowed to adhere to glass coverslips for 20 minutes at room temperature. Currents 
were recorded with an AxoPatch 200B amplifier (Axon instruments) equipped with an 
Axon CV 2032wBU headstage (Molecular Devices). Recording electrodes (3-5 MΩ for 
perforated patch recordings, 5-8 MΩ for conventional whole-cell and inside-out patch 
recordings) were pulled from boroscilicate glass (Sutter Instrument, Novato, CA, USA). 
All patch clamp experiments were performed at room temperature (22 °C). 
Perforated whole-cell patch recording. Gigaohm seals were obtained in bath 
solution of the following composition (in mmol/L): 134 NaCl, 6 KCl, 1 MgCl2, 2 CaCl2, 
10 HEPES and 10 glucose (pH 7.4 adjusted with NaOH). The pipette solution contained 
(in mmol/L): 85 K-aspartate, 1 MgCl2, 30 KCl, 10 NaCl, 10 HEPES, 5 μmol/L EGTA 
(pH 7.2 adjusted with KOH). Nystatin (200 μg/ml) was included in the pipette solution to 
perforate the cell membrane. Perforation was deemed acceptable when series resistance 
was less than 50 MΩ. Currents were filtered at 1 kHz, sampled at 2 kHz, and stored for 
subsequent analysis. Clampex and Clampfit version 9.2 (Molecular Devices) were 
utilized for data acquisition and analysis, respectively. For all experiments, membrane 
potential was held at -70 mV, and all recordings were performed at room temperature (22 
°C). TRPM4 channel activity was calculated as the sum of the open probability (NPo) of 
multiple open states of 1.75 pA. This value was based on the reported unitary 
conductance of TRPM4 (25 pS). NPo was calculated using the following equation:  
     NPo = [(t j · j)/T]
J=1
N
å
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where Po is the open state probability, tj is time spent (in seconds) with j = 1,2,…,N 
channels open. N is maximum number of channels observed, and T is duration of 
measurement. 
Conventional whole-cell patch recording for TRPM4 currents. Cells were initially 
held at a membrane potential (Vm) of 0 mV, and currents were recorded during voltage 
ramps between -120 and +80 mV. Voltage ramps were initiated as soon as whole cell 
conditions were established and were repeated every 2 s during the experiment. The bath 
solution contained (in mmol/L) 156 NaCl, 5 CaCl2, 10 HEPES, and 10 glucose (pH 7.4 
adjusted with NaOH). The bath solution also contained a selective voltage-dependent 
Ca2+ channel (VDCC) blocker nimodipine (200 nmol/L) (Calbiochem, San Diego, CA, 
USA), and a selective large-conductance Ca2+-activated K+ (BKCa) channel blocker 
iberiotoxin (300 nmol/L). To prevent smooth muscle contraction under the condition of 
high intracellular [Ca2+], arteriolar myocytes were pretreated with the myosin light chain 
kinase inhibitor wortmannin (10 µmol/L) 5 mins prior to patch clamp experiments. The 
pipette solution contained (in mmol/L) 156 CsCl, 1 MgCl2, 10 HEPES (pH 7.2 adjusted 
with CsOH). The Ca2+ concentration was adjusted between 1 µM and 100 µM by adding 
appropriate amounts of CaCl2 to 5 mmol/L EGTA calculated using the program 
Maxchelator (http://maxchelator.stanford.edu/). In some experiments, cells were treated 
with the ROCK inhibitor H1152 (1 µmol/L) or the TRPM4 channel blocker 9-
phenanthrol (30 µmol/L) prior to patch recordings. For experiments with RhoA 
activation, the RhoA activator CN03 (0.1 ng/mL, equivalent to 0.85 pmol/L) was 
included in the pipette solution to allow for direct access to the inside of the smooth 
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muscle cells and rapid activation of RhoA. Currents were filtered at 1 kHz, sampled at 5 
kHz, and stored for subsequent analysis. 
Conventional whole-cell patch recording for VDCC currents. The bath solution 
contained (in mmol/L): 125 NaCl, 10 BaCl2, 5 KCl, 1 MgCl2, 0.1 CaCl2, 10 HEPES, 10 
glucose (pH 7.4 adjusted with NaOH). The pipette solution contained (in mmol/L) 130 
CsCl, 1 MgCl2, 10 HEPES, 10 EGTA, 10 glucose, 2 ATP, 0.5 GTP, 5 phosphocreatine 
(pH 7.2 adjusted with NaOH). Cells were initially voltage-clamped at -60 mV, and Cav 
channel currents were recorded by stepping the membrane potential to +10 mV. Ca2+ 
currents were compared in the same cell before and after application of the Rho kinase 
inhibitor H1152 (1 µmol/L). Currents were filtered at 0.5 kHz, sampled at 2 kHz, and 
stored for subsequent analysis.   
Excised inside-out patch recording for TRPM4 channel currents in HEK cells. 
The bath solution contained (in mmol/L): 156 CsCl, 10 HEPES, 1 MgCl2, 0.1 CaCl2 (pH 
7.2 adjusted with CsOH). The pipette solution contained (in mmol/L): 156 NaCl, 10 
HEPES, 1 MgCl2, 5 CaCl2, 10 Glucose (pH 7.4 adjusted with NaOH). Patches were 
initially held at a holding potential of 0 mV during patching and excision. Single channel 
currents were recorded at a membrane potential of -60 mV. TRPM4 channel activity was 
calculated as the sum of the open probability (NPo) of multiple open states of 1.50 pA 
based on the reported unitary conductance of TRPM4 (25 pS). NPo was obtained using 
the method described above for perforated-patch recordings. Single TRPM4 currents 
were compared in the presence and absence of H1152 (1 µmol/L) and CN03 (0.1 ng/mL, 
equivalent to 0.85 pmol/L), respectively. Currents were sampled at 10 KHz, filtered at 0.5 
KHz and stored for subsequent analysis. 
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HEK 293T Cell Culture and Transient DNA Transfection  
Human embryonic kidney (HEK) 293T cells were cultured in Dulbecco’s high glucose 
Modified Eagle Medium (Gibco, Grand Island, NY, USA) supplemented with 0.5% 
penicillin-streptomycin. Cells were maintained at 37 °C with 5% CO2, and sub-cultured 
when confluent using 0.25% trypsin. HEK cells were transiently transfected with a 
plasmid encoding a mouse TRPM4 protein (TransOMIC technologies Inc., Huntsville, 
AL, USA). Cells were cultured for 1-2 days prior to electrophysiology experiments.  
 
Chemical and Reagents  
Buffer reagents, dissociation enzymes, NS309, nystatin, UDP, 9-phenanthrol, 
wortmannin, ionomycin and iberiotoxin were purchased from Sigma-Aldrich (St Louis, 
MO, USA). UTPγS and H1152 were purchased from Tocris (Minneapolis, MN, USA). 
Nimodipine was dissolved in DMSO to a final solvent concentration of 0.1%. All other 
compounds were dissolved in the appropriate salt solution.  
 
Statistical Analysis  
Values are expressed as Mean ± SEM, and n indicates the number of animals. Myogenic 
tone under different conditions was normalized as percentage tone, and calculated as 
follows: 
% Tone = [(Passive diameter – Constricted diameter)/Passive diameter]×100, 
where “Passive diameter” is the diameter in Ca2+-free aCSF at the corresponding pressure 
level. 
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For P2Y receptor agonist responses, constrictions were expressed as percent of 
the maximum contraction induced by the thromboxane receptor activator U46619 (100 
nmo/L).  
Student’s t-test was used to compare two experimental groups. One way ANOVA 
followed by the Tukey multiple comparison test was used in the comparison of multiple 
groups. Mean values were considered significantly different at p ≤ 0.05.  
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Results 
ROCK is involved in pressure-induced and P2Y receptor-mediated vasoconstriction 
and membrane depolarization 
We first examined the functional roles of ROCK in cerebral PAs. We found that a 
selective ROCK inhibitor (H1152) greatly attenuated pressure-induced tone with a half 
inhibitory concentration (IC50) of 0.24 µmol/L (Figure 1A, 1B), indicating a key role of 
ROCK in mediating myogenic response in the brain microcirculation, consistent with its 
contribution in pial arteries16, 22. We have previously established the essential 
involvement of P2Y4 and P2Y6 receptors in cerebral arteriolar myogenic regulation4. 
Therefore, the effects of ROCK inhibition on P2Y receptor-mediated responses were also 
explored. We found that H1152 (1 µmol/L) inhibited UTPγS- (P2Y4 receptor agonist) 
(0.5 µmol/L) and UDP- (P2Y6 receptor ligand) (0.5 µmol/L) induced vasoconstriction by 
85% and 87%, respectively (Figure 1C, 1D). 
To determine whether ROCK-mediated myogenic constriction of PAs depends on 
cytosolic Ca2+, changes in intracellular Ca2+ concentration ([Ca2+]i) following stepwise 
increases in intraluminal pressure were measured. We found that H1152 (1 µmol/L) 
significantly suppressed [Ca2+]i elevations by 30%-45% over a range of pressures from 5-
30 mmHg (Figure 2A, 2B). [Ca2+]i oscillations observed at different pressures in control 
PAs were attenuated by H1152 (Figure 2A). To eliminate the possibility that these effects 
result from direct inhibition of H1152 on L-type VDCCs, whole-cell VDCC activity 
before and after applying H1152 was compared and no significant difference was found 
(Supplementary Figure 1). Further, the observation that myogenic [Ca2+]i elevation could 
be abolished by blocking VDCCs with nimodipine (100 nmol/L) (data not shown) 
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suggests that this response is mediated by Ca2+ entry through VDCCs presumably due to 
membrane depolarization of PA smooth muscle.  
Therefore, we next examined the influence of ROCK inhibition on membrane 
potential. Consistent with our hypothesis, H1152 (1 µmol/L) hyperpolarized PAs held at 
20 mmHg from -35 ± 1 mV to -43 ± 1 mV (Figure 2C, 2D), indicating that ROCK-
mediated myogenic activation occurs in part through membrane depolarization and Ca2+ 
influx in PAs. To confirm this novel ROCK-related mechanism, P2Y receptor agonist-
evoked changes in [Ca2+]i and membrane potential were studied. We found that H1152 (1 
µmol/L) markedly attenuated UTPγS- (0.5 µmol/L) and UDP- (0.5 µmol/L) triggered 
[Ca2+]i increases by 61% and 50%, respectively (Figure 3A, 3B). H1152 also reversed 
agonist-induced smooth muscle depolarization in endothelium-denuded arterioles (Figure 
3C, 3D). Thus, in contrast to the generally accepted view that ROCK influences smooth 
muscle contractility exclusively through Ca2+-sensitization17, these findings demonstrate 
that membrane depolarization and Ca2+ entry are also a crucial part of ROCK-associated 
modulation of vascular tone in the cerebral microcirculation. 
 
RhoA activation enhances myogenic tone and depolarization 
To further elucidate the mechanisms of Rho signaling in PAs, we next investigated the 
effects of RhoA activation on tone and membrane potential. Arterioles pretreated with the 
RhoA activator CN0316, 23(1 µg/mL) for 3 hours developed very high levels of myogenic 
tone (Figure 4A, 4B), which were diminished by H1152 (1 µmol/L) (data not shown). 
Control PAs (cultured for 3 hours in the absence of CN03) also developed substantial 
myogenic tone, but significantly less than RhoA-activated arterioles. In addition, CN03-
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treated vessels exhibited a more depolarized membrane potential than control (-31 ± 1 
mV versus -39 ± 0.5 mV), which was reversed by 1 µmol/L H1152 (-44 ± 1 mV) (Figure 
4C, 4D), indicative of an important role of RhoA/ROCK signaling in modulating 
membrane potential. In light of the well-established contribution of TRPM4 channels to 
myogenic depolarization, we hypothesized that RhoA-stimulated depolarization is 
mediated by TRPM4.  In accord with our prediction, the selective TRPM4 blocker 9-
phenanthrol (30 µmol/L) hyperpolarized CN03-treated arterioles to -44 ± 3 mV (Figure 
4C, 4D), strongly supporting the involvement of TRPM4 in Rho-mediated depolarizing 
mechanisms in PA myocytes.  
 
RhoA/ROCK-signaling activates TRPM4 channels 
In this series of experiments, we studied the direct coupling between RhoA/ROCK 
signaling and TRPM4 channels using the perforated patch voltage-clamp technique. 
UTPγS (0.5 µmol/L) elicited a 3-fold increase in TRPM4 channel activity, which was 
diminished by H1152 (1 µmol/L) (Figure 5A, 5B). Similar inhibition was also observed 
for UDP-activated (0.5 µmol/L) TRPM4 currents (Supplementary Figure 2), pointing to 
an excitatory role of ROCK on TRPM4. To ensure that these results are not due to 
nonspecific effects of H1152 on the TRPM4 channel itself, we utilized the excised inside-
out patch clamp configuration to study single TRPM4 channels expressed in human 
embryonic kidney (HEK) 293 cells. H1152 (1 µmol/L) had no effect on single TRPM4 
currents in these membrane patches (Supplementary Figure 3), indicating no direct 
channel inhibitory action of H1152.  
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Next, effects of RhoA on TRPM4 activity were examined using the conventional 
whole-cell patch configuration, whereby RhoA activation was achieved by directly 
including CN03 (0.1 ng/mL) in the pipette solution. Whole-cell TRPM4 currents were 
potentiated by 4 fold in the presence of CN03 (Figure 5C, 5D). As CN03 had no direct 
influence on TRPM4 channel per se (Supplementary Figure 3), the RhoA activator-
stimulated channel activity is potentially mediated by ROCK activation. Indeed, it was 
partially (68%) inhibited by H1152 (1 µmol/L) and nearly abolished (95%) by blocking 
TRPM4 channels with 9-phenanthrol (30 µmol/L) (Figure 5C, 5D). These data strongly 
support the proposal that RhoA/ROCK signaling couples the mechano-stimulation of 
P2Y receptors to TRPM4 channel opening, which leads to myogenic vasoconstriction in 
cerebral PAs.  
 
ROCK increases the Ca2+-sensitivity of TRPM4 channels 
Our laboratory previously established that protein kinase C (PKC) activates TRPM4 by 
increasing channel sensitivity to intracellular Ca2+ in pial arterial myocytes24. In the 
present study, we hypothesized that ROCK plays a similar role in the PAs, which appear 
to be highly dependent on RhoA/ROCK signaling for myogenic regulation13.   In accord 
with past studies24, 25, TRPM4 activity was influenced by [Ca2+]i (Figure 6). We found 
that in 1 µmol/L [Ca2+]i, TRPM4 current activity levels were very low in both control 
(similar to our previous report24) and in H1152- (1 µmol/L) treated myocytes with peak 
current density at 2.1 ± 0.3 pA/pF and 1.8 ± 0.3 pA/pF, respectively (Figure 6A, 6B). In 
10 µmol/L [Ca2+]i, there was no apparent increase in TRPM4 activity in the presence of 
H1152 (2.1 ± 0.3 pA/pF), whereas there was near maximal current activation in the 
 176 
absence of H1152 (4.3 ± 0.9 pA/pF). In 100 µmol/L [Ca2+]i, currents were maximally 
activated in the presence and absence of H1152 with peak amplitude at 4.6 ± 1.3 pA/pF 
and 4.9 ± 0.9 pA/pF, respectively (Figure 6B). These findings suggest that ROCK 
inhibition increased the apparent threshold of [Ca2+]i for TRPM4 activation, supporting 
the hypothesis that ROCK enhances the Ca2+ sensitivity of TRPM4 channels  in PA 
smooth muscle cells.  
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Discussion 
Here, we investigated the contributions of the RhoA/ROCK signaling pathway to 
myogenic tone development in cerebral intraparenchymal arterioles. The major findings 
of the present study are 1) the RhoA/ROCK signaling is involved in pressure-induced and 
P2Y receptor-mediated smooth muscle depolarization, cytosolic [Ca2+] increase and 
vasoconstriction of cerebral PAs; 2) RhoA/ROCK signaling couples P2Y receptor 
activation to TRPM4 channel opening in PA myocytes; 3) ROCK enhances the apparent 
Ca2+-sensitivity of TRPM4 channels in PA smooth muscle cells. Collectively, these 
results demonstrate that in addition to the traditional Ca2+-sensitization pathway, the Rho 
signaling also facilitates mechano-activation of TRPM4 channels, leading to Ca2+-entry 
through VDCCs and associated myogenic responses in PAs (Figure 7).  
 
Mechanisms of RhoA/ROCK signaling in myogenic vasoconstriction 
A correlation between ROCK function and myogenic reactivity has been previously 
reported in the cerebral circulation9, 22, with a generally accepted mechanism being a 
ROCK-mediated inhibition of myosin light chain phosphatase. This results in greater 
myosin light chain phosphorylation and activation, and enhanced smooth muscle 
contractility, which is not dependent on increased Ca2+ delivery to the contractile 
apparatus17. However, several recent studies point to a regulatory role of Rho signaling 
on the activity of ion channels, including ENaC18, Kv
19 and inward rectifying K+ (Kir) 
channels26. ROCK has also been reported to mediate UTP-induced smooth muscle 
depolarization by inhibiting Kv channels
19, further supporting an important yet 
underappreciated role of ROCK in regulating the excitation-contraction coupling in 
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vascular smooth muscle.  In the present study, we observed that the selective ROCK 
inhibitor H1152 significantly suppressed pressure-induced responses in membrane 
potential, cytosolic [Ca2+] and tone. Furthermore, the RhoA activator CN03 potentiated 
myogenic tone and membrane depolarization, both of which were sensitive to ROCK 
inhibition, providing the first evidence that the RhoA/ROCK signaling pathway 
participates critically in pressure-induced depolarizing mechanisms in cerebral PAs.  
Our laboratory has recently established the coupling between mechano-sensitive 
P2Y4/P2Y6 receptors and TRPM4 channels, and its contribution in mediating myogenic 
depolarization and vasoconstriction in PAs4, 14.  Consistent with ROCK-associated 
mechanisms in myogenic control, here we also observed that P2Y4 and P2Y6 receptor 
ligand-evoked constrictions, [Ca2+]i elevations and depolarization were attenuated by 
H1152. Furthermore, our prior study demonstrated that TRPM4 channels are stimulated 
by P2Y receptor agonists14. In the current work, UTPγS and UDP-activated TRPM4 
currents were reduced by H1152. We also found that the RhoA activator CN03 elicited a 
substantial increase in TRPM4 activity in PA myocytes in a ROCK-dependent manner. 
These findings demonstrate that RhoA/ROCK signaling facilitates pyrimidine receptor-
mediated activation of TRPM4 channels in PA smooth muscle. 
Several mechano-sensitive Gq/11 protein-coupled receptors have been reported by 
us and others4, 27. P2Y4 and P2Y6 receptors appear to mediate stretch-evoked 
vasoconstriction in a ligand-independent manner, because myogenic behavior of PAs is 
not affected by altering ectonucleotidase activity, which regulates the local levels of 
purines and pyrimidines4. This is similar to the involvement of Angiotensin II (Ang II) 
receptors in cerebral pial arterial myogenic tone, which is sensitive to the Ang II receptor 
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inhibitor losartan but not influenced by Ang II converting enzyme (ACE) inhibition27. 
Ang II receptor-mediated myogenic responses rely on Gq/11 protein-coupled, 
phospholipase C  (PLC)-dependent signaling pathways27, 28. This is supported by the 
observations that the PLC inhibitor U73122 diminishes membrane stretch-induced 
responses in an Ang-II receptor/ion channel expression system27, and relaxes pressurized 
rat pial arteries29. In addition, molecular suppression of the γ1 isoform of PLC 
significantly attenuates myogenic depolarization and vasoconstriction, and also inhibits 
hypotonicity-stimulated TRPM4 currents. Interestingly, in our preliminary experiments, 
PLC did not appear to participate in myogenic regulation of PAs since U73122 had little 
effect on arteriolar diameter at a concentration that causes near maximal dilations in pial 
vessels (data not shown). Instead, current data illustrate the novel involvement of the 
Rho-associated mechanisms in P2Y receptor-mediated mechanical responses. 
Interestingly, in addition to Gq/11-protein, P2Y receptors are also coupled to G12/13 and 
initiate Rho signaling cascades in vascular myocytes30. Moreover, several apparent Gq/11 
protein-coupled mechanosensors identified in expression systems27, such as ETA 
endothelin and V1A vasopressin receptors, also couple to G12/13 to stimulate 
RhoA/ROCK-dependent smooth muscle contraction31. Together with the key 
observations in the present study, these data strongly suggest that stretch-induced 
contraction of vascular myocytes is dynamically regulated not only by Gq/11-related 
signaling pathways but also by G12/13-meditated and Rho-dependent cellular mechanisms.   
 
Contribution of RhoA to myogenic constriction of cerebral PAs 
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To further investigate the mechanistic involvement of RhoA in myogenic regulation, we 
utilized the commercially available RhoA activator CN03. This cell permeable 
recombinant protein functions by converting glutamine-63 to glutamate, thus disrupting 
both intrinsic- and GAP-stimulated GTPase activity, leaving RhoA constitutively active23. 
The effectiveness of CN03 has been confirmed in several studies, where RhoA activity in 
native smooth muscle cells is significantly increased following a 2 to 4 hour-incubation 
with CN03 at concentrations ranging from 1 to 5 µg/mL32, 33. Functionally, we detected a 
significant augmentation of pressure-induced tone in arterioles cultured with 1 µg/mL (or 
8.5 nmol/L) CN03 for 3 hours, which was 25% to 30% higher than control, indicating the 
magnitude of responsiveness to pressure is directly associated with RhoA activity levels. 
This is consistent with a previous study on mouse cerebral arteries where CN03 (5 µg/mL, 
4 hours) induced a substantial elevation of myogenic tone16. In the present study, control 
PAs (cultured for 3 hours in the absence of CN03) also developed significant amount of 
tone. This may be due to upregulation of unknown cellular factors during the culture 
process that potentiate myogenic reactivity of PAs. In addition to contractility, activation 
of RhoA also depolarized the smooth muscle membrane through an H1152-sensitive 
pathway, further supporting the notion that myogenic depolarization and vasoconstriction 
in PAs are regulated by upstream RhoA/ROCK signaling cascade.   
A major finding of the present study is that Rho activates TRPM4 channels as 
illustrated with conventional whole-cell patch recordings. Channel activity detected with 
this configuration has been well characterized. These currents exhibit the hallmarks of 
TRPM4 channel properties: [Ca2+]i dependence, outward rectification and time-sensitive 
decay24, 34. Additionally, these currents are diminished by suppressing TRPM4 expression 
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with antisense24.  We also found that the selective TRPM4 blocker 9-phenanthrol nearly 
abolished the channel activity, indicating they are TRPM4 currents. In the present series 
of experiments, CN03 (0.1 ng/mL or 0.85 pmol/L) was included in the pipette to obtain 
direct access to the inside of the cells and induce acute RhoA activation upon membrane 
rupture. TRPM4 currents were markedly activated by CN03. Because CN03 has no direct 
effects on TRPM4 itself (Supplementary Figure 3), this is indicative of an excitatory 
influence of Rho on the depolarizing mechanisms, leading to myogenic activation of PA 
myocytes.  
 
Regulation of TRPM4 channels by ROCK 
In the present study, ROCK regulated the responses of TRPM4 channels to Ca2+. Under 
control conditions, the EC50 of [Ca
2+]i for TRPM4 activation appeared to lie between 1 to 
10 µmol/L. Nevertheless, when myocytes were treated with H1152, the threshold for 
TRPM4 stimulation was elevated beyond 10 µmol/L [Ca2+]i, suggesting that ROCK 
regulates the Ca2+ sensitivity of the channel itself.  The exact mechanisms underlying 
ROCK-associated TRPM4 activation are still unknown. However, several early studies 
showed that ROCK regulates Kv
35 and ENaC18 channel trafficking and expression on the 
plasma membrane to modulate membrane excitability. Although it is not clear whether 
TRPM4 is subjected to this mechanism, the observations that TRPM4 currents can be 
acutely potentiated and attenuated by CN03 and H1152, respectively, point to immediate 
modulatory effects from ROCK, presumably through direct phosphorylation of the Ca2+-
sensing sites on TRPM4.  Importantly, PKC plays a similar role in pial artery myocytes, 
where the PKC activator PMA increases Ca2+ sensitivity of TRPM4 channels24. However, 
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our preliminary experiments showed that PKC inhibition had little effect on PA vascular 
tone (data not shown), which is compatible with minimal contribution of PLC to 
myogenic regulation in cerebral PAs. Several prior studies concerning the roles of PKC 
and ROCK in the cerebral circulation reported similar observations that myogenic control 
in cerebral pial arteries is mediated by PKC and ROCK together24, 36, 37, while only 
ROCK participates in pressure-evoked response in the penetrating arterioles9. 
Interestingly, both PKC and ROCK are serine/threonine kinases with similar consensus 
substrate phosphorylation sites38, further supporting the results that TRPM4 channels can 
be regulated by both enzymes.  Although explanations for the apparent shift of functional 
kinases from large to small cerebral arteries requires further investigation, the unique 
contributions of ROCK in the cerebral microcirculation may provide important insights 
in preventing and treating microvascular diseases. 
 
Conclusion 
Collectively, our data reveal a novel role of RhoA/ROCK-signaling in cerebral 
vasoconstriction, which is determined primarily via activation of TRPM4 channels, 
smooth muscle depolarization and Ca2+ influx through VDCCs. As emerging evidence 
points towards important physiological and pathological contributions of ROCK in the 
cerebral circulation9, 16, a more complete understanding of the cellular mechanisms 
whereby RhoA/ROCK signaling is controlled may lead to development of innovative 
therapeutic strategies for microvascular pathologies in the brain. 
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Figures 
 
 
 
Figure 1. ROCK inhibition suppresses pressure-induced and P2Y receptor-
mediated vasoconstriction in endothelium-denuded PAs. (A-B), A representative 
diameter recording and summary data showing a selective ROCK inhibitor H1152 
reduces myogenic constriction of PAs held at 40 mmHg (IC50=0.24 µmol/L). Lack of 
dilation by NS309 (1 µmol/L) indicates successful endothelium removal. (n=6). (C), A 
representative diameter recording showing H1152 (1 μmol/L) reduces P2Y4 receptor 
ligand (UTPγS: 0.5 μmol/L)-induced vasoconstriction in denuded PAs. (D), Summary 
data showing H1152 reduces P2Y4 (UTPγS: 0.5 mol/L) and P2Y6 (UDP: 0.5 mol/L) 
receptor ligand-initiated constriction of PAs. (n=6). **P<0.01, ***P<0.001 versus 
responses without H1152. 
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Figure 2. ROCK inhibition attenuates myogenic [Ca2+]i elevation and depolarization 
in endothelium-denuded PAs. (A-B), representative diameter recordings and summary 
data showing H1152 (1 µmol/L) inhibits [Ca2+]i elevation and oscillations induced by 
step-wise pressure increase. (n=5 for control, n=4 for H1152) (C-D), H1152 (1 µmol/L) 
attenuates pressure-induced depolarization in arterioles held at 20 mmHg. This pressure 
is selected based on the greatest difference in [Ca2+]i observed in fura-2 Ca
2+ 
measurement tests.  (n=5) *P<0.05, **P<0.01 versus control. 
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Figure 3. ROCK inhibition suppresses P2Y4 and P2Y6 receptor-mediated [Ca2+]i 
increase and depolarization in endothelium-denuded PAs. (A), A representative 
recording of [Ca2+]i measurement showing H1152 (1 μmol/L) inhibits UTPγS-(0.5 
μmol/L) induced [Ca2+]i increase in denuded PAs. (B), Summary data showing H1152 
inhibits UTPγS (0.5 µmol/L) and UDP (0.5 μmol/L)-initiated [Ca2+]i elevation in PAs. 
(n=5). *P<0.05 versus responses without H1152. (C), Representative membrane potential 
recordings showing H1152 (1 μmol/L) attenuates UTPγS-(0.5 μmol/L) induced 
membrane depolarization in denuded PAs held at 3 mmHg. (D), Summary data showing 
H1152 attenuates PA smooth muscle depolarization initiated by UTPγS (n=5) and UDP 
(0.5 μmol/L) (n=4).**P<0.01 versus Control and Agonist. 
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Figure 4. RhoA activation enhances myogenic constriction and depolarization in 
endothelium-denuded PAs. (A-B), Representative recordings and summary data 
showing PAs pretreated with the RhoA activator CN03 (1 µg/mL) develop enhanced 
myogenic tone compared to vehicle-treated arterioles. (n=4) *P<0.05 versus control. (C-
D), CN03-(1 µg/mL) treated arterioles exhibit depolarized membrane potential (n=5) 
compared to control (n=5), which is attenuated by H1152 (1 µmol/L) (n=4) and the 
TRPM4 channel blocker 9-phenanthrol (30 µmol/L) (n=4). Intraluminal pressure=3 
mmHg., **P<0.01 versus CN03, ***P<0.001 versus control and CN03.  
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Figure 5. TRPM4 channel activity is reduced by ROCK inhibition and enhanced by 
RhoA activation in PA myocytes. (A-B), A representative nyastatin-perforated patch 
recording and summary data showing H1152 (1 µmol/L) inhibits UTPγS-activated (0.5 
µmol/L) TRPM4 currents (n=7). ***P<0.001 versus control and UTPγS. (C-D), 
Representative conventional whole-cell recordings and summary data showing CN03 (0.1 
ng/mL) potentiates TRPM4 currents (n=7) versus control (n=8), which is reversed by 
H1152 (1 µmol/L) (n=8) and 9-phenanthrol (30 µmol/L) (n=7). The representative 
currents are selected from cells with membrane conductance of 7-8 pF. [Ca2+]i = 1 
µmol/L. ****P<0.0001 versus control and CN03.  
 
  
 194 
 
 
Figure 6. ROCK inhibition decreases the Ca2+-sensitivity of TRPM4 channels in PA 
myocytes. (A), Representative current-voltage relationships from individual cells 
showing TRPM4 channel activity is Ca2+-activated under control conditions (left) and 
that H1152 (1 µmol/L) inhibits TRPM4 activation by Ca2+ (right). The representative 
currents are selected from cells with membrane conductance of 7-8 pF. (B), Summary 
data of peak outward currents showing H1152 increases the [Ca2+]i-threshold for TRPM4 
activation. H1152 significantly inhibits TRPM4 currents at 10 µmol/L [Ca2+]i. (n=5-9 
cells from 2-3 rats per group). *P<0.05 versus control. 
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Figure 7. Proposed mechanism of pressure-induced, P2Y-dependent activation of 
TRPM4 through the Rho signaling pathway in cerebral arterioles. Mechano-sensitive 
P2Y receptors are stimulated by increase in intravascular pressure, which initiates the 
activation of RhoA and ROCK. ROCK subsequently activates TRPM4 channels, and 
causes membrane depolarization, Ca2+ entry through VDCCs, and activation of MLCK, 
which phosphorylates MLC and results in smooth muscle contraction. Additionally, 
ROCK increases the Ca2+-sensitivity of the contractile machinery via inhibiting MLCP. 
ROCK, Rho-dependent protein kinase; VDCC, voltage-dependent calcium channels; 
CaM, calmodulin; MLC, myosin light chain; MLCK, myosin light chain kinase; MLCP, 
myosin light chain phosphatase; Vm, membrane potential. 
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Supplemental Figure 1. ROCK inhibition has no effect on VDCC currents in PA 
myocytes. (A), representative VDCC currents at +10 mV recorded from PA smooth 
muscle cells before (left) and after (right) application of H1152 (1 µmol/L). (B), 
Summary of VDCC current density before and after application of H1152. n = 4.  
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Supplemental Figure 2. ROCK inhibition reduces P2Y6 receptor-mediated TRPM4 
channel activation. (A-C), Representative perforated whole-cell patch clamp recordings 
and summary data showing UDP (0.5 µmol/L) elevates TRPM4 currents (A), and H1152 
(1 µmol/L) suppresses UDP (0.5 µmol/L)-activated TRPM4 currents (B). (n=7) 
Membrane potential is held at -70 mV.  *P<0.05 versus UDP, and **P<0.01 versus 
Control.  
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Supplemental Figure 3. TRPM4 channel activity is not directly affected by the 
ROCK inhibitor H1152 or the RhoA activator CN03. (A), Representative single 
channel recordings from inside-out patches showing TRPM4 activity in human 
embryonic kidney (HEK) cells overexpressing TRPM4 channels. Membrane potential is 
held at -60 mV. The amplitude of the single channel currents is -1.5 pA. (B), Summary 
data of TRPM4 single channel recordings showing that neither H1152 (1 µmol/L) (n=10) 
nor CN03 (0.1 ng/mL) (n=11) affected TRPM4 activity compared to control (n=20). The 
selective TRPM4 blocker 9-phenanthrol (30 µmol/L) significantly inhibited H1152- 
(n=10) and CN03- (n=9) insensitive currents. *P<0.05 versus H1152 and CN03. 
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CHAPTER 4: UNPUBLISHED DATA 
 
4.1 Involvement of PLC and PKC in Myogenic Constriction of Cerebral PAs 
 
Rationale 
Results presented in Chapter two have illustrated that the coupling between 
mechano-sensitive P2Y4/P2Y6 receptors and TRPM4 channels contribute critically to 
pressure-evoked vasoconstriction of PAs. Since P2Y4 and P2Y6 receptors are Gq-
coupled, the initial hypothesis was that TRPM4 activation by P2Y receptors depends on 
the PLC-DAG-PKC signaling pathway, which is further supported by a previous study 
showing that TRPM4 activity is regulated by PKC1. It is likely that pressure-induced 
membrane depolarization and myogenic tone in cerebral PAs follow the similar PLC-
DAG-PKC-TRPM4 signaling pattern since PKC has been shown to exert substantial 
influence on myogenic responses through sensitizing Cav
2 and inhibiting Kv
3 in other 
vascular beds. In addition, PLC participates in myogenic tone development in rat cerebral 
arteries4. Together, these results suggest the potential significance of the PLC-DAG-PKC 
signaling cascade in pressure-induced and P2Y receptor-mediated activation of TRPM4 
in PA myocytes. 
 
Results 
We unexpectedly observed that the PLC inhibitor U73122 showed minimal 
inhibitory influence on myogenic reactivity of PAs at a concentration of 3 µmol/L 
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(Figure 1).  Comparatively, 3 µmol/L U73122 substantially reduced pressure-evoked tone 
to about 10% of its original level in cerebral pial arteries4, suggesting that PLC activity 
can be nearly abolished by the inhibitor at this concentration. Although PA myogenic 
tone was completely inhibited by a higher concentration (10 µmol/L), it has been 
demonstrated that U73122 at this level elicits significant blocking effects on VDCCs, 
resulting in smooth muscle relaxation5. We also verified this effect on intact vessels by 
demonstrating that 60 mmol/L K+-aCSF solution failed to constrict PAs in the presence 
of 10 µmol/L U73122 (data not shown).  These results argue against the initial hypothesis 
that PLC plays an important role in mediating mechano-activated responses in the 
cerebral microvasculature. 
Next, involvement of PKC in PA myogenic regulation was tested with the 
specific PKC inhibitor chelerythrine. Similar to PLC inhibition, we found that 
chelerythrine (3 µmol/L) only attenuated myogenic tone of PAs by approximately 25% 
(Figure 2A, 2B), whereas the same level of PKC inhibition achieved almost 90% 
suppression on myogenic response in upstream pial vessels1. A previous study from our 
laboratory has also shown that 3 µmol/L chelerythrine completely blocked DAG 
analogue (DOG)-activated as well as cell swelling-stimulated cation currents in pial 
arterial myocytes, indicating that 3 µmol/L is adequate to effectively inhibit PKC activity 
in vascular smooth muscle6. In support of this notion, we also observed that P2Y4 and 
P2Y6 receptor agonist-induced constrictions of denuded PAs could be markedly 
attenuated by chelerythrine (3 µmol/L) (Figure 2C, 2D). It is not clear why PKC 
inhibition elicits a much smaller attenuating effect on pressure-induced constrictions 
compared to agonist-initiated responses, especially since we have established that 
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P2Y4/P2Y6 receptors are critical mechanosensors in PA myocytes7. It is likely that 
stimuli-triggered contractile responses are differentially regulated by diverse cellular 
signaling mechanisms. In other words, activation of PKC can be substantially evoked by 
P2Y receptor ligands, but not so much by wall tension. This may result from different 
conformational changes on the G protein-coupled receptors (P2Y receptors in this case) 
stimulated by different stimuli, leading to activation of distinct G protein-associated 
signaling pathways. However, resolving this issue requires extensive biochemical studies 
on the analysis of crystal structures of GPCRs, which is beyond the scope of this 
dissertation.  
 
 
Figure 1. Effects of the PLC inhibition on pressure-induced vasoconstriction in 
endothelium-denuded PAs. (A-B), representative diameter recordings showing the PLC 
20
40
60
80
100
D
ia
m
e
te
r 
(m
m
)
U73122 (µM)
0.03
0.1
0.3
1
3
10
10 mins
Ca2+-free
aCSF
20
40
60
80
100
D
ia
m
e
te
r 
(m
m
)
NS309
U73122 (µM)
0.3
1
3
5
10
30
10 mins
A
B
 202 
inhibitor U73122 has little effect on myogenic vasoconstriction at lower concentrations 
(≤ 3 µmol/L). Pressure-induced tone is substantially inhibited by U73122 at 10 µmol/L or 
higher through non-specific inhibitory effects on VDCCs. 
  
 
Figure 2. PKC inhibition suppresses P2Y receptor agonist-induced vasoconstriction, 
but has little effect on myogenic tone in endothelium-denuded PAs. (A-B), A 
representative diameter recording and summary data showing a PKC inhibitor 
chelerythrine only partially reduces myogenic constriction of PAs at lower concentrations 
(≤ 3 µmol/L). A higher concentration (10 µmol/L) of Chelerythrine has non-specific 
blocking effects on VDCCs and nearly abolishes myogenic tone. (n=3) (C), A 
representative diameter recording showing Chelerythrine (3 µmol/L) reduces P2Y4 
receptor ligand (UTPγS: 0.5 μmol/L)-induced constriction in denuded PAs. (D), 
Summary data showing chelerythrine (3 µmol/L) reduces P2Y4 (UTPγS: 0.5 µmol/L) 
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and P2Y6 (UDP: 1 µmol/L) receptor ligand-initiated constriction of denuded PAs. (n=4). 
*P<0.05, **P<0.01 versus responses without chelerythrine. 
 
4.2 The Constitutive Activity of ROCK in PA Smooth Muscle Cells 
Rationale 
Basal activity of TRPM4 channels in PA myocytes were previously reported by 
us and others using perforated whole-cell patch technique8, 9. Interestingly, constitutive 
activity of TRPM4 channels appear to be more prominent in the myocytes isolated from 
PAs than those from pial arteries.  As results from Chapter three of this dissertation have 
demonstrated that ROCK plays a key role in regulating TRPM4 in PAs, we hypothesize 
that ROCK is basally active to sustain TRPM4 activity, leading to depolarization and 
constriction in the absence of mechanical stimuli.  
 
Results 
In agreement with our prediction, the selective ROCK inhibitor significantly 
reduced constitutive TRPM4 currents in PA myocytes (Figure 3), indicating that basal 
ROCK activity contributes critically to sustaining channel activity in unstimulated 
smooth muscle cells. Because H1152 has no direct blocking effect on TRPM4 channels 
per se (see Supplementary Figure 3 in Chapter three), the reduced whole-cell currents 
should result from inhibited ROCK activity. These results are in concert with other 
observations by us that denuded PAs are quite depolarized and constricted at very low 
intraluminal pressures (3~5 mmHg) as illustrated in Chapters two and three.  
Additionally, H1152 significantly reduced intracellular [Ca2+] in PAs held at 5 mmHg 
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(see Figure 3A in Chapter III). These observations point to ROCK being constitutively 
active in PA smooth muscle. This could be an essential vascular control element in vivo 
for tight regulation of local blood flow.  In that scenario, constitutive ROCK induces 
arteriolar constriction, even at low intravascular pressures, and positions the arterioles to 
be highly responsive to dilator or to additional constrictor stimuli. In accord with this 
proposal, several studies have shown that cerebral arterioles exhibit enhanced myogenic 
depolarization and tone compared to the larger diameter pial arteries10, 11, and that ROCK 
plays a critical part in regulating cerebral vascular tone in vivo12. 
 
 
 
Figure 3. ROCK inhibition reduces basal TRPM4 channel activity in PA smooth 
muscle cells. (A-B), A representative recording and summary data showing H1152 (1 
µmol/L) reduces basal TRPM4 channel activity. (n=5) *P<0.05 versus Control. 
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS 
 
Novelty and Significance 
Results presented in Chapter two and Chapter three illustrate several novel 
aspects of myogenic control mechanisms in the cerebral microcirculation. These 
observations provide the first direct evidence that TRPM4 channels are coupled to 
mechano-sensitive G protein coupled receptors (GPCRs) to mediate pressure-evoked 
responses. This is demonstrated by the findings that P2Y receptor-mediated 
depolarization and constriction are highly dependent on the levels of TRPM4 channel 
expression and activity, and that P2Y receptor ligands markedly activate TRPM4 currents 
in PA smooth muscle cells. The important link between TRPM4 and GPCRs is 
corroborated by Gonzales et al.1, who recently reported that in cerebral pial arteries, 
TRPM4 channels are associated with upstream Ang II receptor activity, since the Ang II 
receptor antagonist losartan attenuates TRPM4 currents in pial arterial myocytes1.  To our 
surprise, the Ang II receptor does not seem to participate in tone regulation in the 
microvasculature since neither Ang II nor Ang II receptor inhibitor modulates arteriolar 
diameter. Several possibilities could account for the apparent lack of involvement of Ang 
II receptors. This may be attributed to reduced or absent receptor expression. It could also 
result from the effects of dilatory mechanisms (e.g. TRPV42, 3) stimulated by Ang II 
receptor activation, which counterbalance the contractile influence of Ang II on the PAs. 
Either way, the functional mechanosensors seem to have shifted from Ang II receptor to 
P2Y receptors in the cerebral microcirculation, supporting the notion that PAs are 
 207 
uniquely regulated by cellular signaling mechanisms that are distinct from other vascular 
beds. Notably, although different mechanosensors are present, both Ang II and P2Y 
receptor-initiated responses converge on activation of TRPM4 channels, indicating that 
TRPM4-mediated depolarization represents the basis for myogenic excitation-contraction 
coupling mechanisms. Presently, this mechanism has only been reported in the cerebral 
circulation. However, activation of depolarizing TRPM4 channels may be a common 
feature of most vascular beds as this channel has been detected in pulmonary, aortic and 
renal arteries4. 
The most recent work in this thesis project, described in Chapter three, reveals a 
novel contribution of ROCK to pressure-induced vasoconstriction. ROCK is widely 
accepted as a mediator of “Ca2+-sensitization” via inhibiting myosin light chain 
phosphatase, thus promoting myosin light chain activation and smooth muscle 
contraction that is not dependent on increased Ca2+ delivery to the contractile machinery5. 
Interestingly, contrasting results from Chapter three of this dissertation provide the first 
evidence that RhoA/ROCK signaling also regulates cytosolic [Ca2+] through TRPM4-
dependent smooth muscle depolarization. Therefore, at least in cerebral PAs, by both 
elevating average [Ca2+] and increasing Ca2+-sensitivity of the contractile apparatus, 
ROCK stimulates dual effects to modulate myosin-actin interaction and smooth muscle 
contractility. This may partially account for the significantly enhanced myogenic 
depolarization, [Ca2+]i elevations, and constrictions observed in PAs compared to pial 
vessels over the same range of intravascular pressures6, 7. Though regulation of ion 
channel activity and membrane potential by ROCK has been previously reported8-10, 
Chapter three provides the first definitive evidence that in cerebral PAs, RhoA/ROCK 
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activity plays an important yet underappreciated role in the Ca2+-dependent 
electromechanical coupling mechanisms.  
Several Gq/11 protein-coupled receptors have been recently identified as 
mechanosensors in expression systems. One in particular, the Ang II receptor was found 
to mediate stretch-induced responses through phospholipase C (PLC)-associated 
pathways in both HEK cells and pial arterial smooth muscle cells1, 11. However, these 
signaling pathways do not appear to regulate myogenic response in PAs based on the 
evidence that neither PLC nor PKC has any sizable effect on PA myogenic tone at 
concentrations that cause near maximal relaxation in the upstream pial vessels. Instead, 
Chapter three of this dissertation unveils the key involvement of G12/13 protein and 
downstream RhoA/ROCK signaling in the myogenic control mechanisms. This thesis 
work has advanced the concept that mechano-sensitivity is an important feature of Gq/11-
coupled receptors. Specifically, several stretch-sensitive Gq/11-coupled receptors, such as 
P2Y purinergic and endothelin-1 receptors, can also stimulate G12/13 protein and elicit 
Rho-associated signaling cascades12, 13. As myogenic tone represents one of the most 
fundamental vascular functions, it is therefore not surprising to find that its transduction 
mechanisms are dynamically regulated by both Gq/11 protein-associated pathways and 
G12/13 protein-mediated, Rho-facilitated signaling. Notably, that PA myogenic response is 
largely dependent on Rho reactivity further emphasizes that PAs rely on unique signaling 
pathways to facilitate pressure-induced responses. 
As numerous cardiovascular diseases influence the reactivity of cerebral PAs, 
which in turn lead to further deterioration of brain function14-18, characterization of 
distinct cellular signaling factors and pathways in the cerebral microcirculation may 
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provide useful therapeutic targets specific for treating microvascular diseases in the brain 
without triggering side effects on the surface brain arteries or peripheral circulation.   
 
Future Directions 
Following from these interesting findings, one major aim of future work will be to 
determine the underlying molecular mechanisms responsible for Rho-elicited activation 
of TRPM4 channels. There are several possibilities. First of all, the observations that 
TRPM4 currents can be acutely attenuated and potentiated by ROCK inhibition and 
RhoA activation, respectively, strongly point to direct modulatory effects of 
RhoA/ROCK on TRPM4 channels. A previous study from Nilius and coworkers has 
shown that PKC enhances the Ca2+-sensitivity of TRPM4 channels by phosphorylating 
two serine residues in the C-terminus19. Since both PKC and ROCK are serine/threonine 
kinases with similar consensus substrate phosphorylation sites20, it is therefore postulated 
that ROCK also directly phosphorylates TRPM4 to decrease the threshold of [Ca2+]i for 
channel activation.  
Moreover, potentiation of TRPM4 activity by PKC also involves increased 
channel translocation to the plasma membrane21, indicating that PKC triggers two major 
effects on the channel protein; not only does it acutely augment channel activity by 
modulating its sensitivity to Ca2+, but it also elevates channel density as a mechanism to 
increase membrane excitability. As PAs are highly dependent on ROCK to govern 
TRPM4-mediated myogenic responses, it is plausible that ROCK also contributes to 
sustaining a high level of TRPM4 expression in arteriolar smooth muscle, which may 
account for the physiologically enhanced myogenic control in the microcirculation. In 
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agreement with this possibility, RhoA/ROCK signaling has been reported to regulate ion 
channel expression in vascular smooth muscle. For example, RhoA significantly 
increases the percentage of ENaC in the plasma membrane versus the cytosol in 
expression systems8. In addition, RhoA/ROCK was found to activate Kv1.2 channel 
endocytosis pathways and block recycling of endocytosed channel back to the plasma 
membrane, leading to a significantly diminished level of functional channels10.  
Thirdly, participation of actin-regulatory systems in vascular smooth muscle 
contraction has long been established22-26. Recent evidence suggests that actin dynamics 
are implicated in RhoA/ROCK-associated responses in vascular smooth muscle. In 
expression systems, RhoA/ROCK was shown to affect Kv1.2 channel trafficking through 
an actin-dependent mechanism that encompasses the LIM-kinase/cofilin pathway10. This 
concept was further verified in rat cerebral pial arterial myocytes, where ROCK 
facilitates UTP-induced actin polymerization27. Pharmacological disruption of actin 
cytoskeleton substantially prevents UTP-initiated, ROCK-dependent Kv current 
inhibition27. Moreover, this study provides important evidence that the force-generating 
actin dynamics also contribute to membrane excitability regulation, since disrupting actin 
structure significantly inhibits UTP-evoked smooth muscle depolarization in cerebral 
arteries27. Intriguingly, early studies have demonstrated that actin polymerization is 
stimulated by increased intravascular pressure, and subsequently brings about smooth 
muscle contraction25. Based on these converging evidence, it is possible that, in addition 
to direct force generation, ROCK-mediated actin remodeling may also determine TRPM4 
channel activity, hence mediating pressure-induced responses in cerebral PAs. Although 
the mechanisms underlying TRPM4 stimulation in the vasculature have been the subject 
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of substantial research effort, it is clear that additional, extensive and detailed molecular, 
biochemical and biophysical assessments will be required to advance this field. 
As previously mentioned, identifying the unique features of physiological control 
mechanisms in the cerebral PAs is indispensable for developing novel medical strategies 
regarding prevention and treatment of microvascular diseases in the brain. Even though 
the pathological implications of P2Y receptors and TRPM4 have not been reported in 
cerebral microcirculation, impaired PA myogenic regulation observed in several stroke-
related diseases implies that these essential signaling factors may be pathologically 
altered. Therefore, another major aim of future research will be to investigate these 
signaling pathways in vascular disease models, and to discover possible new targets that 
may allow for “bench to bedside” transition, which eventually leads to new drugs and 
practical treatment options.  
One possible intervention is restoring myogenic tone of PAs after subarachnoid 
hemorrhage. Subarachnoid hemorrhage (SAH), commonly resulting from aneurysm 
rupture, is defined as the extravasation of blood into the subarachnoid space28. Rapid 
discharge of blood immediately after aneurysm rupture may result in an acute elevation 
of intracranial pressure, leading to cessation of blood flow, global cerebral ischemia and 
death28. Further, a significant portion of patients who survive the initial hemorrhage are 
still severely impacted by delayed and sustained constriction of cerebral arteries and 
penetrating arterioles (cerebral vasospasm), which is the major contributor to death and 
disability following SAH28. An experimental rat SAH model is widely used in research of 
this type.  Following repeated injections of tail blood into the cisterna magna on two 
consecutive days, rats exhibit many of the features of SAH found in humans, including 
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vasospasm, behavioral deficits, and impaired neurovascular coupling6, 28, 29. Using the 
above SAH model, Nystoriak et al. observed that isolated PAs from SAH rats exhibited 
markedly enhanced pressure-induced vasoconstriction compared to control rats6. 
Interestingly, this increase in myogenic responsiveness is tightly correlated with 
augmented smooth muscle depolarization and arteriolar wall Ca2+. Tone/[Ca2+] 
relationships are very much similar between PAs from control and SAH animals, 
indicating that the Ca2+ sensitivity of the contractile apparatus is unaffected by SAH6. 
Rather, increased myogenic reactivity can be attributed to SAH-induced membrane 
depolarization, which may result from activation of depolarizing ion channels (TRPM4, 
TRPC6) or suppression of hyperpolarizing K+ conductance.  
Wellman and colleagues have demonstrated that inhibition of Kv currents 
contributes to SAH-triggered membrane depolarization and constriction of cerebral pial 
arteries through a mechanism involving oxyhemoglobin-evoked activation of tyrosine 
kinase EGF receptor and Kv channel internalization
30-32. However, effects of SAH on 
cerebral PAs may also depend on RhoA/ROCK-TRPM4-mediated depolarizing 
mechanisms. In support of this hypothesis, mRNA levels of RhoA and ROCK are 
elevated in basilar arteries that exhibit vasospasm after SAH33.  As the Ca2+-sensitization 
mechanisms appears to be unaffected by SAH in PA myocytes6, the enhanced 
RhoA/ROCK expression may logically elicit two parallel effects: activating TRPM4 
channels and inhibiting Kv channels, both of which lead to potentiated myogenic 
depolarization and vasoconstriction of cerebral PAs.  Furthermore, results from clinical 
and experimental investigations show that endothelin-1, a potent vasoconstrictor, is a 
major cause of cerebral vasospasm after SAH34. Elevated levels of ET-1 have been 
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verified in the cerebrospinal fluid and plasma of patients after SAH and cerebral 
infarction34, 35. In addition, antagonizing ETA receptors can reverse ET-1-elicited 
vasoconstriction34, suggesting that activation of smooth muscle ETA receptors is 
indispensable for sustained vasospasm.  
Among the ET-1-triggered cellular mechanisms involving Ca2+-dependent and 
Ca2+-independent contractions, RhoA/ROCK pathway is stimulated by ET-1 as observed 
in rabbit basilar arteries36. It is thus plausible that ET-1-triggered ROCK signaling 
subsequently activates TRPM4 channels. More supporting evidence comes from the 
observation that ETA receptor expression level is remarkably increased following a 
canine two-hemorrhage SAH model37.  Since the ETA receptor has been identified as a 
mechanosensor in expression systems, what might be happening in the cerebral 
microcirculation is that, following SAH, expression of ETA receptor is elevated in the PA 
myocyte plasma membrane, which confers increased pressure-induced responses, as well 
as dramatically enhanced ET-1-evoked vasoconstriction due to increased circulating 
levels of ET-1. Both mechanisms converge on activation of RhoA/ROCK signaling, 
which could lead to TRPM4-mediated depolarization and pronounced vasoconstriction. 
Further, prolonged stimulation of ETA receptors further increases ROCK expression, 
leading to sustained vasospasm.  
As illustrated above, RhoA/ROCK signaling, TRPM4 channels and VDCCs 
appear to be the common denominators in the proposed mechanisms. Thus, inhibiting this 
signaling pathway may be very effective in treating or preventing cerebral vasospasm. 
The specific VDCC blocker nimodipine is clinically approved for this pathology. In 
clinical trials, nimodipine markedly reduced the incidence of delayed neurological 
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deficits and cerebral infarcts38. However, it did not significantly influence the incidence 
of moderate to severe angiographic vasospasm39. Also, prophylactic use of nimodipine 
revealed minimal improvements on neurological outcome38. Further, use of fasudil after 
SAH, a selective ROCK inhibitor, is also a matter of controversy. It was reported in one 
randomized clinical trial that this drug exhibited significant reductions in angiographic 
vasospasm, symptomatic vasospasm and radiographic infarcts with improved clinical 
outcome40. Nevertheless, another clinical trial showed that fasudil failed to improve the 
incidence of symptomatic vasospasm and radiographic infarcts41, indicating that clinical 
application of fasudil requires further validation. Judging by the current situation, more 
effective measures are needed.  
The side effects of oral administration of nimodipine range from dizziness, 
lightheadedness, flushing, swelling ankles/feet to fainting and arrhythmia, most of which 
result from unwanted systemic effects of nimodipine on peripheral vessels and the heart. 
The ROCK inhibitor fasudil also relaxes vascular beds in addition to the ones undergoing 
vasospasm. One way to resolve the issues mentioned above would be to limit the affected 
region to the brain by directly administrating drugs to the cerebral spinal fluid (CSF) via 
the cisterna magna. Since CSF enters the parenchyma along paravascular spaces that 
surround penetrating arterioles42, drugs applied this way gain direct access to the cerebral 
PA smooth muscle cells. This method was initially used to create an SAH model by 
injecting blood into CSF. Our laboratory has advanced the use of this method of drug 
delivery and demonstrated that in vivo injection of TRPM4 antisense 
oligodeoxynucleotides effectively reduced TRPM4 channel expression in both pial and 
parenchymal arteries, and functionally suppressed PA myogenic tone43. One advantage of 
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this method is that the medicine is locally delivered to the brain, thus concentrations can 
be adjusted to a much lower level, which further reduces possible side effects. Because 
the administered drugs are in CSF, they can now elicit effects without passing through 
blood-brain barrier, making drug development less complicated. Further, in addition to 
using pharmacological compounds, such as VDCC blockers and ROCK inhibitors, this 
method also opens the door to using molecular constructs, such as antisense or siRNA, 
which could effectively decrease the expression levels of RhoA, ROCK, TRPM4 or 
VDCC in the cerebral vasculature and prevent vasospasm.  
However, this method is not without disadvantages. The biggest problem of this 
approach is that it is extremely invasive. Currently, it may only be applied to lab animals 
to determine the effects of different compounds on sustained vasospasm. Furthermore, as 
CSF cycles through the ventricles in the brain and spinal cord, drugs in the CSF may also 
affect the central nervous system and lead to severe adverse effects. Nevertheless, it is 
possible that with careful and extensive characterization and validation, this method will 
eventually become a useful therapeutic strategy for treating cerebral vascular and 
microvascular pathologies.  
 
Conclusions 
In this dissertation, data are presented in support of the central role of TRPM4 
channels in facilitating mechano-sensitive P2Y receptor-initiated, RhoA/ROCK 
signaling-dependent myogenic depolarization, [Ca2+]i elevation and vasoconstriction in 
cerebral PAs. The unique involvement of ROCK in the Ca2+-dependent 
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mechanocheminal coupling mechanisms in PA myocytes may represent a novel target for 
prevention and treatment of cerebral microvascular diseases.  
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Introduction 
Myogenic tone is a fundamental aspect of vascular behavior in resistance arteries. 
Despite its importance, little is known about the mechanisms involved in control of 
myogenic regulation in the cerebral microcirculation. A recent study comprising 
heterologous expression of G protein coupled receptors and TRPC6 channels as well as 
examination of stretch-induced mechanisms in brain pial and systemic arteries, lead to 
the important proposal that Angiotensin II receptors function as mechanosensors to 
mediate myogenic reactivity in vascular smooth muscle cells1. Interestingly, although 
parenchymal arterioles display substantial pressure-induced tone, the Ang II receptor 
inhibitor candesartan showed no effect on vascular diameter of the PAs. This was in 
agreement with an absence of vasoconstrictor responses to Ang II itself in these vessels. 
In light of the lack of contribution of Ang II receptors in vascular reactivity in PAs, other 
GPCRs in myogenic tone regulation were investigated. The primary focus was on P2Y 
receptors, as previous evidence in mesenteric resistance arteries indicated that pyrimidine 
receptors may contribute to pressure-evoked responses of systemic arteries2, 3. Therefore, 
in the present study, expression and functional involvement of P2Y receptors in PA 
myogenic behavior were explored. My contribution to this journal article involved RT-
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PCR experiments for P2Y receptor message. Methods and results of this component in 
the study are as follows.  
 
Methods 
RNA was prepared from isolated arterioles with endothelium present. First-strand 
cDNA was prepared from 720 ng total RNA using the Sensiscript Reverse Transcriptase 
kit (Qiagen). PCR reactions were hot started at 94 °C for 10 minutes and exposed to 38 
cycles of 94 °C for 60 seconds, 60 °C for 90 seconds, and 72 °C for 60 seconds, and 
followed by 72 °C final extension for 10 minutes. All reaction products were resolved on 
1.8% agarose gels. GAPDH transcript was used as a positive control. Primer sequences 
are shown in Table 1.  
Table 1: PCR Primer Sequences 
Receptor Forward Primer Reverse Primer 
P2Y2 5'-TTCCACGTCACCCGCACCCTCTTATTACT-3' 5'-CGATTCCCCAACTCACACATACAAATGATTG-3' 
P2Y4 5’-GTAACTGCCCACCCTCGTCTACTA-3’ 5’-GTCCGCCCACCTGCTGAT-3’ 
P2Y6 5’-CGCAACCGCACTGTCTG-3’ 5’-TCTCTGCCTCTGCCACTTG-3’ 
 
Results 
I first determined that message for predominant vascular P2Y receptors (P2Y2, 
P2Y4 and P2Y6) is present in parenchymal arteriolar extract. In agreement with previous 
studies examining localization of P2Y receptors in coronary and cerebral pial arteries, 
message for each of these receptors is present in PAs (Figure 1). P2Y2 and P2Y6 
appeared to be more abundantly expressed than P2Y4 receptors in parenchymal 
arterioles. However, because RT-PCR tests were performed on intact arterioles, whether 
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the mRNA message came from smooth muscle cells or endothelium remains an open 
question. Further myography experiments from this study illustrated that P2Y2 receptors 
are not involved in regulation of vascular tone, suggesting either P2Y2 receptors are not 
present in PA smooth muscle, or they are not coupled to contractile cellular signaling 
pathways. By contrast, both P2Y4 and P2Y6 receptor agonists elicited concentration-
dependent vasoconstriction in endothelium-denuded PAs, indicating that these two 
receptors are present and functionally active in PA smooth muscle cells (data not shown). 
 
Figure 1. Message for P2Y2, P2Y4, and P2Y6 receptors is present in PA 
homogenates as measured using RT-PCR. NT = No Template control. 
 
To test the possible link between P2Y receptor activity and myogenic tone in PAs, 
We next investigated the effects of P2Y4 and P2Y6 antisense ODNs on pressure-induced 
vasoconstriction in PAs. I found that expression of P2Y4 and P2Y6 receptors was 
substantially reduced by corresponding antisense ODNs, as indicated by semi-
quantitative PCR (Figure 2). These ODNs were quite selective for their targets as 
antisense designed against P2Y4 receptors had no effect on P2Y6 receptor expression 
(Figure 2A) and similarly, P2Y6 antisense significantly reduced P2Y6 receptor 
 P2Y2  P2Y4 P2Y6  GAPDH      NT  
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expression without affecting P2Y4 message levels (Figure 2B). Further functional studies 
illustrated that myogenic tone in PAs treated with antisense ODNs targeting the two 
receptors was reduced by ~50%, respectively, compared with control (sense-treated) 
arterioles (data not shown), indicating that P2Y4 and P2Y6 receptors play critical roles in 
mediating myogenic responses in cerebral PAs.   
 
Figure 2. Effects of antisense oligodeoxynucleotides on P2Y receptor message levels. 
(A-B), Semi-quantitative PCR indicates a specific and substantial decrease in P2Y4- or 
P2Y6- message levels in arteries exposed to antisense versus sense ODNs. Sense or 
antisense ODN-treated PAs from three animals were pooled in each case to assess 
relative message abundance.  
 
Significance 
The RT-PCR results in Figure 1 indicated the existence of the vasoactive P2Y 
receptors in cerebral PAs. It set the ground for further investigation of their functional 
significance in pressure-induced responsiveness. Semi-quantitative PCR data in Figure 2 
supported this study by validating the effectiveness and specificity of designed antisense 
     P2Y4 ODNs!
Sense      Antisense!
P2Y4!
P2Y6!
GAPDH!
     P2Y6 ODNs!
Sense      Antisense!
P2Y4!
P2Y6!
GAPDH!
A B
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ODNs targeted to the corresponding receptors. As the subsequent functional studies 
showed significant reduction of myogenic constriction by either P2Y4 or P2Y6 receptor 
antisense, these RT-PCR tests serve as proper control experiments to preclude the 
possibility of cross-suppressing effects of ODNs on these two proteins, and provide more 
confidence in drawing the conclusion that both P2Y4 and P2Y6 receptors are essential 
contributors to myogenic tone development in cerebral PAs.   
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